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(v)  Zusammenfassung 
Zusammenfassung 
RNA-Interferenz (RNAi) ist ein natürlicher sequenzspezifischer Mechanismus der post-
transkriptionellen Genregulation, der von kurzen, doppelsträngigen RNA-Fragmenten (small interfering 
RNAs (siRNA)) ausgeführt wird. Trotz ihres hohen therapeutischen Potenzials bleibt die sichere und 
effiziente systemische Abgabe von siRNAs an eine große Anzahl von erkrankten Zellen, um einen 
therapeutischen Gen-Knockdown auszulösen, eine Herausforderung. Darüber hinaus werden neue 
quantitative Methoden zur schnellen und präzisen Beurteilung der Aktivität von siRNA-basierten 
Therapeutika benötigt.  
In dieser Arbeit wurden zunächst Folat-gerichtete monomolekulare Nucleinsäure / Lipid-Partikel 
(FolA-mNALPs) entwickelt, die mit Hilfe mikrofluidischer Methoden hergestellt wurden. Nachfolgend 
wurde die Funktionalität dieser Partikel hinsichtlich der zukünftigen Verwendung als siRNA-Lieferanten 
getestet. Zweitens wurde die Einzelzellkinetik des Gen-Silencing durch siRNA mit mikrostrukturierten 
Zellkultivierungssubstraten in Kombination mit Zeitraffer-Fluoreszenzmikroskopie (Life-Cell-Imaging auf 
Single-Cell-Arrays, LISCA) quantifiziert. 
 Insbesondere konnten wir zeigen, dass mikrofluidische Selbstorganisation kombiniert mit 
rationalem Design der Lipidformulierung zu Nanopartikeln kleiner Größe und enger Größenverteilung führt, 
die im Durchschnitt einzelne siRNA-Moleküle enthalten, welche mit einer einzelnen Lipiddoppelschicht 
bedeckt sind (mNALP). Die Stabilität von Folat-funktionalisierten mNALPs in biologischen Flüssigkeiten 
und ihre biologische Leistungsfähigkeit hinsichtlich der zellulären Internalisierung und Gen-Silencing wurde 
untersucht. Kleine Größen, effizientes Targeting und vorgestellte Gen-Silencingfähigkeiten im Anschluss an 
die erleichterte Freisetzung aus Endosomen machen mNALP zu einem vielversprechenden System für die 
zukünftige Entwicklung eines in vivo siRNA-Wirkstoffs.  
Darüber hinaus untersuchten wir mit LISCA die Größenordnung des durch siRNA induzierten 
mRNA-Abbaus. Durch mathematische Modellierung der Genexpression und Anpassung der 
Expressionszeitverläufe konnten die Populationsverteilungen der biochemischen Raten, einschließlich der 
mRNA-Abbauratenkonstanten für einzelne Zellen bestimmt werden. Die Expressionszeitverläufe wurden 
durch Überwachung der dynamischen Veränderungen der Einzelzellfluoreszenzintensitäten von 
Reporterproteinen (eGFP-Ziel und CayRFP-Referenz) bestimmt. Die daraus resultierended kinetischen 
Parameter erlaubten sowohl die Quantifizierung der Effizienz des Gen-Silencing als relative Änderung der 
mRNA-Abbaurate, als auch die Identifikation der Subpopulationen von Zellen, welche von der siRNA-
Aktivität betroffen sind. Zusätzlich konnten durch Analyse von Korrelationen zwischen kinetischen 
Parametern von CayRFP- und eGFP-Expression die Eigenschaften der mRNA-Abgabe und 
Expressionskinetik bestimmt werden. Der vorgestellte Ansatz ermöglicht die genaue Quantifizierung der 
Aktivität von siRNA-basierten Therapeutika auf eine akkurate und schnelle (<30h) Weise. 
  
(vi)  Abstract 
Abstract 
RNA interference (RNAi) is a natural sequence-specific mechanism of post-transcriptional 
gene regulation mediated by short, double stranded RNA fragments e.g. small interfering RNAs 
(siRNA). Despite its high therapeutic potential, the safe and efficient systemic delivery of siRNAs 
into a large number of diseased cells to trigger therapeutic gene knockdown remains challenging. 
Moreover, novel quantitative methods for assessing activity of siRNA-based therapeutic agents in 
a fast and precise manner are needed. 
In this work, we first present the development of the folate-targeted monomolecular nucleic 
acid/lipid particles (FolA-mNALPs) formed using microfluidic-based method and studied their 
functionality regarding prospective use as a siRNA delivery agent. Secondly, we quantify the 
single-cell kinetics of siRNA-mediated gene silencing using micro-patterned cell cultivation 
substrates combined with time-lapse fluorescence microscopy (life-cell imaging on single-cell 
arrays, LISCA). 
In particular, we demonstrate that microfluidic self-assembly combined with rational design 
of lipid formulation results in nanoparticles of small size and narrow size distribution that on 
average contain a single siRNA molecule covered with a single lipid bilayer (mNALP). We 
investigate the stability of folate-functionalized mNALPs in biological fluids, and their biological 
performance in terms of cellular internalisation and silencing efficiency. Small sizes, efficient 
targeting and silencing capability following facilitated endosomal release make mNALP a 
promising system for the future development of an in vivo siRNA delivery agent.  
Furthermore, using LISCA we investigate the magnitude of siRNA-induced mRNA 
degradation. By mathematical modelling of gene expression and fitting of expression time-courses 
we obtain the population distributions of biochemical rate constants, including single-cell mRNA 
degradation rate constants. The expression time-courses are gained by monitoring the dynamic 
changes in single-cell fluorescence intensities of reporter proteins (eGFP target and CayRFP 
reference). Obtained kinetic parameters allow us to quantify the silencing efficiency as a relative 
change in mRNA degradation rate constants, to identify the subpopulations of cells affected by 
siRNA activity and, by analysis of correlations between kinetic parameters of CayRFP and eGFP 
expression, to infer on the properties of mRNA delivery and expression kinetics. The presented 
approach allows for the precise quantification of the activity of siRNA-based therapeutics in an 
accurate and fast (<30h) manner.
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1. Introduction 
1.1. Discovery of RNA interference and its consequences  
For years, the biological functions of RNA were thought to be limited to information 
transfer and decoding or structural functions in forms of messenger (mRNA), transfer 
(tRNA) and ribosomal RNA (rRNA) respectively. Although, the discoveries of last 40 
years have extended our understanding of RNA functionality giving evidence of e.g. 
enzymatic activity of RNA.1 What could be even more important, the revealed regulatory 
behaviour of non-coding RNA forms have revolutionized our understanding of biological 
plasticity of functional gene regulation and its impact on variety of natural processes of 
embryo development, cell differentiation and many others.2 
The most prominent evidence of the significance of RNA-mediated post-
transcriptional regulation of genes is the process of RNA interference (RNAi). RNAi relies 
on selective enzymatic degradation of targeted mRNA or blocking of protein translation 
that is led by short complementary RNA fragments. The mechanism is highly specific 
towards targeted mRNA sequences and is widely spread among many eukaryotic 
organisms including roundworms (C.elegans),3 flies (D. melanogaster),4 plants (P. 
hybrida),5,6 yeasts (S.pombe),7 mammals8 including humans9 and many others. The core 
cascade of RNAi pathway consists of two enzymatic processes performed sequentially by 
Dicer endoribonuclease and RNA-induced silencing complex (RISC).10 Dicer processes 
precursor forms of non-coding RNAs - double stranded (dsRNA), short hairpin (shRNA) 
or pre-micro RNA (pre-miRNA). Namely, they are cleaved into active, 20-25 bp, helical 
forms - double strands of small interfering RNA (siRNA) or short hairpins of microRNA 
(miRNA). miRNA or the guiding strand of siRNA are further incorporated into the RISC 
complex and serve as a targeting templates to recognize mRNA molecules of 
complementary sequence. siRNA-guided recognition leads to enzymatic degradation of 
mRNA by Argonaute 2 (AGO2) endonuclease that constitutes the active subunit of RISC. 
In contrast, miRNA repress the translation of encoded proteins by ribosome blocking 
activity of RISC complex. Importantly, it has been shown that introduction of the short 
double-stranded siRNA into the cells results in successful gene silencing circumventing 
Dicer activity.11 Aside those two general mechanisms multiple other RNAi-related 
pathways were discovered revealing wide-spread relevance of the process.2 
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Fig.1.1. Two major pathways of RNA interference in mammalian cells 
In the siRNA pathway starts by cleavage of double stranded RNA into short 21-25 bp siRNA 
fragments by Dicer enzyme. siRNA is further incorporated into AGO2 and RISC complex is formed. 
The perfect complementarity of siRNA guide strand to its mRNA target leads to enzymatic cleavage 
of mRNA by catalytic domain of AGO2. The cascade can be also triggered by introduction of siRNA 
in intermediate steps. The endogenous miRNA pathway starts with primary micro RNA (pri-miRNA) 
transcribed by polymerase II (Pol II) in the cell nucleus. Upon processing of pri-miRNA by Drosha 
enzyme complex into precursor miRNA (Pre-miRNA) and nuclear export into the cytoplasm 
mediated by Exportin 5, the Pre-miRNA template enters the main Dicer-RISC pathway. The 
imperfect base pairing within miRNA releases the passenger strand leaving the mature miRNA 
bounded to active RISC. The recognition of targeted mRNA leads to effective inhibition of 
translation. RISC binding may also lead to degradation of mRNA in processing (P)-bodies. 
Reprinted with permission from De Fougerolles et al.10 Copyright (2007) Springer Nature. 
Steadily unfolding research has shown that RNAi plays important roles in cell 
differentiation,12, 13 embryonic development,14, 15 cancer metabolism16–18 and processes of 
viral infection and host response to it19,20 etc.. In particular, it is proposed that RNAi 
pathways have opened the area for co-evolutionary interaction of host organisms and viral 
parasites. Host organism can use RNAi as a defence mechanism that provides control over 
components of innate immunity pathways by modulating gene expression using genome-
encoded miRNAs21, 22 or as a direct defence against the viral gene expression.23 On the 
other hand, viruses can modulate host responses by blocking the resistance 
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mechanisms.23,24 Furthermore, the genetically-encoded forms of miRNA have been proven 
to play crucial role in meiotic maturation of mice oocytes,25, 26 during zygotic development 
of zebrafish embryos,15 hematopoetic lineage12 and dendritic cell differentiation.13 The 
characteristic distorted miRNA profiles have been observed in different types of tumours 
and constitute a sensitive cancer biomarkers.18 Moreover, the exosome-derived miRNA 
that are secreted from tumour cells have been shown to interact with stromal cells in the 
tumour micro-environment modulating cancer progression, metastasis, angiogenesis and 
escape from immune recognition.17 siRNA- and shRNA-driven RNA interference have 
been also successfully utilized for genome-scale loss-of-function screens (high-throughput 
RNAi screens) in cultured cells and model organisms.27,28 The method facilitates broad 
modality in analysis of gene functions due to high specificity of optimized siRNA 
sequences towards their mRNA targets.29 
1.2. siRNA in systemic gene therapy – latest advances in gene delivery 
systems 
The high modality in terms of sequence-specific silencing, practical flexibility and 
sequence specificity of RNAi opened a new field for therapeutic endeavours.  By exploiting 
the siRNA-induced RNAi, silencing of nearly any gene can be achieved that reveals broad 
therapeutic potential of siRNA beyond the prospects for typical small-molecule drugs. 
Moreover, single siRNA-loaded RISC complex can be responsible for degradation of 
multiple mRNA molecules that is reflected in high efficiency in gene silencing.30 RISC 
recycling ensures efficient therapeutic effect for 3-7 days in rapidly dividing cells and for 
up to several weeks in non-dividing cells.31 Importantly, the use of intermediate, short 
siRNA is crucial from a point of pharmaceutical interest as it reduces the potential for innate 
immune interferon response that can occur due to the interactions of long (>30 bp) shRNA 
with intracellular RNA receptors.32 The therapeutic action of synthetic siRNA against e.g. 
liver cirrhosis,33 hepatitis B virus (HBV),34 ovarian cancer,35 bone cancer,36 
hypercholesterolaemia37 and many other diseases have been shown and many clinical trials 
have been initiated.38 Despite evidence that "naked", chemically-modified forms of siRNA 
have been effective in targeting particular brain39 and lung40 diseases, the systemic delivery 
of therapeutic siRNA to the most of tissues in human body still requires systems to facilitate 
efficient transfection of targeted cells. 
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Fig.1.2. Barriers on efficient systemic delivery of nucleic acid nanoparticles 
Following intravenous injection the nanoparticles can bound to serum protein or being opsonized 
by antibodies leading to elimination from bloodstream by components of complement system [1]. 
Particles can be eliminated in the liver by activity of Kupffer cells that limits their activity in the 
targeted side of the disease, including hepatocytes [2]. Loose structure of blood vessels in tumour 
surrounding allow the relatively large (~100 nm) nanoparticles to accumulate in the tumour tissue 
(the enhanced permeability and retention (EPR) effect) [3]. Additionally, access to the cell surface 
is limited by the dense structure of extracellular matix that is penetrable only by small and shielded 
nanoparticles [4]. Finally, when the particles reach the side of therapeutic action and are 
successfully internalized by diseased cells e.g. by endocytosis, they need to be capable to escape 
the endosomes efficiently before being degraded in late endosomes/lysosomes [5]. Reprinted with 
permission from Szoka et al.41 Copyright (2007) Springer Nature. 
Therapeutic nucleic acids (NAs) are not easily incorporated by cells and require 
involvement of active transport mechanisms to pass the cellular membranes due to its high 
molecular weight (~13 kDa in case of siRNA) and highly negative surface charge. 
Moreover, they are prone to degradation by nucleases present in the bloodstream and 
extracellular matrix. For this reason, multiple methods for selective and safe delivery of 
exogenous nucleic acids into a large numbers of cells in human body are under constant 
development. Both, viral and non-viral approaches have been verified for systemic delivery 
of NAs. Despite the high efficiency of viral vectors their limited packing capacity and 
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safety concerns have spurred the quest for alternative, non-viral systems.42 The research on 
self-assembled nucleic-acid-based nanoparticles has made significant progress by 
exploiting the synergies between material science and nanotechnology. Some of systemic 
delivery issues have been partially resolved by using complexes of NAs assembled with 
cationic agents (e.g. lipids or polymers). Multiple of those first- and second-generation 
systems exploit the relations between particle structure and function.43 For instance, tuned 
composition of particle-forming lipids can lead to structural changes in lipid membrane 
structure leading to triggered transitions into endosomolytic inverted hexagonal phase.44, 45 
Similarly, polyethyleneimine (PEI) delivery systems exploit the "proton sponge" effect of 
polymer swelling in low-pH endosome environment to facilitate efficient release.46 Further 
advances in non-viral lipid-based delivery of siRNA include the development of stable 
nucleic acid/lipid particles (SNALP) that present efficient therapeutic action against 
HBV,47 the synthesis of novel lipid-like molecules (lipoids) and the screening of produced 
chemical libraries for increased efficiency;48 use of ionizable lipids for improved escape 
from endosomes45 and tunable microfluidic-based synthesis of lipid nanoparticles 
(LNPs).49 
In general, three key criteria of the non-viral delivery systems need to be met. 
Namely, a) the nanoparticles need to encapsulate and shield the NAs efficiently against the 
degradation of nucleases and opsonisation in bloodstream, b) the nanoparticles need to be 
provided with selective targeting method coupled with effective mechanism for the entry 
into the cell c) the synthesis needs to be robust, easily scalable and yield small particles 
with narrow size distribution and controlled structure.  
In particular, the stability of nanoparticles is commonly increased by surface coating 
with polyethylene glycol (PEG). PEG chains provide a steric hindrance on interactions with 
blood proteins and the components of complement system.50–53 It also prevents nonspecific 
interaction with cell membranes and unwanted side effects in healthy cells. However, the 
PEG-shielding can also interfere with the release of particles from endosomes into the cell 
cytoplasm. For this reason, several detachment strategies (e.g. use of pH-cleavable 
chemical linkers like AzMMMan) can be introduced in order to remove the PEG-grafting 
layer from the nanoparticle surface on demand, i.e. due to the pH drop in the late 
endosomes.54, 55 
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Moreover, the targeting to a specific cell types or cells in distinct metabolic state 
can be achieved using various surface ligands that can trigger specific uptake of 
nanoparticles by receptor-mediated endocytosis.56–59 Targeting, used together with PEG-
shielding, minimizes the potential side effects in non-targeted cells. Here, the non-specific 
cell binding is reduced and the biological effect of delivered NAs is limited to the cells, 
tissues or organs targeted. The representative examples of successful targeted delivery 
systems for siRNA include Genospheres, SNALPs and folate- or GalNAc-targeted lipo- 
and polypexes.52, 56–61 
Finally, the colloidal properties of NPs determine their pharmacokinetics. Aspects, 
such as particle morphology, zeta potential and size distribution have significant influence 
on their biological functions in vivo.62, 63 Large (>100 nm) and charged particles are prone 
to protein absorption, fast clearance from the bloodstream and cannot penetrate the solid 
tumours and dense tissues.41 Contrary, the small (<50 nm) nanoparticles can diffuse 
through the structure of extracellular matrix and show increased efficiency of the drug 
delivery into solid tumours.64, 65 Recently, novel microfluidic synthesis methods have 
improved the control over the size and size polydispersity of formed nanoparticles.49, 66–70 
In the future, the method can provide an efficient control over the self-assembly allowing 
for rational bottom-up design of particle structure and functionality. 
1.3. Applications of microfluidics in bioscience and technology. 
Currently, the microfluidic technology have found numerous applications, 
improving analytical and preparative methods for chemical synthesis, biological analysis, 
cell biology and many other disciplines. Particularly, the small sample volumes, precise 
control of reaction micro-environment and facilitated automation of sequential processes 
show great benefits in development of high-throughput screening methods or lab-on-chip 
approaches to improve standard biochemical assays. 
The major premise of microfluidic technology lies in the employment of the unique 
characteristics of fluid flow in the microscopic scale.71, 72 Conditions of fluid flow in micro-
scale systems are determined by the relation between the magnitudes of viscous and inertial 
effects. The quantity describing the relative contributions of both phenomena on fluid 
behaviour is the dimensionless Reynolds number given by the relation:  
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 = 	
                                                                                                                        (eq.1.1) 
where: Lh is the characteristic length scale (e.g. the diameter of the micro-channel), uave is 
the average velocity of the flow, ρ is the fluid density and µ is its viscosity. Based on 
empirical studies, the Reynolds number values larger than 2000 describe turbulent flows 
where the inertial forces are dominant. On the other hand, the values below 1000 
correspond to laminar (streamline) flows. In this regime, dominated by viscous 
contributions, flow loses significantly its chaotic nature and occurs in parallel layers with 
no disruption between them. The laminar flow regime is dominant in micro-channels due 
to their small dimensions, where the speed of flows often would have to exceed the speed 
of sound in order to enter the turbulent regime.  
The increased determinism of the flow behaviour allows for a precise control in 
processing small sample volumes (e.g. in droplet microfluidics approaches73), for 
manipulation on micrometer length scales74–76 and to exploit micro-scale transport 
phenomena77, 78 etc. Among others, the successful execution of those principles allowed for 
high-throughput screens of protein crystallization conditions using micro-droplets,79,80 
size-dependent cell sorting,75 single-cell trapping81 or control over compound gradients in 
optimizing cell culture conditions.82 
Moreover, development of soft lithography in PDMS allowed for fast prototyping 
and fabricating devices83 that, when optimized, can be incorporated as a generic 
components into a elaborative integrated platforms.84 Due to automated sequential fluid 
handling methods85 and possibilities for incorporation of the detection units within the 
single multifunctional on-chip device86 the entire pipeline of analytical procedures can be 
executed within one chip and with minimal sample volume requirements. The most 
prominent examples of such systems are the microfluidic-based digital PCR systems,87,88 
single cell sequencing89, 90 and protein crystallization assays79, 91 accompanied by multiple 
others.92–94 
Microfluidics have also found applications in cell and tissue biology. The 
significant advantages compared with conventional methods arises here from the increased 
control of the cell micro-environment and opportunities to incorporate fluid flows or 
mechanical forces that all together brings the assays closer to in-vivo-like conditions.96 In 
particular, it was shown that mouse fibroblasts reveal increased viability when exposed to 
CdSe/ZnSe quantum dots under flow conditions in microfluidic device when compared to  
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Fig.1.3. Examples of microfluidic applications in bioscience and technology 
a) The single-cell digital PCR chip design (left) consists of micro-chambers (blue) separated using 
pneumatic valve system (red). Each chamber can entrap a single bacterium cell. The outcome of 
single-cell PCR analysis of bacteria extracted from hindgut content of a single Z. nevadensis 
(termite) individual (right). Red signal is related with 16S rRNA gene present in multiple bacteria 
species. Green signal indicates presence FTHFS gene specific to bacteria activating 
homoacetogenesis pathway. b)  The microfluidic chip design to generate concentration gradients 
(left). The gradient of hydrofluoric acid (HF, middle inlet channel) was generated in stepwise 
dilutions with water (side channels). The colors in close-up frames indicate the depth of FH-etched 
SiO2 micro-channels (right). The depth profile is also shown in the graph in bottom right c) The 
microfluidic device mimicking in vivo environment of breathing lung (top). The alveolar-capillary 
barrier was modelled by tissue grown on flexible, thin and porous PDMS membrane inside 
compartmentalized channels. The contraction forces were applied by changing the pressure within 
adjacent chambers causing mechanical stretching of the membrane. Similar changes in the lung 
membranes are present when the movement of the diaphragm causes changes in intrapleural 
pressure (bottom). Adapted with permission from: a) Ottesen et al.87 Copyright (2006) The 
American Association for the Advancement of Science., b) Jeon et al.77 Copyright (2000) American 
Chemical Society. and c) Huh et al.95 Copyright (2010) The American Association for the 
Advancement of Science. 
  
9  1. Introduction 
standard assays.97 Recent years have brought also numerous approaches to develop 
biomimetic systems resembling the organ-level functions like i.e. blood-brain barrier 
models,98 “lung-on-chip”,95 “gut-on-chip”99 or “liver-on-chip”100 systems. For instance, it 
was shown that exposition to mechanical strains in "lung-on-chip" system that are similar 
to those occurring while breathing altered responses of cultured tissues in terms of toxic 
and inflammatory responses to silica nanoparticles. Similarly, shear forces caused by flow 
in "gut-on-chip" system improved the ability to sustain intestinal microbe co-cultures. 
Those and similar approaches can also improve the reliability of in vitro assays in terms of 
novel drug development and toxic responses to therapeutic nanoparticles. Furthermore, the 
multiple techniques for cell trapping , single cell detection and single-cell lysate analysis 
spurred the efforts in cell-to-cell variability investigations94,101–103 that are discussed in 
further sections. 
1.4. Microfluidic synthesis of nanoparticles 
The microfluidic technology offers a well-controlled environment for synthesis of 
inorganic and organic nanoparticles. Gained control facilitates precise tuning of particle 
properties that includes size and size distribution. As mentioned before, those two 
parameters are of crucial importance in terms of in vivo performance of gene delivery 
systems. Microfluidic synthesis is also easily scalable without losses in nanoparticle quality 
that allows for production of significant amounts of the product for therapeutic use.104 
Generally, in case of inorganic nanoparticles the synthesis occurs by controlled 
nucleation and growth that might be triggered by several factors including changes in 
temperature or relative concentration of substrates.105 Obtaining narrow size distribution 
requires homogenous, rapid nucleation and subsequent growth to the desired size in an 
absence of further nucleation. Those processes can be tuned by control over time of reagent 
mixing, reaction temperature and reaction time.  In conventional macroscopic scale 
methods all of mentioned parameters can vary significantly within a sample leading to 
broadly distributed local mixing times, temperature and concentration gradients and 
uncontrolled reaction times. In contrast, microfluidic approaches offer precise control over 
mixing times by varying solvent flow rates or channel geometry. The temperature gradients 
are also reduced due to better heat transfer related with large surface area of the sample and 
small volume. The reaction time can be tuned by micro-channel length that directly 
corresponds to incubation times or by adding the quenching agents at precise downstream 
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channel locations during the process of particle formation.106 In particular, two-phase 
droplet mixers based on chaotic advection107 were used with success to synthesize e.g. 
quantum dots, gold and iron oxide nanoparticles.108–110 As a result, the control over the size 
and polydispersity of quantum dots, which relate directly to their spectral properties was 
achieved. Similarly, the system allowed for synthesis of gold nanoparticles of controlled 
size and shape or iron oxide nanoparticles with high magnetization. 
 
Fig.1.4. Continuous flow microfluidic micro-mixers 
a) The PLGA-PEG nanoparticles formed by solvent exchange method on hydrodynamic-focusing 
microfluidic device (top). The nanoprecipitation of particles happens by nucleation and 
aggregation within characteristic time scale (τagg, middle). When the mixing is performed in a 
micro-scale the diffusive mixing time of solvents is shorter than the time of forming particles 
causing homogenous environment of the particle synthesis (bottom). b) The diffusive mixing time 
can be shorten even more by complex folding of mixed fluids caused by herringbone micro-stirring 
structures within the channel. The perturbations in flow profile increase the contact area between 
the fluids and shorten the diffusive distance between the solvent layers.  Adapted with permission 
from: a) Karnik et al.66 Copyright (2008) American Chemical Society., b) Stroock et al.111 Copyright 
(2002) The American Association for the Advancement of Science.  
Amphiphilic organic molecules, like e.g. lipids or block copolymers can self-
assemble into nanoparticles when they experience change in the quality of surrounding 
solvent. A common way to execute the solvent exchange is to mix the solutions of particle-
forming molecules (e.g. in alcohol) with anti-solvent (e.g. water). Similarly like in case of 
inorganic particles, the kinetics of the solvent exchange relates with the homogeneity of 
nanoparticle nucleation and the time of mixing solvents directly influence the size and size 
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distribution of formed particles.112 In particular, if the mixing time exceeds the 
characteristic timescale for molecules to nucleate and particles to grow (between ~10 and 
100 ms depending on the size of amphiphilic molecules) the particle assembly happens 
under varying solvent quality.113 This prevents efficient stabilization of nanoparticles 
where effects related with mass transport can lead to large, polydisperse particles of varying 
structure and composition. The described scenario takes place when macroscopic mixing 
is introduced. In contrast, if the mixing time is shorter than the characteristic timescale of 
particle aggregation the hydrophilic parts of molecules (e.g. PEG chains) efficiently 
stabilize the nanoparticle leading to formation of uniform particles of small size.114 
Shortening of solvent mixing times can be accomplished using microfluidic mixing 
devices, which enable control of the mixing kinetics and by that facilitate tuning of size 
and polydispersity of formed nanoparticles. 
Several microfluidic micro-mixers facilitating rapid solvent exchange have been 
reported.115 Among the most widely used are hydrodynamic-focusing mixers66 and 
continuous flow mixers with stirrer micro-structures (e.g. herringbone micro-mixer111). In 
hydrodynamic focusing geometry the solvent stream is squeezed between two adjacent 
water streams and mixing occurs rapidly due to diffusion in the outlet channel. The micro-
stirrers positioned alongside the mixing channel geometry result in complex folding of 
mixed fluids and increasing the contact area for improved diffusive mixing. Multiple 
polymer and lipid nanoparticle systems have been reported all of which have presented 
tunable sizes, narrow size distribution, high batch-to-batch reproducibility and increased 
loading with drugs and therapeutic nucleic acid compared with conventional solvent 
exchange methods.69 Special distinction should be granted to lipid nanoparticles (LNPs) 
composed of novel ionisable lipid (DLinKC2-DMA) and siRNA that were prepared using 
herringbone micro-mixer116 since this drug delivery system have presented high 
performance during in vivo trials for siRNA-based gene therapy.117 
1.5. Relevance of single-cell observations in biosciences 
The cell is a basic structural and functional unit of living organisms. Most molecular 
processes occur on the cellular level, they act out their own specialized function, they are 
capable of reacting to external micro-environment and of being involved in complex 
signalling with other cells in their surroundings. The complex behaviour of cells within 
clonal populations, tissues and organs emerge as a consequence of single-cell interactions 
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and decision making. Importantly, it was shown that even genetically identical cells from 
the same population present tremendous differences in e.g. mRNA and protein levels or 
phenotype variations.118, 119 Understanding the behaviour of single cells is often crucial to 
resolve the details of processes that, as a consequence, emerge on the higher levels of 
biological organization. Although, most cellular processes including molecular network 
interactions, dynamic responses and cell morphology are examined by cell-population-
average techniques where the single cell information is lost.  
 
Fig.1.5. Estimation of intrinsic and extrinsic cellular noise contributions 
Two genes controlled by identical regulatory sequences (e.g. CFP and YFP presented in green and 
red respectively) can serve as system decoupling the intrinsic and extrinsic contributions to the 
noise in bacteria. a) In the absence of intrinsic contributions, the amount of both fluorescent 
proteins and thus the single-cell fluorescence intensity fluctuate in a correlated fashion. Although, 
the protein levels might vary significantly from cell to cell within the clonal population due to 
extrinsic contributions.  b) The expression of proteins in individual cells become uncorrelated as 
the stochastic effects of biochemical noise (intrinsic cellular noise) contribute to the variability. c) 
The plot presenting the population distributions of YFP vs. CFP normalized fluorescence derived 
from single-cells of clonal E.coli populations. Each point represents the mean fluorescence 
intensity of each cell. The spread of the scattered cluster perpendicular to the diagonal reflects the 
intrinsic noise contribution whereas spread parallel to the diagonal corresponds to extrinsic effects. 
Adapted with permission from Elowitz et al.120 Copyright (2002) The American Association for the 
Advancement of Science. 
The non-genetic cell-to-cell variability is referred frequently as cellular noise and is 
divided within framework of intrinsic and extrinsic contributions. The intrinsic noise 
indicates the variation within identically-regulated quantities occurring within the same 
cell. The intrinsic noise arises from the inherently probabilistic and discrete nature of 
biochemical reactions. In particular, the intrinsic contributions in cellular noise present in 
transcription and translation have been extensively investigated on the single-cell and 
molecular level.120, 121 Moreover, there is evidence that certain motifs of molecular 
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signalling pathways might evolve to regulate the uncertainty levels caused by intrinsic 
noise within the regulatory networks.122, 123 The examples of such stochastic regulatory 
systems have been reviewed.120–125 The influence of stochastic contributions on protein and 
mRNA levels have been investigated in the genome-wide studies on cell-to-cell variability 
in clonal populations of E.coli and Saccharomyces.118, 126 Although the molecular make-up 
of the genetically identical cells revealed vast cell-to-cell variations, the studies indicate 
that the origins of observed variability come from the upstream influences rather than from 
the intrinsic expression noise directly.127, 128 Those upstream influences refer to the 
interactions between investigated stochastic system and other regulatory elements 
originating from inside the cell or its environment. Discussed effects may affect multiple 
genes simultaneously contributing to the variations in identically-regulated quantities 
occurring between individual cells in clonal population and therefore constitute the 
extrinsic effects in cellular noise. However, the upstream variability might originate from 
the stochastic as well as deterministic influences. Moreover, even if the upstream source 
has probabilistic contributions, the system in total might not be stochastic. For instance, 
there is evidence that an increased number of regulatory mechanisms (also those of 
stochastic nature) contribute to increased robustness of the system to the intrinsic noise.129–
132
 Interestingly, this observation might explain the tendency of biological systems to 
evolve into the complexity observed in the eukaryotic domain of life. Although, there are 
empirical difficulties in clearly defining the magnitude of stochastic and deterministic 
influences on cell-to-cell variability, especially at the level of cell activity or phenotype, 
the determinism can be qualitatively stated by correlating the predetermining factors with 
the observed cell response. Along those lines, multiple studies have revealed causal links 
affecting cell-to-cell variability in case of apoptosis,133–135 induced pluripotency,136 
differentiation of stem cells,137,138 cancer cell heterogeneity,139–141 viral infection,142, 143 
endocytosis143 as well as nuclear factor-κB (NF-κB) signalling,144 yeast pheromone 
response145, 146 etc. The variations in phenotypes and activity of single-cells have been 
found to originate (at least in part) from e.g. differences in cell size, growth rate, metabolic 
state of the cell, cell ancestry, nutrient availability, cell micro-environment (e.g. substrate 
rigidity or spatial confinement) and population context of individual cells including cell-
cell contacts, local cell density, amount of free space per cell or relative location within 
group of growing cells.  All those factors, that are often present in in vitro studies, might 
result in complex and heterogenic multicellular behaviour presented normally in natural 
environments of cell colony or multicellular organism. Examples could be found in the 
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mechanisms of quorum sensing in bacterial colonies147–149 or, in case of eukaryotes, in 
subpopulations of cancer cells presenting different proclivity for viral infection and 
endocytic activity within clonal cell colonies.143 Importantly, discussed effects might not 
be efficiently deduced using methods based on population averaged measurements. In 
particular, sparse or otherwise poorly-identified subpopulations might be lost during 
analysis. For instance, the rare subpopulations of slow-growing "persister cells", that are 
less susceptible for Ampicilin treatment and enable the colony survival under stress 
conditions, have been identified in clonal populations of E.coli.150 
 
Fig.1.6. Examples of possible deterministic influence sources on cell-to-cell variability 
The triggered or increased cell activity in given investigated aspect (red cells) can be triggered by 
several trackable factors such as: (a) differences in cell size, (b) local cell density, (c) the position 
within cell colony related to e.g. number of cell-cell contacts, (d) common ancestry of given cell 
subpopulation or (e) differences in other metabolic factors that can be tracked by e.g. repeated cell 
stimulation. Adapted with permission from Snijder et al.151 Copyright (2011) Springer Nature. 
The non-genetic variability within cell populations might have a significant impact 
on the outcome of pharmacological treatment of complex diseases. For instance, the drug 
treatment of cancer cells resulted in highly variable phenotypic responses, giving hints how 
non-genetic variability may contribute to drug resistance in tumours.152 Moreover, the 
protein expression profiles and proliferation rates within solid tumours seem to be specific 
to the factors such cell density and location within the tumour mass.141 The drug-resistant 
states may also occur transiently as an effect of reversible epigenetic changes.153 The cell-
to-cell fluctuations in proteome make-up, either stochastic or deterministic in nature, are 
likely to significantly affect drug responsiveness in cells and may need to be accounted in 
designing the future treatment strategies.134, 154 Although, the measurement techniques used 
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in the diagnostics are facing genuine practical challenges in resolving the population 
heterogeneities,155 stressing the need for novel analytical approaches. 
1.6. Time-lapse microscopy as a tool to investigate single-cell behaviour. 
 
Fig.1.7. Generic pipeline of quantitative time-lapse fluorescence microscopy experiment 
a) The sample handling is mostly done prior the imaging. It includes the cell treatment with 
chemicals, transfection, fluorescent labelling with low-molecular-weight dyes or fluorescent 
antibodies etc. and, in case of high-throughput methods, is often done using pipetting robots on 
micro-array. b) The image acquisition is performed using automated microscopes. The imaging 
might be done using various techniques e.g. epifluorescence, total internal reflection fluorescence 
(TIRF), confocal microscopy etc. c) The imaging data usually can exceed several gigabytes and 
require efficient software and hardware solutions, d) To acquire a single-cell information at the 
population-wide scale the automated image analysis needs to be perform. It includes efficient and 
careful background correction methods, image clustering, cell shape analysis etc. and depends 
strongly on performed assay. Currently, this step occurs to be a bottleneck in development of real 
time methods as it is time consuming and demands high computation power computers. e) Finally, 
the single-cell data can be integrated to gain the knowledge on investigated processes using data 
mining techniques. It allows to formulate models of the investigated system, gain the knowledge on 
the system dynamics and cell-to-cell variations in biological responses. The image acquisition and 
processing might need multiple iterations to optimize the analysis. Similarly, gained information 
might reflect the need of additional experiments (dashed lines). Adapted with permission from 
Pepperkok et al.157 Copyright (2006) Springer Nature. 
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The microscopy-based assays to investigate the single cell behaviour are capable of 
providing morphological and spatial information on cells under investigation extending the 
analysis on their population context and phenotypic variations.143, 152, 156 The live-cell time-
lapse assays also allows for revisiting the same individual cells over time providing the 
temporal resolution that outreaches the capabilities of most other methods like e.g. flow 
cytometry, plate-reader-based assays or fixed-cell microscopy assays. Time-lapse 
fluorescence microscopy is capable of assessing the molecular activity in situ, in the context 
of natural environment of living cells due to the extended palette of fluorescent protein 
reporters that when carefully incorporated within the molecular pathways, can provide 
quantitative information on investigated processes and their dynamics.157–159 The extended 
temporal resolution and capability to track individual cells opens the possibilities to 
investigate the dynamic responses of molecular networks within the single cells on the 
population-wide scale.158, 160, 161 Importantly, the kinetic single-cell response might lose its 
characteristic time profile as the averaging over population might obscure the kinetics of 
the process (i.e. the stepwise processes might occur as smooth continuous changes).160, 161 
In the context of RNAi, live-cell time-lapse imaging was shown to be instrumental in 
performing large-scale RNAi screens162 and to study the activation and kinetics of miRNA-
mediated RNAi.163 
Although, the microscopy-based methods provide high-content information on 
single-cell behaviour, a proper execution of those assays demands highly reproducible cell 
handling and labelling techniques to maintain the quality of high-throughput analysis.157,164 
For instance, the quantitative fluorescence readout demands precise detection methods 
combined with accurate image processing and analysis.158,160,165 Similarly, the cell 
identification and tracking or phenotype analysis requires robust and reliable image 
segmentation methods often combined with machine learning to access desirable 
results.166,167 The complexity of computational post-processing can be reduced 
experimentally by use of single-cell arrays that simplify the spatial identification of 
particular cells. For instance, approaches such as microfluidic-based hydrodynamic cell 
isolation arrays,81 single-cell micro-well arrays168 or functional micro-structured cell 
cultivation surfaces169, 170 have been successfully introduced to investigate e.g. the kinetics 
of enzyme activity in single cells,102 DNA damage,171  nanoparicle-induced apoptosis172 or 
kinetics of gene expression after mRNA transfection.165 Particularly, micro-wells and 
surface micro-patterning also allows control particular aspects of the micro-environment of 
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individual cells or cell-cell interactions (e.g. surface area available for cell adhesion, 
volume of cell micro-environment or cell-cell contacts)55, 173, 174 and, potentially, more 
complex analysis of cellular responses in comparative studies of cells within colonies. 
 
Fig.1.8. Strategies for organizing single cells into spatial arrays 
a) The microfluidic chips consisting of arrays of hydrodynamic cell isolation traps (left panel) and 
the mechanism of cell trapping (left and middle panels). b) The PDMS-based micro-wells can be 
prepared by molding on the master structures (left panel). The cells occupy the position in micro-
wells after seeding on structured surface and the fraction of occupied wells depends on the 
geometry of the wells (right panel). c) Similarly, adherent cells after seeding on micro-pattern (top 
panel) migrate on the PLL-PEG(2000)-passivated surfaces (middle panel) and attach onto square 
areas functionalized with fibronectin (top and bottom panel). By optimizing the amount of seeded 
cells, the high fraction of occupied adhesion sides is achieved and in the same time the double 
occupations minimized (bottom panel). Adapted with permission from: a) Di Carlo et al.102 
Copyright (2006) American Chemical Society., b) Rettig et al.168 Copyright (2005) American 
Chemical Society. and c) Reiser et al.170 Copyright (2018) Springer Nature.  
  
18  2. Experimental methods and approaches 
1.7. Scope of presented work 
In this work, we aim at two general goals. Firstly, we develop the synthesis method 
for size-limited lipid-based delivery system for siRNA. In particular, we use microfluidic 
platform for controlled and scalable synthesis of monomolecular nucleic acid/lipid 
nanoparticles (mNALPs) that have been rationally designed to encapsulate a single 
molecule of siRNA in a highly curved, PEG-grafted, lipid bilayer. We present the benefits 
of the method, investigate the stability of formed nanoparticles and their biological 
performance in in vitro cell experiments. Secondly, we explore the utility of 
epifluorescence microscopy based single-cell assays to resolve the kinetics of RNA 
interference. We utilize the method to investigate the delivery of nucleic acids into the 
cultured cancer cells by commercial transfection system and the single-cell-level silencing 
efficiency on the scale of the whole cell population. The aim of the method is to provide 
fast, time-independent and sensitive assay for accessing the biological activity of siRNA 
delivery systems. 
2. Experimental methods and approaches 
2.1. Microfluidic chip devices 
Two microfluidic chip devices were designed for the purpose of mNALP synthesis 
and conversion of fluorescence intensities to the number of expressed fluorescent proteins 
in single-cell time-lapse experiments. The details on microfluidic chip manufacture are 
given in protocols section. 
2.1.1. Hydrodynamic focusing micro-mixing chip device 
The chip design is based on previously published geometries.66,176 In general, the 
design consists of one main channel and two side channels meeting in the junction point in 
the 45° angle in respect to the direction of the main channel. Here the central 50% (v/v) 
isopropanol/water stream is clutched by two water side streams flowing from the side 
channels to the narrow jet. Due to the low Reynolds number regime the flow in the junction 
point and outlet channel remains laminar. The microscopic width of the focused jet ensures 
the rapid diffusive exchange of the solvent and fast equilibration in nearly aqueous 
conditions (5% (v/v) isopropanol/water). 
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Fig.2.1. Hydrodynamic focusing chip design 
The scheme of hydrodynamic focusing chip design and the scanning electron microscopy (SEM) 
images of PDMS micro-channels in selected chip regions. The inserts I, II and III present the details 
of the regions marked on the top overview image. Reprinted from Krzysztoń et al.175 
The detailed design of the micro-chip is presented on Fig.2.1. The channels have 
rectangular cross section with height h = 74 µm and width w = 200 µm or w = 100 µm for 
middle and side channels respectively. During the synthesis, the total flow in the outlet 
channel is equal Q = 1 ml h-1 and the flow rate ratios between central and side flows is 
equal 1:9. In those conditions the mixing time can be estimated using two-dimensional 
model, presented by Karnik et al..66 The Poiseuille flow profile in the outlet channel is 
described by eq.2.1. 
() = 	   ( − 4)                                                                                        (eq.2.1.) 
where: w – with of the channel, µ – fluid viscosity, dP/dx – pressure gradient along the 
channel length, y – the lateral distance from the center of the channel. Given that the profile 
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is not significantly disrupted by the viscosity of isopropanol/water mixture in the central 
stream, the average velocity of the flow in the outlet channel can be approximated by  
, ≈ (0) = 	                                                                                                      (eq.2.2.) 
This relation holds when: 
!"#
" ≪
!#
                                                                                                                                   (eq.2.3.) 
where the width of focused stream wf is given by 
 ≈ !%(&'()                                                                                                                            (eq.2.4.) 
µf – viscosity of focused fluid, R–flow ratio between focused and adjacent streams. 
The relation eq.2.2. is satisfied for focused stream of 50% (v/v) isopropanol/water (µf ~ 
3,62 cP) by two adjacent water flows (µ ~ 0,9 cP). With accordance to Fickian diffusion 
theory, the mixing time can be determined according to the relation: 
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The 200 µm wide outlet channel in presented design results in the width of focused stream 
wf = 13 µm and corresponding mixing time τmix ~ 34 ms, assuming the isopropanol 
diffusivity D ~ 10-9 m2 s-1 and flow rate ratio R = 1/9. However, this time corresponds to 
that taken for the change in solvent environment and does not take the dynamics of 
nanoparticle formation into account. To avoid possible negative effects of mass transport 
on particle formation, the outlet channel is extended to the length L = 164 cm, allowing for 
full diffusive equilibration of the sample inside the channel. In presented calculations we 
assume that the effects of particle-forming molecules dissolved in 50% (v/v) 
isopropanol/water in central focused stream can be neglected. 
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Fig.2.2. Bright-field and fluorescence images of the T-junction during mixing 
The two side streams of water constrain the middle stream of 400 nM dsDNA-Cy3 and all lipid 
components in 50% (v/v) iso- propanol/water to a narrow jet due to low Reynolds number of the 
flow. Total flow 1 mL h−1; flow rate ratio 1 : 9. w – outlet channel width, wf – width of the focused 
stream. Adapted from Krzysztoń et al.175 
Furthermore, the parameters of flow in the micro-channels needs to be taken into 
consideration to verify the laminar flow regime. For the rectangular geometry systems 
described by low Reynolds numbers the relation between backpressure (∆P) and the flow 
rate is given by: 
23 = 45 = 6!7#                                                                                                                  (eq.2.6.) 
and 
8 = 9:,;%(<)                                                                                                               (eq. 2.7.) 
where: RΩ − the flow resistance of the channel, L – the length of the channel, h – height of 
the channel, w – width of the channel, Q – flow rate through the channel. For displacement 
driven flow with the rate of Q = 1 ml h-1, flown inside the channel of height, h = 74 µm, 
width, w = 200 µm and length, L = 164 cm (channel flow resistance RΩ = 296,33*109 kg 
m-4 s-1) the backpressure equals ∆P = 822,91 mbar. Calculated pressure together with given 
outlet channel length results in the average liquid velocity of uf, ave ≈ 0.019 m s-1 according 
to eq.2.2. Finally, knowing the average fluid velocity and assuming that the characteristic 
length scale of the system (Lh) is equal to the outlet channel with Lh = w = 200 µm, the flow 
in the outlet channel corresponds to the Reynolds number Re ≈ 2, according to the equation 
eq.1.1. The effects of different viscosity and density between 50% v/v isopropanol/water 
mixture and pure water (µ  ~ 0.9 cP, ρ = 1 g cm-3) are considered negligible. 
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Fig.2.3. Bright-field and fluorescence images of first 6 turns of meandering outlet channel 
Two adjacent water streams squeeze the middle stream of 1 µM Cy3 in 50 % (v/v) 
isopropanol/water into a narrow jet seen at the most left images (Total flow 1 mL h-1; flow rate 
ratio 1:9). The numbers on the bottom of images represent the downstream distances from the T-
junction and the Dean numbers for given flow rate and channel geometry. The cross sectional flow 
profiles in curved regions of the channel are not disrupted by the inertia effects. Reprinted from 
Krzysztoń et al.175. 
Additionally, for curved channel the centrifugal inertia effects need to be taken into 
account. The relative contribution of centrifugal forces in relation to viscous forces for 
curved geometries is described by Dean number (Dn). 
=> = ? @                                                                                                                                 (eq.2.7.) 
where: r − the channel curvature radius, d – the hydraulic diameter of the channel. For 
rectangular channel cross section d is given by: 
A = 7!7&!                                                                                                                                          (eq.2.8.) 
In described geometry the first and last half turns (r = 50 µm, d = 108 µm) results in Dean 
numbers, Dn = 2,11. The full turns (r = 150 µm, d = 108 µm) results in Dn = 1,22. 
In conclusion, we have presented that the mixing within the microfluidic chip occurs 
solely due to diffusion and the flow is free from chaotic turbulences that might contribute 
to uncontrolled formation of undesired clusters during particle synthesis. The statement 
holds, since the Reynolds number inside the outlet channel remains significantly below the 
critical values of transition (~1000) and turbulent flow regime (~2000) for selected flow 
rate.177 Also the Dean number in the curved parts of the channel remains below the critical 
value for first-order Dean vortex flow (~36).178 The values of the Reynolds and Dean 
numbers, suggest that the flow remains purely laminar. Observation of the flow in the 
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junction position (Fig.2.2.) and up to ~90 mm downstream in the outlet channel (Fig.2.3.) 
promotes this finding as no signs of instabilities and other disruptions in laminar flow 
profile due to presence of alcohol and channel curvatures is seen. 
2.1.2. Microfluidic chip device for calibrating fluorescence intensities 
 
Fig.2.4. Fluorescence calibration chip design 
a) The scheme of fluorescence calibration chip design. Black and grey areas represent the SU8 
thickness of ~100 µm and ~8,4 µm respectively. Domains of different thickness were exposed in two 
separate exposition cycles and aligned using LPKF ProtoLaser LDI stage options. b) SEM images 
of PDMS micro-channels in central chip region. 
The chip is constructed of 11 parallel and non-connected micro-channels narrowing 
down in the middle of the chip structure (Fig.2.4.). The channel reaches the size (20 um 
width and ~8 um height, determined using Scanning Electron Microscopy (SEM)) with the 
cross section comparable with the cross section of the cell. The channels were filled with 
the solution of the fluorescent proteins of varying concentrations and used in the conversion 
procedure between fluorescence intensities determined from image analysis and the 
numbers of expressed proteins per cell in single-cell microscopy experiments. The details 
are described in protocols section. 
2.2. Fluorescence Correlation Spectroscopy (FCS) and confocal 
microscopy 
The Fluorescence Correlation Spectroscopy (FCS) is an experimental technique 
based on analysis of fluorescence intensity fluctuations detected from diffraction-limited 
volume of a liquid sample. The fluctuations originate from temporal variations in number 
and brightness of fluorescent entities in the detection volume. Those variations may result 
from multiple physical and chemical processes e.g. as an effect of transport (diffusion, flow, 
active transport), photophysical processes, chemical and photochemical reactions. The 
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method became the wide-spread biochemistry method to investigate e.g. molecular 
interactions, protein binding, aggregation etc. and is also used in high-throughput screens 
for drug discovery. 
2.2.1. Basic theoretical background 
The information on investigated processes (e.g. diffusion kinetics) can be accessed 
through the analysis the fluorescence intensity fluctuations	B(C) = 〈B〉 + GB(C) in the 
domain of time.179 The important assumption made in presented analytical approach is that 
the sample is in thermodynamic equilibrium and the ergodic principle holds for the system 
under investigation. 
The information on the processes causing the observed fluorescence intensity 
fluctuation can be gained through the analysis of the self-similarities of the signal and its 
delayed copy. The analysis of repeated patterns of such kind can be conveniently done 
using the correlation functions.180,181 The expression describing second order correlation 
function is given by: 
H+I()()) = 〈JK(L)JM(L&N)〉〈JK〉〈JM〉 ,                                                              ) ≥ 0,                       (eq. 2.9.) 
where: Fi,j – the functions undergoing correlation (i.e. fluorescence intensities detected), τ 
– the delay time (correlation time). The angular brackets denote the ensemble average that 
under the assumption of ergodicity is replaced by time average. If both Fi and Fj represent 
the same signal recorded by one detector the relation eq. 2.9. is referred as autocorrelation 
function (ACF). Autocorrelation functions can be considered the measure of mentioned 
self-similarities between the signal and its delayed copy as a function of the delay time. 
The autocorrelation of time-dependent fluorescence intensity fluctuations is directly 
related to the expression eq. 2.9. and is expressed as: 
P++()) = H++()()) − 1 = 〈RJK(L)RJK(L&N)〉〈JK〉#                                                                     (eq. 2.10.) 
Since, the fluorescence excitation and emission of a single dye are uncorrelated 
processes, the time between those events is random. This induces incoherence between the 
fluorescence signals emitted by different molecules residing the detection volume. Hence, 
the measured fluorescence intensity detected at a particular time point from the detection 
volume depends only on the photophysical properties of the dye, the parameters of 
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detection system, the sample illumination and the concentration of the dye. The expression 
describing the detected intensity is given as: 
B(C) = ST(U) VW(U, C)dY                                                                                       (eq. 2.11.) 
and: 
T(U) = Z(U)[(U)[\  ,                                                                                                      (eq. 2.12.) 
	]: = ^8_(](U))                                                                                                        (eq. 2.13.) 
V = ]:`abc                                                                                                           (eq. 2.14.) 
where: W(r) – function describing effective shape of the detection volume, q – molecular 
brightness of the dye, r – vector describing position of volume unit within detection region, 
I(r) - position dependent excitation intensity, σexc – excitation cross section of the dye, φ – 
fluorescence quantum yield of the dye, κ – total fluorescence detection efficiency, S(r) – 
normalized fluorescence collection efficiency and c(r,t) – position and time dependent 
concentration of the dye/particle. 
 The ideal solution of point like particles in open volume is considered. In those 
conditions, the number fluctuations of particles in detection volume are described by 
Poisson statistics: 
3(>, 〈d〉) = 〈e〉fg! exp	(−〈d〉)                                                                                    (eq. 2.15.) 
where 3(>, 〈d〉) is the probability to detect given number of particles n inside the detection 
volume at any given time point. 
The assumption implies also that the fluctuation in concentration of different fluorescent 
entities in multiple component system are independent at every given time point: 
〈GW+(U, 0)GWI(Ul, 0)〉 = W+̅G+IG(U − Ul)                                                                    (eq. 2.16.) 
where: W+̅- the mean concentration of the i-th fluorescent component, G+I- the Kronecker 
delta and G – Dirac delta function. The correlation function of i-th component is given by: 
〈GW+(U, C)GW+(Ul, 0)〉 = W+̅n+(U, Ul, C)                                                                         (eq. 2.17.) 
and n+(U, Ul, C) is the Green’s function characterizing particle motion. 
 In described case the relation describing the single component ACF is given by: 
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P()) = ∬p(U)q(U,Ur,L)p(Ur)stsurb̅(Sp(U)st)#                                                                                 (eq. 2.18.) 
The zero boundary value of the ACF is given by the inverse of the average effective number 
of particles in confocal volume: 
P(0) = 〈e〉                                                                                                               (eq. 2.19.) 
and is given by: 
〈d〉 = W̅Y                                                                                                              (eq. 2.20.) 
where: 
Y = (Sp(U)st)#Sp(U)#st                                                                                                      (eq. 2.21.) 
is the effective detection volume. For confocal detection geometry, described below in 
instrumentation section, the shape of the detection volume can be successfully 
approximated by 3D Gaussian ellipsoid: 
T(_, , v) = exp w− (#9x#)@\# −
y#
y\# z                                                                        (eq. 2.22.) 
The shape elongation of the Gaussian ellipsoid can be characterized by structure parameter: 
{ = y\@\                                                                                                                        (eq. 2.23.) 
For the given Gaussian approximation the effective number of molecules in the detection 
volume is given by: 
〈d〉 = |% ⁄ ~:v:W ̅                                                                                                     (eq. 2.24.) 
According to this relation the concentration of the fluorescent entities can be determined 
knowing the dimensions of the detection volume. What is important, the background signal, 
resulting from the detector dark counts or scattering background, contributes to the 
reduction of the amplitude of ACF. Thus, the effect needs to be taken into account while 
estimating the concentration of fluorescent particles: 
P(0) = 〈e〉 w1 −
〈J〉
〈J〉&〈J〉z

                                                                                        (eq. 2.25.) 
where 〈B〉is the mean background intensity. 
27  2. Experimental methods and approaches 
Additionally, knowing the effective number of particles the molecular brightness of 
the fluorescent entities can be estimated using the counts per molecule per second (CPM), 
defined as: 
CPM = 〈J〉〈e〉                                                                                                                 (eq. 2.26.) 
2.2.2. Autocorrelation function in systems characterized by pure diffusion 
In most cases of biochemical and colloidal science research FCS is used to address  
questions related with transport phenomena, colloidal properties of the sample e.g. sizes of 
diffusing particles or kinetic coefficients of reactions occurring in investigated systems. 
The fluctuations in concentration of particles in an n-component system consisting of  
active transport, diffusion and chemical reaction dynamics are termed by the reaction-
diffusion equation: 
LW+(U, C) = =+∇W+(U, C) + ∑ +IgI WI(U, C) − I(U) · ∇W+(U, C)                             (eq. 2.27.) 
that in the case of a system characterised by pure Fickian diffusion dynamics is reduced to: 
LW+(U, C) = =+∇W+(U, C)                                                                                          (eq. 2.28.) 
where:	=+- diffusion coefficient of i-th system component, I- flow velocity of i-th system 
component, +I- the elements of kinetic rate coefficients matrix describing reaction 
kinetics. 
The Green's function characterizing the free diffusion of the i-th component of the system 
in d dimensions is given by: 
n+(U, Ul, C) = 	 (-.KL) #⁄ exp w−
(U9Ur)#
-.KL z                                                                    (eq. 2.29.) 
For the case of a one component system the ACF function is represented as: 
P()) = 〈e〉P())                                                                                                      (eq. 2.30.) 
and the normalized ACF for free normal diffusion in 3 dimensions P()) can be derived 
from eq. 2.18., eq. 2.22. and eq. 2.30. as: 
P()) = (&N N⁄ )&#N N⁄                                                                                      (eq. 2.31.) 
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where f – the structure parameter of detection volume given in eq.2.23. and )- the diffusion 
time being the characteristic time of the decay of fluorescence correlations given by: 
) = @\#-.                                                                                                                      (eq. 2.32) 
 The effective size of the detection volume can be determined using a standard 
sample of particles of known diffusion coefficient. Then the determination of the diffusion 
times of sample under investigation is possible. 
With accordance to the kinetic theory, at the low Reynolds number regime diffusive 
movement of spherical particles without external potential field, the diffusion coefficient 
D is given by Stokes-Einstein equation: 
= = ;1                                                                                                                 (eq. 2.33.) 
that links the diffusion kinetics with the particle sizes through the hydrodynamic radius 7. 
Here: kB – Boltzmann constant, µ – solvent viscosity, T – temperature in Kelvins. 
 The case of n-component system of non-interacting particles the autocorrelation 
function is represented by: 
P()) = ∑ K#KKfK' (N)〈e〉(∑ KKfK' )#                                                                                             (eq. 2.34.) 
and  
+ = bK̅∑ bK̅fK'                                                                                                                  (eq. 2.35.) 
〈d〉 = Y∑ W+̅g+                                                                                                  (eq. 2.36.) 
where +- the molar fraction of i-th component, 〈d〉- total effective number of particles 
in the detection volume, V+- the molecular brightness of i-th component. Importantly, in 
this case the amplitude of correlation function is determined by apparent number of 
molecules in detection volume 〈d〉-that can significantly differ from 〈d〉. 
〈d〉 = (:) = 〈d〉 (
∑ KKfK' )#
∑ K#KfK'                                                                             (eq. 2.37.) 
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2.2.3. Triplet blinking kinetics 
Given the quantum nature of fluorescence emission the kinetics of photophysical 
processes related photon emission are generally affecting the autocorrelation functions. In 
particular, the intersystem crossing kinetics between electronic singlet and triplet state is 
generally observed. Given the prolonged kinetics of phosphorescence the molecules 
residing in long-lived triplet state are not emission-active and thus not detected in the 
detection volume. When the kinetics of the dyes entering the triplet state is taken into 
account the ACF of single component system have a form: 
P()) = 〈e〉 w1 + 9 exp	(− NN )z P())                                                                    (eq. 2.38.) 
when the multicomponent equivalent is given by: 
P()) = 〈e〉 w1 +

9 exp	(− NN )z
∑ K#KKfK' (N)
(∑ KKfK' )#                                                        (eq. 2.39.) 
where: T – the fraction of molecules present in detection volume that entered the triplet 
state and ) – the triplet blinking time. 
For practical reasons the expression describing two component diffusion kinetics 
with triplet state used during evaluation of experimental data had form: 
P()) = ¡: + g(J&¢(9J)) w1 + 9 exp	(− NN )z £

(&N N'⁄ )

&N (#N')⁄ + ¤
9J
(&N N#⁄ )

&N (#N#)⁄ ¥       (eq. 2.40.) 
where: ¡: - offset, > = 	 〈dtot〉 =	>1 + >2 – effective number of particles in confocal 
volume, )- diffusion time of particles 1, )- diffusion time of particles 2, B – fraction of molecules 
of species 1 (B =  = > (> + >)⁄ ), ¤ – relative brightness of particles 2 in relation to particles 
1 (¤ = V V⁄ ). 
2.2.4. FCS and Confocal microscopy instrumentation 
The FCS acquisition demands the setup providing tightly focused laser beam and 
highly efficient collection of photons emitted from the detection volume. Commonly, the 
confocal microscopy setups are adopted for this purpose, where the confocal volume serves 
as the detection area.  
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Fig.2.5. Typical confocal-microscopy-based setup for fluorescence (cross-)correlation 
spectroscopy 
The detection and excitation happens through high-numerical-aperture, water-immersion 
objective. The dichroic mirrors, Dm1 and Dm2, 1) separate the fluorescence signal from laser 
excitation(s) and 2) spectrally disjoin the fluorescence signals into related detection channels, 
respectively. The split fluorescence light is subsequently filtered (Fr1 and Fr2). The detection of 
fluorescence signal emitted from effective detection volume (shown in the insert on the right, r0 and 
z0 represents the radiuses of short and long axes of 3D Gaussian ellipsoid ) is possible due to two 
properly aligned pinholes (P1 and P2) and is done through fluorescence filters within two detectors 
(Det1 and Det2). Detected signal is correlated using the hardware cotrelator and processed data 
are stored. 
In presented work, we use the Zeiss LSM 510 ConfoCor2 experimental system 
equipped with a C-Apochromat 40x/1,2 high-numerical-aperture, water-immersion 
objective. Objective is capable of refractive index correction important during 
measurements in 50% v/v isopropanol/water solutions. We have done the measurements 
using 543 nm HeNe or 488 nm argon laser excitation and BP 560–615 nm or BP 500–530 
nm emission filters for Cy3/CayRFP and ATTO488/eGFP respectively. Measured 
fluorescence signals are correlated using hardware correlator. Samples are measured in 8-
well LabTek II chamber slides (170 um bottom glass thickness, Nunc, Thermo Scientific). 
The detection volume calibration is performed using Rhodamine 6G, Alexa 546 and 
Alexa488.182,183 The sample temperature is controlled by equilibration to the ambient 
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temperature of air conditioned room (25˚C). The data evaluation is done using PyCorrFit 
software, developed by Thomas Weidemann (Max Planck Institute of Biochemistry, 
Martinsried, Germany) and Paul Müller (Biotechnology Center of the TU Dresden, 
Germany). The schematic representation of the setup is given on the Fig.2.5. 
The same optical setup in imaging working mode was used to acquire confocal 
images during particle binding and uptake evaluation in in vitro cell experiments. The 
temperature control was carried out using Ibidi Heating System (Ibidi GmbH). The 
acquisition was done using two detection channels - green: ATTO 488, 488 nm argon laser 
excitation, BP 500–530 nm emission; and red: LysoTracker, 545 nm HeNe laser excitation, 
LP 560 nm emission. Z-Stacks consisting of 11 slices at increments of 0,5 µm were 
obtained. Image processing was done using ImageJ software. 
2.3. Flow cytometry (FC) 
Flow Cytometry (FC) is a laser-based, single-cell method to investigate the cell 
morphology and physiology. The method has found an established position in clinical 
diagnostics184 and biomedical research.185 It is also highly accurate preparative method 
allowing for separation of cells of different kind, physiological state etc..186 
FC relies on analysis of fluorescence and scattered laser light emitted/scattered by 
the single cells passing through the laser beam. The single-cell flow is assured by using 
hydrodynamic focusing flow geometry, where the stream of cell suspension is squeezed 
inside the column of flowing sheath fluid. Due to small size of focusing junction and the 
outlet channel the low Reynolds number regime is sustained and the flow remains laminar. 
The spatial constrains on core flow causes the separation of suspended cells flowing 
through the outlet channel. The cell flow and the laser beam are crossing each other 
orthogonally in the detection point upstream from the junction. The scattered and/or 
fluorescence light is filtered and detected through the optical detection units in direction 
orthogonal to both, laser beam and flow, and in direction parallel to the laser beam 
(Fig.2.6.). 
The angular profile of the scattered laser light holds the information on cell 
morphology and underlying physiological state of the cell. The angular dependence of 
scattered light intensity relates strongly with the sizes of scattering particles. Due to that 
relation, the intensity of light scattered in small angles (forward scattering) carries the 
information on cell sizes. The cell granularity, morphological state of the organelles etc. 
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brings a dominant contribution to the light scattered in higher angles (side scattering) as the 
internal cell structures are much smaller and the angular intensity profile of the light 
scattered from small objects is more evenly distributed than from big particles.187 
 
Fig.2.6. Simplified representation of the flow cytometry setup 
The sheath fluid squeezes the central flow of cell suspension into a narrow stream, causing single-
cells to pass the orthogonal laser beam, one cell at a time. Side and forward scattered light are 
detected in a direction orthogonal to each other and to the cell stream. Fluorescence signal is 
detected in the direction parallel to side scattered light. 
More specific information on cell state can be accessed using fluorescent reporter 
proteins, that when efficiently designed, give quantitative and qualitative information on 
molecular processes within the cell, gene expression etc.188–190 Similarly, the fluorescent 
biomarkers activated or accumulated inside cells presenting particular metabolic state or 
activity e.g. apoptosis191,192 or increased or decreased mitochondrial activity,193 can be used. 
Commonly, fluorescent antibodies are used also to access the expression of cell membrane 
proteins or binding affinities.194, 195 
The cell identification and quantitative assessment of cellular activity can be done 
using analysis of fluorescence and scatter light intensities or correlation analysis of those 
parameters. The different cell types or cells presenting different metabolic state most show 
characteristic patterns of scattered values allowing for precise identification and 
quantitative analysis. Additionally, acquired information can be used for real-time 
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differentiation between cells and subsequent automatic sorting of life cells using sorting 
units. 
2.3.1. Flow cytometry instrumentation 
In presented work, we use the flow cytometry to quantify the specific binding and 
uptake of folate-functionalized mNALPs. The CyFlow Space flow cytometer (Sysmex 
Partec GmbH, Görlitz, Germany) was used. The scattered 488 laser light was detected in 
directions orthogonal and parallel to the laser beam using BP 488/10 filters. The fluorescent 
light of ATTO488-labelled mNALPs bounded/up-taken by cells was detected in direction 
orthogonal to the laser beam using BP 536/40 filter. The cell counts were gated basing on 
forward vs. side scatter intensity correlation plots and equal number of cells are analyzed 
for each sample. The detailed description of binding/uptake experiment protocol and cell 
handling is given in protocols section. 
2.4. Live – cell Imaging of Single-Cell Arrays (LISCA) 
The combination of micro-patterned surfaces with live-cell time-lapse 
epifluorescence microscopy provides a versatile platform (Live-cell Imaging of Single-Cell 
Arrays; LISCA), that enables fast and robust quantitative readout of single-cell 
fluorescence intensities from spatially organized cells and cell-specific changes in those 
intensities in time (Fig.2.7.). In particular, the method has presented its utility in single-cell 
kinetic analysis of molecular processes underlying gene expression165,170 and correlations 
of cellular events related with apoptosis172 on the population-wide scale. The method relies 
on precise image processing, mathematical modelling and analysis of numerical data. We 
obtain the single-cell fluorescence intensities from image time series of cells separated on 
a structured cultivation surface. Single-cell fluorescence intensity time-courses can be 
converted into the number of fluorescent proteins expressed per cell and fitted using 
analytical formulas derived from a model of expression. Fitting results in distributions of 
kinetic parameters of molecular processes related with gene expression given in absolute 
values. 
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Fig.2.7. Experimental workflow of live-cell imaging of single-cell arrays (LISCA) 
The cells seeded on micro-patterned cultivation surfaces occupy the arrayed adhesion sides, one 
cell per side. The temporal changes in fluorescence signals of each cell are detected during time-
lapse imaging. Acquired images are firstly corrected for the background signal and then processed 
using customized ImageJ plugin. The spatial separation of cells on the micro-patterns facilitates 
the single-cell readout of fluorescence intensities. Yielded numerical data can be further analysed 
using mathematical modelling. 
2.4.1. Micro-patterned surfaces for cell cultivation 
The surface micro-patterns provide spatial confinement of the cell and significantly 
reduce the experimental noise related to cell movement during the time of experiment.170,196 
The pattern consists of 30 × 30 µm squared adhesion sites arrayed in square 2D lattice (90 
µm lattice distance) and is prepared by plasma-induced micro-patterning technique 
(preparation procedure is schematically presented in Fig.2.8). Fibronectin-coated adhesion 
sides are embedded in cell-repellent surface functionalized with PLL(20k)-g(3,5)-PEG(2k). 
Cells seeded on the micro-pattern migrate on the polymer-functionalized surface and upon 
encountering one of the adhesion sides, they attach and spread on the fibronectin-coated 
area (Fig.2.7). Due to the adjusted seeding concentration, on average only one cell occupies 
each adhesion side. Details regarding micro-pattern preparation are given in protocols 
section. 
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Fig.2.8. Micro-pattern production – master structure and workflow 
a) The image of master structure used to prepare the micro-patterns. The insert presents the close-
up of selected area of the pattern, dimensions of the grid and side length of square elementary grid 
unit. b) The schematic representation of steps of micro-pattern preparation. (1) The cured PDMS 
stamp is cut out from top of master structure and then brought into direct contact with the 
microscopy slide. (2) The slide surface that is unprotected by the stamp are exposed to oxygen 
plasma. (3) The plasma-exposed areas are passivated by exposing them to PLL(20k)-g(3,5)-
PEG(2k) solution. (4) The remaining, square areas are rendered cell-adherent by incubating them 
with fibronectin solution that results in (5) protein absorption on non-passivated surfaces. 
2.4.2. Time-lapse microscopy instrumentation 
The time-lapse imaging was performed using inverted Nikon Ti-Eclipse 
epifluorescence microscope equipped with CFI Plan Fluor DL 10X objective, Andor Clara-
E camera, and Lumencor SOLA LED lamp and motorized stage. The excitation and 
detection of eGFP and CayRFP fluorescence was done using BP 450-490/BP 500-550 and 
BP 530-560/ BP 590-650 filter sets respectively. Images were collected every 15 min 
within 30h – long experiments at multiple selected positions of the microscopy slide. 
During experiments cells were incubated at 37 °C. The temperature control was done using 
Ibidi heating system (Ibidi GmbH). 
2.4.3. Fluorescence background correction algorithm and image analysis 
To reduce the influence of background signal on the quality of quantified cell 
fluorescence intensity a background correction was performed. The procedure is based on 
the algorithm described by Schwarzfischer et al.197 The method is based on statistical 
analysis of acquired images, identification of background-related fragments of the image, 
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intensity interpolation to remaining cell-related regions and subsequent subtraction of 
created background matirx from original image. 
Firstly, the cell-related regions are identified based on statistical analysis of pixel 
greyscale values and clustering. In detail, the acquired 16-bit TIFF greyscale images are 
divided into non-overlapping, square, 16x16 pixels segments. Four statistical moments 
(mean, variance, skewness and kurtosis) of pixel intensity values are determined for each 
of segments and scattered on the four-dimensional space defined by statistical moments. 
The cell-related segments are identified using DBSCAN clustering algorithm (Density-
Based Spatial Clustering of Applications with Noise) using statistical data from the 
segments.198 Two parameters of the algorithm are predefined. The minimum number of 
cluster core point “neighbours” is defined by rounded logarithm of the number of image 
segments and maximum distance between two “neighbour points” is defined by half the 
four-dimensional interquartile range. Since the segments of a background have features that 
are the most similar to each other the algorithm calibrated as described before finds one 
cluster cloud associated with the segments of background. All other segments not assigned 
to this cluster is defined as cell-containing pixels. 
Secondly, the intensity of background fluorescence is interpolated into the cell-
related segments. The mean intensity of each cell-associated segment is calculated as mean 
of segment intensities within its square-shaped surrounding in iterative manner. 
Interpolated intensities are added to the pool of background-defining segments and 
accounted for in further steps. The size of the surrounding is defined by the side length of 
the square (e) given in number of segments per side: 
 = 2 ∗ round­2,5 ∗ >¯°_b²² |⁄ ³ + 1                                                                       (eq. 2.41.) 
where: >¯°_b²² -  the number of segments that belong to given cell region. If the square-shaped 
surrounding has less than e2 background segments defined (e.g. due to other cell with undefined yet 
background in the near proximity), the segment under evaluation is skipped and re-evaluated in 
following iterations. The iteration is held until the background has been interpolated for the 
whole image. 
Finally, the mean greyscale values of each segment comprising the completed 
background are subtracted from pixel values of the original image. Pixel intensities are 
restricted to non-negative greyscale values. 
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Fig.2.9. ImageJ plugin used for quantitative image analysis 
ImageJ plugin used for quantitative image analysis facilitates quick readout of single-cell 
fluorescence intensities. The grid of square regions of interest (ROIs) is predefined in a way that it 
matches the spacing of micro-pattern (thin yellow lines). The ROIs associated with single cells are 
selected manually (thick coloured lines) and the mean pixel intensity is calculated from each of 
them. 
The background-corrected images were used to form stacks of time-resolved images 
from each imaged position within the microscopy slide. The mean fluorescence intensities 
were determined as mean greyscale value of pixels within each cell-containing, square ROI 
(Fig.2.9.). The grid of defined sized ROIs was generated using an in-house written ImageJ 
plugin. The grid was chosen in a way that each predefined square region is overlapping 
with the micro-paterned adhesion sides and the grid is fitting the spacing of the micro-
pattern. 
2.4.4. Fluorescence calibration to protein numbers 
To obtain the absolute numbers of parameters describing protein expression kinetics 
the number of expressed protein per cell needs to be obtained. The conversion of measured 
fluorescence intensities into the number of proteins expressed in each cell requires 
calibration procedure. For this purpose, specially designed microfluidic chip was used (see 
Microfluidic chip design section). Prior to the experiment, the micro-channels were 
incubated with 3 mg mL-1 Pluronic F127 water solution at 4 °C for 24h to passivate the 
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channel surface. Subsequently, channels are washed with PBS pH 7,4 and filled with 
solutions of decreasing concentrations of fluorescent proteins - enhanced green fluorescent 
protein (eGFP) and and Cayenne red fluorescent protein (CayRFP). Proteins were 
expressed and purified according to the procedure described in protocols section. Filled 
channels were imaged using the exposition parameters and filters used during the time-
lapse experiment (Fig.2.10. bottom row). The mean fluorescence intensities of each channel 
are evaluated using in-house written ImageJ plugin described in image analysis section. 
The average of 11 measurements in different positions inside the channels is used and the 
standard deviation was taken as measurement error. Measurements were corrected for the 
background signal measured outside the channel.  
 
Fig.2.10. Fluorescence calibration for conversion of single-cell fluorescence intensities into the 
numbers of expressed proteins 
Micro-channels of a height comparable with the cell thickness (~8,4 µm as determined during SEM 
imaging) are filled with a) eGFP or b) CayRFP solutions of varying concentrations and imaged 
using the same exposure parameters and filters used for time–lapse experiments (top). The 
fluorescence intensity was quantified as the average pixel intensity using customized ImageJ plugin. 
The concentration of proteins is determined using fluorescence correlation spectroscopy (bottom). 
The linear fit was used to calibrate the exact numbers of molecules in each cell (middle). The cross 
talk between red and green channel in case of CayRFP was taken into account. 
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The concentration of fluorescent proteins was determined using Fluorescence 
Correlation Spectroscopy (Fig.2.10. top row). The model accounting for single 3D 
diffusion component and triplet state dynamics was used (eq. 2.38.). The size of confocal 
volume was calibrated using Alexa 488 or Alexa 546 during the measurements of eGFP 
and CayRFP solutions respectively. The effective number of particles in confocal volume 
was determined by fitting of model function to the experimental data. The correction for 
detector dark counts and scattering background was performed according to eq. 2.25. 
Knowing the effective number of particles and the size of confocal volume the 
concentration of evaluated solutions was determined. 
Tab.1. Fit parameters obtained during fluorescence calibration and used in fluorescence 
conversion into numbers of proteins. 
y = a*x a [#103 molecules] Error a [#103 molecules] Adj. r2 
eGFP 7,03 · 10-3 0,10 · 10-3 0,9988 
CayRFP 9,95 · 10-3 0,14 · 10-3 0,9992 
 
a [(#103 molecules)-1] Error a [(#103 molecules)-1] Adj. r2 
CayRFP (crosstalk) 1,28 0,06 0,9914 
The number of fluorescent proteins per pixel was calculated knowing the channel 
height (~8,6 µm as determined from SEM images of the channels), the surface area per 
pixel (0,65 µm × 0,65 µm) and the concentration of protein solutions. The calculated 
protein numbers per pixel were plotted against mean pixel intensity and the linear fit to the 
data is done using orthogonal least squares method. The obtained fit parameters were used 
to recalculate the mean fluorescence intensities obtained during time-lapse experiment to 
the number of proteins per pixel. To obtain the total number of expressed proteins 
calculated values were multiplied by number of pixels in cell-containing square ROIs. The 
cross talk between red and green channel, observed in case of CayRFP, was taken into 
account (Fig.2.10., middle and bottom row). The error of the determined molecule number 
was calculated using an error propagation, taking into account all the fitting errors and the 
square root of the mean pixel intensities. 
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2.4.5. Data processing and analysis 
The single-cell mRNA expression was evaluated using three-stage gene expression 
model detailed in the results section. The solution of ordinary differential equations eq.2.42, 
eq. 2.43. and eq. 2.44. 
´*1eµ¶(L)
´L =	−G ∗ ^d¡(C)                                                                                (eq. 2.42.) 
´J∗(L)
´L =	−	· ∗ PB3∗(C) − ¸* ∗ PB3∗(C) + ¸ ∗ ^d¡(C)                 (eq. 2.43.) 
´J(L)
´L =	−	· ∗ PB3(C) + ¸* ∗ PB3∗(C)                                                     (eq. 2.44.) 
related to this model, is given by the relation (eGFP example): 
PB3(C) = ^:¸tl ¹ º¶9R¶&»¶ e9­º
¶&»¶ ³­L9L\¶³ − º¶9R¶ e9º
¶(L9L\) − »¶(º¶9R¶)­º¶9R¶&»¶ ³ e9R
¶­L9L\¶³¼            (eq. 2.45.) 
where: eGFP(t) - the number of mature eGFP molecules, t - the time, mG0  - the number of 
delivered mRNAG molecules, ktl - the translation rate constant, βG - eGFP degradation rate 
constant, kGm - eGFP maturation rate constant and δG -mRNAG degradation rate constants. 
The analytical solution was obtained using initial conditions of mRNAG(0)=mRNAG0=mG0 
, eGFP*(0)=0 and eGFP(0)=0.  To decrease the number of free parameters the degradation 
β and maturation rates km are determined in translation block experiments. The three-stage 
model is here reduced to maturation and degradation kinetics of fluorescent proteins. The 
solution of ordinary differential equations eq. 2.46. and eq. 2.47. describing the model 
´J∗(L)
´L =	−	· ∗ PB3∗(C) − ¸* ∗ PB3∗(C)                                                  (eq. 2.46.) 
´J(L)
´L =	−	· ∗ PB3(C) + ¸* ∗ PB3∗(C)                                                     (eq. 2.47.) 
is given by the relation (eGFP example): 
PB3(C) = PB3:e9º¶L + PB3:∗ ½e9º¶L − e9­º¶&»¶ ³L¾                                   (eq. 2.48.) 
where the number of initial mature and immature eGFP proteins during translation block is 
given by eGFP*0 and eGFP0 respectively. Expressions given by equations eq. 2.45. and 
eq. 2.48. are fitted to corresponding single-cell time-courses of expressed protein numbers 
using the least-squares method. While evaluating the remaining parameters of mRNA 
expression, the protein degradation and maturation times are kept fixed at values 
determined during translation block experiments. The initial number of mRNA molecules 
41  3. Results 
and the translation rate constant are fitted jointly as one parameter, m0ktl, since they are not 
separately identifiable in the model. The linear fits to scattered eGFP vs. CayRFP fit 
parameters (m0ktl, t0, δ) were done using the orthogonal least squares method. Initial 
translation rates (m0ktl) and mRNA degradation constants (δ ) are fitted in log-log 
representation. The log-normal fits to population distributions of mRNA degradation 
constants (δ ) are done using the Levenberg–Marquardt algorithm. 
3. Results 
In this chapter, the results of performed experiments are presented and discussed. 
The content is divided in two parts where we detail firstly, the microfluidic synthesis 
optimization of mNALPs, their stability in biological fluids, receptor-mediated uptake and 
silencing activity. Second part contain the description of double-reporter assay used to 
investigate single-cell siRNA-mediated silencing, followed by comparison of direct 
analysis of fluorescence intensities and kinetic analysis of mRNA expression in terms of 
quantification of silencing efficiency. Finally, we analyse the correlations observed 
between kinetic determinants that describe expression of targeted eGFP and reference 
CayRFP. Furthermore, in order to determine the kinetic constants related with protein 
expression in an unbiased manner the additional measurements of protein maturation and 
degradation rate constants were needed. The results are detailed in relevant sections. In 
addition, we include a brief discussion on observed interdependencies between single-cell 
degradation rates of eGFP- and CayRFP-mRNA. Our considerations take into account 
differences in codon usage between coding sequences of both mRNA constructs used 
during the experiments. 
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3.1. mNALP assembly and activity 
 
Fig.3.1. Structure and assembly of mNALPs in a hydrodynamic focussing chip device 
a) The proposed structure mNALPs. The single 21 bp dsDNA/siRNA is tightly covered with highly 
curved, PEG-coated lipid bilayer. b) The assembly route of mNALPs in hydrodynamic focusing 
micro-chip. The rapid mixing at the nanoliter scale leads to changes in the solvent properties that 
triggers the particle formation. Adapted from Krzysztoń et al.175 
The mNALPs are composed of DOTAP, DOPE, DOPC and DSPE-PEG(2000) in 
the molar rations (1:5:6:1,2). We rationally designed the lipid composition to efficiently 
encapsulate the single, short (~ 21 bp) double stranded oligonucleotides in a highly curved, 
PEG-coated lipid bilayer (Fig.3.1a.).198 In previous studies it was shown that the 
DOTAP/DOPE/DNA systems are forming an inverted hexagonal phase when the 
DOTAP:DOPE molar ratios are between 1:3 and 1:5.44 The structural unit cell of hexagonal 
phase comprises of a single DNA/RNA double helix tightly covered with highly curved 
lipid monolayer. In the rational design of mNALP structure, we chose the composition of 
lipids in a way that the formed DOTAP/DOPE monolayer is closed by additional outer, 
DOPC/DSPE-PEG(2000) monolayer. The PEG-shield causes the curvature of bilayer to be 
preserved and stabilizes the structure of mNALP due to the steric hindrance. It is assumed 
also, that the total density of DSPE-PEG(2000) accumulated on the outer layer reaches ~ 9 
mol% that assures the optimal blood circulation times for comparable systems i.e. stealth 
liposomes.199 
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As an assembly route for forming mNALPs we chose the solvent exchange. In this 
method, the solution of particle-forming molecules (e.g. lipids, polymers) is typically 
dissolved in a nonpolar solvent i.e. alcohol and then rapidly diluted in excess of nucleic-
acid-containing water or buffer. The rapid change in solvent quality triggers the formation 
of particles. The method gives a high control on the particle nucleation and self-
assembly.113 Although, the kinetics of particle formation couples with the mixing process. 
Thus, the additional control over mixing kinetics using microfluidics brings the modality 
in the particle synthesis (Fig.3.1b.).66, 116 
Here, we investigate the size, encapsulation efficiency and homogeneity of 
mNALPs produced in two mixing modes - by microfluidic mixing on hydrodynamic 
focusing chip and by dropwise addition and vortexing. Further, in in vitro experiments, we 
test the target-specific uptake of folate-functionalized mNALPs by folate-receptor-
overexpressing KB cells, their abilities to release the encapsulated nucleic acids and 
silencing efficiency. We also probe the unspecific interaction of mNALPs with blood serum 
and plasma components and their general stability in those biological fluids. To overcome 
the problem of increased chemical and biological instability of RNA we use the 21 bp 
double stranded DNA in all experiments excluding the silencing efficiency test. It was 
proven previously that siRNA and DNA duplexes of the same length result in mNALP 
samples of the same quality.198 
3.1.1. Evaluation of starting solvent conditions 
Formation of particles is triggered by the decrease of the non-polar solvent content 
(isopropanol) in the solution by mixing with water. In order to minimize the diffusive 
distance between the particle-forming molecules we modify the standard solvent exchange 
protocol in a way that all of used lipids and nucleic acids are dissolved in 50% (v/v) 
isopropanol/water mixture prior to particle formation. Although, the increased content of 
isopropanol might cause the precipitation of nucleic acids from the solution due to 
decreased electric permittivity of the environment and the premature electrostatic 
interactions between positively charged DOTAP and negatively charged nucleic acids. This 
unwanted interaction might cause the altered self-assembly process and lead to formation 
of clusters or other unwanted structures. 
To validate the starting conditions one need to confirm that the 50% (v/v) 
isopropanol content is sufficient to prevent lipids from aggregation. In the same time, the 
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electrostatic interactions between DOTAP and nucleic acids need to be screened 
sufficiently in order to prevent micro-precipitation. We assess this issue using Fluorescence 
Correlation spectroscopy (FCS). We perform the measurements using Cy3-labelled 21bp 
DNA (Cy3-dsDNA) dissolved in 50% (v/v) isopropanol/water together with all lipid 
components in concentrations varying within the range used during synthesis optimization. 
We normalize the obtained diffusion times (τ) by the value measured for naked DNA in the 
same solvent conditions (τDNA). No significant differences are found between the diffusion 
times of naked DNA and lipid/DNA mixtures in all used concentrations indicating that no 
precipitation or aggregation is present (Fig.3.2c.). 
 
Fig.3.2. Evaluation of starting solvent conditions 
a) The cylindrical model of 21 bp dsDNA. The length of the DNA and its diameter are denoted l 
and d respectively. b) The viscosity-normalized ACFs of naked DNA in 50 % (v/v) 
isopropanol/water (red) and pure water (black). The curves overlap well indicating that the 
viscosity changes are the dominant factor in changes in DNA diffusion times between both 
conditions. DNA concentration, cDNA = 50 nM. c) The relative diffusion time of DNA in the presence 
of lipids (DOTAP:DOPE:DOPC:DSPE- PEG(2000) in molar ratios 1:5:6:1,2 in 50% (v/v) 
isopropanol/H2O) for different total DNA concentrations. Lipid concentration is expressed as the 
charge ratio of the cationic DOTAP to the polyanionic DNA. No significant change in relative 
diffusion times is seen. Adapted from Krzysztoń et al.175 
Additionally, we test the influence of isopropanol on the diffusion of naked DNA. 
By applying the parameters of B-form of DNA double helix we calculate the diffusion 
coefficients of 21 bp double stranded DNA for both solvent conditions. To this end, we use 
the cylindrical approximation of DNA double helix (Fig.3.2a.) and the calculate related 
values of diffusion constants (D) using modified Stokes-Einstein equation (201): 
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= = µ%²                                                                                                                     (eq. 3.1.) 
and 
¡ = ln ½ ²¾ + 0,312 + 0,565 ² − 0,1 
#
²#                                                                     (eq. 3.2.) 
where: l – the length of the cylinder (l = 6,8 nm), d – the cylinder diameter (d = 1,9 nm), kB 
– Boltzmann constant, µ – solvent viscosity (water, µ ~ 0,9 cP; 50% v/v isopropanol/water, 
µ ~ 3,62 cP), T – temperature in degrees Kelvin (T = 298K). We obtain the experimental 
values of DNA diffusion coefficients using Rhodamine 6G as a reference (DR6G = (4,14 ± 
0,05) · 10-6 cm2 s-1).182 The calculated and experimental values are in good agreement 
(Tab.2) indicating that no precipitation or significant changes in diffusive behaviour of 
DNA other than viscosity effects occur. Additionally, the viscosity normalized ACFs 
obtained in both solvent conditions overlap further confirming this finding (Fig.3.2b.). We 
calculate the apparent hydrodynamic radius (RhDNA) of free dsDNA from experimentally 
obtained diffusion coefficient (RhDNA = 2,37 nm, water). In further experiments, naked 
DNA serves as size reference. We calculate the hydrodynamic radiuses of formed 
nanoparticles by multiplying RhDNA by the relative diffusion times (τpart/ τDNA). 
Tab.2. Experimental and theoretical diffusion coefficients of naked 21-bp ds DNA. 
Predictions are made in accordance with the cylindrical model.  
  cylindrical model predictions experimental data 
  DDNA [cm
2 s-1] DDNA [cm
2 s-1] 
Water 9,02 · 10-7 (1,10 ± 0,19) · 10-6 
50% (v/v) Isopropanol/water 2,50 · 10-7 (2,81 ± 0,22) · 10-7 
3.1.2. Influence of mixing modes and synthesis optimization 
We investigate the impact of mixing mode on the quality of produced mNALP 
sample using FCS. In particular, we assess the sizes of produced particles, encapsulation 
efficiency of nucleic acids and sample homogeneity. We vary the Cy3-dsDNA (cDNA) and 
lipid concentrations (on Fig.3.3. represented as charge ratio (ρ) between positively charged 
DOTAP and negatively charged Cy3-dsDNA) between 4 and 80 nM (55 ng mL−1 – 1,1 µg 
mL−1) and between 0,42 and 420 µg mL−1 (charge ratio ρ; 0,2 - 10) respectively. During 
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variations of lipid concentration, the DNA concentration and the molar ratios between 
different lipids are preserved. 
 
Fig.3.3. Effects of mixing mode – optimal charge ratio and DNA concentration 
Influence of the DNA concentration and the charge ratio between cationic DOTAP and Cy3-dsDNA 
on the hydrodynamic radius of formed particles and the DNA encapsulation efficiency. The data 
obtained with hand-mixed (left) and microfluidic-mixed (right) samples are presented. The grey 
bars present trends obtained at optimal DNA concentrations (20–40 nM). Adapted from Krzysztoń 
et al.175 
We prepare the hand mixed samples by dropwise addition of lipid/DNA solutions 
in 50% (v/v) isopropanol/water into deionized water and vortexing. The starting solutions 
are diluted 10-fold leading to the final isopropanol content of approximately 5% (v/v). 
Similarly, we keep the flow rate ratios of 1:9 during microfluidic synthesis resulting in the 
same dilution factor. We evaluate the acquired autocorrelation functions (ACFs) using two-
component diffusion model with triplet state dynamics (eq. 2.40.). Equivalent model with 
single-component diffusion is not capable of reproducing the experimental data efficiently. 
We use free, non-complexed Cy3-dsDNA and Rhodamine 6G 182 as particle size reference 
and for calibration of confocal volume size, respectively. We keep fixed the diffusion time 
of free Cy3-dsDNA and structure parameter f (eq. 2.23.) determined from Rhodamine 6G 
autocorrelation function during fitting. No changes in water viscosity are detected due to 
residual isopropanol content. 
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Fig.3.4. Detailed view of particle formation at optimal DNA concentration (cDNA = 40 nM) 
The hydrodynamic radius of particles and encapsulation efficiency are presented as a function of 
the DOTAP/Cy3-dsDNA charge ratio. Triangles (▲) indicate the data obtained with the 
microfluidic mixing method, squares (■) denote the results for vortex mixing by hand. Adapted from 
Krzysztoń et al.175 
We estimate the hydrodynamic radius (Rh) of formed particles using measured 
diffusion times and apparent hydrodynamic radius of free Cy3-dsDNA according to 
equations eq. 2.40. and eq. 2.38., respectively. Additionally, we estimate the encapsulation 
efficiency by fraction of diffusing complexes obtained directly from the fits. The formation 
of lipid/DNA complexes occur above isoelectric point (ρ = 1) for all Cy3-dsDNA 
concentrations in both mixing modes. Although, the high concentrations of Cy3-dsDNA 
(cDNA > 40 nM) associates with the aggregate-related high intensity spikes present already 
above charge ratio ρ = 0,4, as seen in the time-dependent fluorescence traces (Fig.3.5.). 
Contrary, the low concentrations of Cy3-dsDNA (cDNA < 20 nM) leads to low, maximal 
encapsulation rates of 30%. Sudden stepwise assembly of particles of 19,2 nm in radius is 
a result of an increasing charge ratio at the optimal Cy3-dsDNA concentrations (cDNA 
between 20 and 40 nM).  
Due to microfluidic synthesis the particle size reaches a steady level and is not 
exceeded even at high charge ratios (Fig.3.4.). Moreover, we observe the significant 20% 
increase in encapsulation efficiency when compared to samples obtained by dropwise 
addition and vortexing. Additionally, the microfluidic-synthesized samples presents 
significantly narrower size distributions that is reflected in experimental variance in 
measure particle size between individual measurements (represented as error bars on 
Fig.3.4.). Inspection of fluorescence time-traces and the ACFs obtained for samples 
prepared by both mixing methods are supporting those findings (Fig.3.5.). Fluorescence  
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Fig.3.5. Effects of mixing mode on – encapsulation efficiency and sample homogeneity 
a) The normalized ACFs of samples prepared by vortexing (○) and microfluidic mixing (▼) at 
optimal conditions (cDNA = 40 nM, ρ = 5) and of Cy3-DNA (□). The dashed line shows the ACF 
calculated for a single component mNALP system (particles with hydrodynamic radius Rh = 19,2 
nm) representing the 100% encapsulation efficiency. The solid lines represents fits to experimental 
data. b) Top: The ACFs obtained by the single 15 s measurement runs of samples prepared by (I) 
vortex mixing by hand exhibit relatively high deviations in shape and amplitude when compared to 
the ones obtained for (II) microfluidic-mixed samples (average, black curve; single measurements, 
grey curves) Bottom: The corresponding fluorescence time-traces show frequent high-intensity 
sparks (I) in vortexed samples. Contrary, the time-traces obtained from microfluidic-mixed samples 
show sparse events of such kind. Adapted from Krzysztoń et al.175 
time-traces revealed frequent high intensity spikes indicating that large and bright 
aggregates are formed frequently during particle synthesis by hand mixing. Moreover, the 
ACFs from repeated single measurements of the same sample show decreased variation in 
shape and amplitude in case of microfluidic mixing when compared to vortexed samples 
(Fig.3.5b.). This finding reflects increase in sample homogeneity. Increase in encapsulation 
efficiency is further reflected in significant shift towards higher diffusion times between 
averaged ACFs obtained for samples prepared by both mixing modes (Fig.3.5a.). As a 
conclusion of presented analysis, we chose the Cy3-dsDNA concentration cDNA = 40 nM 
and charge ratio ρ = 5 as optimal conditions of efficient mNALP synthesis. 
Importantly, to achieve site-specific activity of mNALPs additional surface 
functionalization is required. We functionalized mNALPs by replacing 16,7% of the 
DSPE-PEG(2000) used in previously described lipid formulation with folate-conjugated 
DSPE-PEG(2000)-FolA. The presence of folate ligands in the distal end of PEG-tethered 
lipids did not change the assembly behaviour of formed particles (Fig.3.6.). 
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Fig.3.6. Effects of particle functionalization with FolA on mNALP formation 
a) The comparison of hydrodynamic radii of FolA-functionalized (full bars) and non-functionalized 
mNALPs (empty bars). Particles are prepared at charge ratio ρ = 5 with varying Cy3-DNA 
concentrations. Red bars denote the optimal Cy3-DNA conditions for mNALP synthesis. b) The 
ACFs of FolA-functionalized and non-functionalized mNALPs prepared at optimal synthesis 
conditions (cDNA = 40 nM, ρ = 5). The curves overlap well showing negligible deviations between 
each other. Adapted from Krzysztoń et al.175 
3.1.3. mNALP stability in blood serum and plasma 
 
Fig.3.7. Effects of water evaporation on mNALP stability 
The autocorrelation curves (ACFs) for FolA-mNALPs prepared by the microfluidic mixing method 
under optimal conditions; cDNA = 40 nM, ρ = 5 (black), and after 35-fold sample concentration 
(water evaporation at 45 °C in high vacuum) and re-dilution. Curves show negligible deviation, 
revealing the stability of the particles after concentration up to 1,4 µΜ. Adapted from Krzysztoń et 
al.175 
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Next, we test the stability of folate-functionalized mNALPs and their affinity to 
interact with blood serum proteins. We perform the experiments in PBS buffer with 
increasing volume fraction of serum or plasma ranging between 10 to 80% (v/v) serum/PBS 
and 30 to 90% (v/v) plasma/PBS. Fola-mNALPs are concentrated 10 times and re-diluted 
to the Cy3-dsDNA starting concentration of 40nM in serum/PBS or plasma/PBS. 
Independent experiments show that the 35-fold concentration of mNALPs by solvent 
evaporation does not lead to aggregation or significant material losses during the process 
(Fig.3.7.). 
 
Fig.3.8. Effects of serum/plasma concentration on diffusive behaviour of Cy3 and Cy3-dsDNA 
The relative changes in diffusion time (τdiff) of Cy3 (black) and Cy3-DNA (read) in function of 
increased serum and plasma content (given as volume fraction, % (v/v)). The differences are 
tracked in reference to corresponding diffusion times in water. The similar linear changes suggest 
that increase in viscosity is the dominant factor in diffusive behaviour of both Cy3 and Cy3-DNA. 
Adapted from Krzysztoń et al.175 
We monitor the sizes of particles over 7 days using FCS in relation to the Cy3-
dsDNA reference diluted in the same medium. Additionally, we validate the diffusive 
behaviour of Cy3-dsDNA in serum and plasma samples for proper evaluation of diffusive 
components present in investigated samples. Similar increases in relative diffusion times 
are present for Cy3 and Cy3-dsDNA samples suggesting that the changes are resulting from 
viscosity effects (Fig.3.8.).  
We normalize the obtained values of hydrodynamic radiuses of particles by the 
value measured at the first day of experiment. The particle size did not change significantly 
over the time of entire experiment in both blood plasma and serum. Similarly, like in the 
case of synthesis optimization studies, the experimental variance of particle size determined 
in individual measurements is presented as error bars on the Fig.3.9. The measured particle 
fraction decreases over the time span of the experiment and reaches the lowest level  
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Fig.3.9. Stability of FolA-mNALPs in blood serum and plasma 
The stability of FolA-mNALPs in blood serum (left) and plasma (right). The time dependent changes 
in relative hydrodynamic radius and encapsulation efficiency are given. The changes are related 
to values measured at day 1. Adapted from Krzysztoń et al.175 
of 50% in highest concentrations of serum/plasma after 3 and 1 day in blood serum and 
plasma respectively. Since the measurements significantly affected by high fluorescence 
intensity spikes are disregarded from the experiment, the decrease in particle fraction can 
be linked to increased aggregation. We observe the relatively fast degradation of particles 
and broadening of size distribution represented as increase in the size of error bars in blood 
plasma samples compared to serum. The effect can be associated with fibrinogen 
coagulation that is not present in blood serum. 
 
Fig.3.10. The shelf life time of FolA-mNALPs 
The time dependent changes in relative hydrodynamic radius and encapsulation efficiency are 
given. Changes are related to values measured at day 1. Adapted from Krzysztoń et al.175 
Additionally, we investigate the colloidal stability of FolA-mNALPs that reveals 
the room temperature shelf life-time of at least 24 days. The data analysis are performed in 
the same way as the of plasma/serum stability experiments (Fig.3.10.).  
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3.1.4. Cell binding and uptake experiments 
 
Fig.3.11. Specific binding and uptake of FolA-mNALPs - confocal microscopy 
The confocal images of KB/WT cells showing co-localized late endosomes/lysosomes (stained with 
LysoTracker DND-99, red) and mNALPS (labelled ATTO488-dsDNA, green) - top row. The yellow 
regions indicate the co-localization of both red and green signals. The co-localization points are 
also marked with black tilted arrows. Blue vertical arrows indicate the perinuclear region as 
deduced from characteristic arch shape of late endosome distribution. The middle and bottom rows 
present the separated red and green channels respectively. To increase the contrast the background 
in the green channel is shown in white. From the left to right: data for FolA-mNALPs are com- 
pared to the controls (FolA-mNALPs in the presence of excess folate, non-targeted mNALPs, naked 
dsDNA and untreated cells). Reprinted from Krzysztoń et al.175 
Further, we verify the specific binding to folate receptors and uptake of folate-
functionalized mNALPs in in vitro studies using wild-type epithelial carcinoma KB cells 
(WT/KB). The folate receptors are significantly overexpressed in many types of human 
cancers and the folate-mediated endocytosis is often utilized for specific cancer targeting 
of nanoparticles (61). To ensure high-levels of overexpressed folate receptors, WT/KB cells 
are cultivated in low-folate-content RPMI 1640 medium (~5 nM). We investigate the 
specificity and efficiency of uptake both qualitatively and quantitatively using confocal 
imaging and flow cytometry respectively. In both cases the 21 bp dsDNA used for mNALP 
synthesis are doubly labelled with ATTO488 (ATTO488-dsDNA). 
We perform the confocal imaging on cells incubated in FolA-mNALP-containing 
folate-free RPMI1640 medium. We use the total ATTO488-dsDNA concentration of 50 
nM and 50 min incubation time. Cells incubated with bare ATTO488-dsDNA, non-folated 
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mNALPs and untreated cells are taken as negative controls. Additional control of cells 
incubated with FolA-mNALPs and with folate receptors saturated with 100 µM of folate is 
used to verity the particle-receptor binding and receptor-mediated endocytic uptake. We 
analyse the intracellular distribution of mNALPs using lysosome/late endosome staining 
with LysoTracker Red DND-99. The number of cell-bounded/internalized particles is 
significant only in case of FolA-mNALP sample (Fig.3.11, green). Low number of cell-
bounded particles are present in both mNALP controls, in the amounts comparable to the 
negligible unspecific bonding levels of bare ATTO488-dsDNA. Fluorescence signal of 
FolA-mNALPs co-localize significantly with the lysosomes/late endosomes (Fig.3.11, 
overlay), which accumulates mostly in the perinuclear region (Fig.3.11, red). Those 
findings suggest that FolA-mNALPs are internalized inside the cells mostly due folate-
receptor-mediated endocytosis, since competitive inhibition of receptors and lack of folate 
targeting reduces the uptake/binding levels drastically. Moreover, the strong co-
localization of lysosome/endosome and FolA-mNALP signals indicates that most of the 
internalized particles reside inside those organelles. 
 
Fig.3.12. Studies of dose dependence on FalA-mNALP binding and uptake by folate-receptor-
overexpressing KB/WT cells 
a) The fluorescence intensity distributions of cells incubated with ATTO488-labelled mNALPs as a 
function of concentration. b) The corresponding mean fluorescence intensities. The colours 
represent as follows: blue, FolA-mNALPs; orange, FolA-mNALPs after a brief acidic washing step; 
red, non-targeted mNALPs; green, non-coated ATTO488-dsDNA; black, untreated cells. Adapted 
from Krzysztoń et al.175 
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Further, we quantify the dose dependence and kinetics of FolA-mNALP binding 
and uptake using flow cytometry. Here, we use the same controls as in case of confocal 
imaging (excluding the competitive blocking of folate receptors). We distinguish between 
the internalized and surface-bound particles by detachment of mNALPs from the cell-
surface receptors. Binding of folate to folate receptors is sensitive to environment 
acidification and folate is released from the receptors at low pH. In order to release the 
surface-bounded FolA-mNALPs cells are briefly exposed to acidic condition in two 
additional washing steps with ice-cold acidified saline pH 3,4 (~ 10 s each washing step).57 
Cell viability after low-pH treatment was verified with Trypan blue assay revealing 92,3% 
viable cells. During the experiments, we use two batches of FolA-mNALP-treated cells. 
Additional cell batch is briefly exposed to low-pH conditions. We use the difference in 
detected fluorescence intensities between those two batches as a measure for amount of 
surface-bond particles. 
 
Fig.3.13. Studies of time dependence on FalA-mNALP binding and uptake by folate-receptor-
overexpressing KB/WT cells 
a) The fluorescence intensity distributions of cells incubated with 50 nM of ATTO488-labelled 
mNALPs as a function of incubation time. b) The corresponding mean fluorescence intensities. The 
colours represent as follows: blue, FolA-mNALPs; orange, FolA-mNALPs after a brief acidic 
washing step; red, non-targeted mNALPs; green, non-coated ATTO488-dsDNA; black, untreated 
cells. The purple areas in b) and trace in c) shows the difference between mean fluorescence 
intensities of acid-treated and acid-non-treated cells and represents the fraction of surface-bound 
FolA-mNALPs. The black line on c) shows the exponential fit to the data (k = (0.13 ± 0,02) min−1, 
r2 = 0.993). Adapted from Krzysztoń et al.175 
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Firstly, we incubate the WT/KB cells for 50 min with increasing concentration of 
FolA-mNALPs ranging between 10 and 85 nM of ATTO488-dsDNA. The mean 
fluorescence intensity of cells not exposed to acidic conditions is almost constant between 
all used concentrations suggesting that the saturation of folate receptors even at lowest used 
concentration of particles is achieved (Fig.3.12.). Contrary, cells exposed to acidified saline 
show an increase in fluorescence intensity with increasing particle concentration revealing 
rise in particle uptake. Negative controls of bare ATTO488-dsDNA and non-folated 
mNALPs show only a minor increase (~20%) in fluorescence intensity, revealing low 
unspecific binding that is also in accordance with confocal microscopy findings. 
Secondly, we investigate the kinetics of FolA-mNALP uptake. WT/KB cells are 
incubated with FolA-mNALPs containing 50 nM ATTO488-dsDNA in gradually 
increasing time periods ranging between 7,5 and 37,5 min. The increase in incubation time 
directly correlates with increase in cell fluorescence (Fig.3.13.). The difference between 
low-pH-treated and untreated batches decreases exponentially revealing the kinetic uptake 
rate of k = (0,13 ± 0,02) min-1 and levels off after at longer incubation times. The finding 
suggests that balance between receptor binding and cell internalization is reached within 
first 20 min of incubation. The negative controls of bare ATTO488-dsDNA and non-folated 
mNALPs show only minor increase in fluorescence intensity over time reaching levels 
observed in previous studies of concentration dependent binding/uptake. 
3.1.5. Silencing experiments 
We evaluate the silencing activity of siRNA-loaded FolA-mNALPs using a 
luciferase assay. We use the KB cells stably expressing enhanced Green Fluorescent 
Protein / Luciferase fusion protein (eGFPLuc/KB). Cells are incubated with FolA-
mNALPs containing 50 nM of siRNA in Folate-free RPMI 1640 medium. Two siRNA 
sequences are used: siGFP sequence, that targets the mRNA encoding eGFPLuc fusion 
protein and siCtrl control sequence to monitor potential false positive unspecific effects. 
The cells incubated with the non-folated mNALPs are taken as negative control. Moreover, 
the increased release of particles is facilitated in an additional batch of cells incubated in 
medium supplemented with 100 µM chloroquine - endosomolytic agent. After 48h of cell 
incubation, we assess the silencing activity by monitoring luciferase activity in a 
luminometric assay using a plate reader. The amounts of luciferase reaction product, 
luciferin, is quantified by the detected fluorescence intensity levels. We monitor the relative 
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changes in fluorescence intensities in comparison to untreated eGFPLuc/KB cells. The 
down-regulated luciferase activity is only observed in siGFP FolA-mNALP-treated cells in 
presence of chloroquine (Fig.3.14.). No unspecific gene silencing mediated by siCtrl 
sequence under all tested conditions can be seen. Presented results together with endosome 
co-localization studies suggest that particles are not capable of efficient escape from 
endosomes. Although, when released from endosomal environment by additional means, 
mNALPs are capable of releasing encapsulated siRNA into the cytoplasm. 
 
Fig.3.14. Quantification of silencing efficiency of FolA-mNALPs in KB cells expressing the 
eGFPLuc fusion protein (KB/eGFPLuc cells) 
Cells are incubated with siGFP-mNALPs (white) and FolA-mNALPs (grey) in the presence (right 
panel) and absence (left panel) of endosomolytic agent - chloroquine (chlq, 100 µM). Luciferase 
expression changes are presented as relative changes compared with untreated control cells. 
Adapted from Krzysztoń et al.175 
3.2. siRNA mediated mRNA degradation kinetics 
In this chapter, we analyse the kinetics of siRNA-mediated gene silencing on a 
single-cell level and use the determined kinetic parameters describing the process to 
quantify the silencing efficiency in a robust manner. 
In standard flow cytometry or plate reader in vitro assays the quantitative 
assessment of siRNA silencing efficiency is carried out on the level of cell population, by 
indirect measurement of protein levels. Here, the fluorescence intensity of reporter proteins 
or the products of their enzymatic activity (as in case of fluorescent protein reporters or 
luciferase reporters respectively), serves as a measure for the silencing efficiency. 
Importantly, the outcome of discussed assays is sensitive to the selected time points of 
measurement. Although flow cytometry and plate reader can be also used for kinetic 
measurements of fluorescence, the single-cell context of measured kinetics is then lost. 
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In contrast, quantitative time-lapse microscopy can resolve the full dynamic range 
of single-cell fluorescence intensity changes. By careful calibration and conversion of 
fluorescence intensities the numbers of expressed fluorescent reporter proteins can be 
derived and subsequently the expression kinetics can be mathematically modelled. The 
presented analytical approach gives direct access to the kinetic parameters of expression 
processes extending the quantitative single-cell analysis to the dynamic context. In 
comparison to standard methods based on fluorescence intensity analysis, the determined 
kinetic constants are time independent and constitute the absolute measures describing gene 
expression kinetics. Moreover, the single-cell level of analysis offers access to features that 
are not available on the population-averaged level that includes cell-to-cell variability and 
behaviour of rare and otherwise poorly detectable cell subpopulations. 
We use quantitative epifluorescence time-lapse microscopy combined with micro-
patterned cell culture substrates (Live-cell Imaging of Single-Cell Arrays, LISCA) to 
investigate the siRNA-induced silencing activity on the single-cell level. We utilise the 
changes in expression of enhanced Green Fluorescent Protein (eGFP) to quantify the 
silencing efficiency of delivered siRNA. Firstly, we present the quantitative outcome of 
direct fluorescence analysis following pDNA/siRNA transfection, both on single-cell a 
population-averaged level and compare the obtained results. Secondly, we estimate the 
silencing efficiency as a relative fold-change in mRNA degradation rate constants caused 
by siRNA activity. The mRNA degradation rate constants are obtained by mathematical 
modelling of eGFP expression following eGFP-mRNA transfection. Second, eGFP-siRNA 
delivery is used to modulate mRNA expression time profiles and observed changes are 
thoughtfully analysed. The internal reference of second, non-homologous reporter protein 
(Cayenne Red Fluorescent Protein, CayRFP) is used as an expression reference. 
Additionally, the correlations between kinetic parameters describing expression of both 
eGFP and CayRFP are analysed giving detailed insights into the processes of mRNA 
delivery and siRNA-induced silencing. 
3.2.1. Dual-reporter assays 
Silencing efficiency of siRNA is quantified using two, pDNA- and mRNA-based 
dual-reporter assays. We investigate the relative changes in expression of siRNA-targeted 
eGFP in relation to CayRFP reference (Fig.3.15.). Use of two non-homologous fluorescent 
proteins expressed from two identically controlled genes helps to decouple the silencing 
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Fig.3.15. Dual-reporter assay in time-lapse fluorescence imaging experiments 
The cells (as an example A549 cells) are seeded on the micro-pattern and spread on fibronectin-
coated adhesion sites (b).After pDNA/mRNA and subsequent siRNA transfection the changes in 
single-cell fluorescence of CayRFP reference and eGFP target are monitored (a) and can be 
quantified (b) yielding in fluorescence intensity time-courses. The incubation times used for 
transfection of the indicated RNAs are indicated in grey and purple. The incubation periods of 
mRNAs and siRNA transfection are indicated in grey and purple respectively (b). 
process from other, extrinsic factors that contributes to the fluctuations in protein 
expression levels. Both, eGFP- and CayRFP-encoding plasmids (pDNAG and pDNAR 
respectively) contain the same constitutive CMV promoter. Similarly, both eGFP- and 
CayRFP-mRNA (mRNAG and mRNAR respectively) constructs contain Kozak consensus 
sequence, initiation codon (AUG), anti-reverse CAP analog (ARCA) and poly-A tails of 
the same length (105 - 120 bases) to ensure the same efficiency of translation of both gene 
constructs (Fig.3.16.). In addition, both gene sequences have similar length, expressed 
proteins have similar size and undergo an oxygen-related maturation processes. pDNAG 
and pDNAR  or mRNAG and mRNAR are premixed in an equimolar rations prior to 
complexation with lipofectamine. In this way, the statistical variation between the numbers 
of eGFP- and CayRFP-encoding nucleic acids per transfection complex is minimised. Our 
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experimental assumption provides that on average the equimolar ratio remain preserved 
during the cellular uptake and release of complexes. 
 
Fig.3.16. The schematic representations of eGFP- and CayRFP-mRNA sequence constructs  
The schematic representations of eGFP- and CayRFP-mRNA sequence constructs used during 
experiments (mRNAG and mRNAR respectively). Both constructs bear a Kozak translation initiation 
sequence facilitating efficient initiation of translation, a poly-A tails of a length ranging between 
105 and 120 bases and anti-reverse CAP analog (m2 7,3’-OG[5']ppp[5']G ,ARCA) at the 5’ end for 
increased translation efficiency. 
3.2.2. Comparison of single-cell and population-averaged fluorescence analysis 
The pDNA-based dual-reporter assay is used to investigate the siRNA activity by 
the direct analysis of fluorescence intensities. We perform the analysis in analogy to 
standard flow cytometry or plate reader assays. The dual-reporter assay relies on two 
sequential transfections. Firstly, plasmid reporters are internalised by the cells during 1h 
incubation with pDNA/lipofectamine complexes. Secondly, the transfection medium is 
exchanged and eGFP-targeting siRNA is delivered during 30 min incubation with 
siRNA/lipofectamine complexes immediately after first incubation is finished. Following 
the second incubation the time-lapse imaging is started. We use the cells transfected only 
with pDNA as a control. Huh-7 cells are used. 
The representative examples of single-cell fluorescence intensity time-courses 
obtained for control cells are shown in Fig.3.17.a. as grey lines. Single-cell time-courses 
show sigmoidal time dependence with the time of fluorescence onset that varies 
significantly between particular cells. Fluorescence intensities of the individual cells level 
up and reach significantly diverse values. Time-courses of siRNA-treated cells show 
reduced eGFP fluorescence intensity levels compared to the control. Population-averaged 
fluorescence intensity presents a gradual increase in both experimental conditions over the 
time of experiment and reveals the qualitative difference when compared to single-cell data. 
Population-averaged fluorescence intensities are also altered by the activity of siRNA 
revealing significant difference between eGFP expression time-course of siRNA-treated 
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and control cells (Fig.3.17b.). Small differences in CayRFP expression are present in the 
initial stages of protein expression between siRNA-treated and control cell populations 
both on single-cell and population level. This effect can be attributed to unspecific activity 
of siRNA or other side-effects.201, 202 
 
Fig.3.17. Single-cell pDNA expression dynamics 
(a) Single-cell time-courses of eGFP and CayRFP fluorescence intensities (grey lines) following 
transfection with plasmid DNAs vary significantly between each other. On average, the maximum 
fluorescence intensities decrease following siRNA delivery (top row: siRNA-treated vs. control 
cells). Grey and purple areas denote the periods of cell incubation with pDNA and siRNA 
transfection complexes respectively. (b) Population-averaged eGFP and CayRFP time-courses 
shown as green and red lines (both in (a) and (b)). In the insert in (b), population-averaged data 
are plotted in a log scale. 
Next, we evaluate the silencing efficiency and discuss the differences that arise 
when the analysis is carried out on population and single-cell level. In this experiment, we 
quantify the silencing efficiency by a change in the relative fluorescence that is defined as 
fluorescence intensity ratio eGFP/CayRFP of the targeted eGFP in relation to internal 
CayRFP reference. Fig.3.18.a presents the values of relative fluorescence calculated from 
the population-averaged <eGFP> and <CayRFP> fluorescence intensities at five selected 
time points. Presented analysis are analogous to plate-reader-based assays. In order to 
eliminate the effect of the different quantum yield of both fluorescent proteins the average 
of relative fluorescence values from selected time points obtained for the control cells is 
taken as reference point. Normalized data are presented in Fig.3.18a. on the right axis of 
the plot as a percent of the reference. Based on the normalization the relative fluorescence 
is found to decrease from 62,5% to 8% between 10 and 30 hours post transfection. In a 
second round of analysis, the population average of single-cell relative fluorescence values 
<eGFP/CayRFP> at five selected time points are considered. We select the reference time 
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point for normalisation in a way that is analogous to the procedure described for population-
averaged data. Similar analysis might be performed using flow cytometry assays.  The 
single-cell-level analysis revealed the decrease in relative fluorescence from 21,7% to 
0,59% between 10 and 30 hours post transfection (Fig.3.18b.).  
 
Fig.3.18. Single-cell vs. population-averaged fluorescence analysis – silencing efficiency 
Population-averaged eGFP/CayRFP relative fluorescence intensity (a) and average single-cell 
eGFP/CayRFP relative fluorescence intensity (b) plotted as a function of time (blue: control cells; 
orange, siRNA-treated cells). Five selected time points are presented. The single-cell data of 
siRNA-treated cells shows a stronger decrease in relative fluorescence reflecting the silencing 
efficiency than does the population-averaged data. Relative error of the eGFP/CayRFP relative 
fluorescence intensities obtained from (c) population-averaged and (d) single-cell data analysis. 
Notably, the outcome of both analytical approaches varies significantly. The 
explanation can be found when the cellular noise in protein expression levels is considered 
(120).  Fig.3.19a. shows the distributions of the relative fluorescence for both siRNA-
treated (orange) and control cells (blue). Obtained single-cell distributions vary over two 
and three orders of magnitude in siRNA-treated and control cells respectively. Shift 
between mean values of those distributions reflects the silencing efficiency and is smaller 
than the widths of distributions in each of selected time points. In addition, scatter plots of 
eGFP vs. CayRFP fluorescence intensities reveal the correlations between single-cell 
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values (Fig.3.19b.). This observation suggest that the total cellular noise is significantly 
affected by the extrinsic contribution. Importantly, the extrinsic noise is significantly 
reduced when the expression control is referenced at the level of single-cells, which 
demonstrates the significant benefits of single-cell approach.  
Yet, the major drawback of quantifying the siRNA silencing efficiency by 
comparative changes in reporter fluorescence intensities is the fact that the outcome is time 
dependent. Even when the CayRFP expression reference is in use, the changes in relative 
eGFP/CayRFP fluorescence intensity do not reach the steady value over the 30 h post 
transfection (Fig.3.18.a.b., orange). Additionally, the measurements performed at early 
time points are affected by significant standard error limiting the accuracy of the 
measurement (Fig.3.18c. and Fig.3.18d.). The described features limit the analytical utility 
of direct fluorescence analysis and introduce method-related biases. To overcome this 
problem, in further experiments we exploit the full kinetics of measured single-cell 
fluorescence time-courses and derive the mRNA degradation rate constants using a 
mathematical model of protein expression. 
 
Fig.3.19. Single-cell fluorescence analysis – population distributions 
(a) Distribution of single-cell eGFP/CayRFP relative fluorescence intensities (orange: siRNA-
treated cells, blue: control cells). (b) Single-cell eGFP vs. CayRFP fluorescence intensity scatter 
plots for various time points. The distribution of clusters reveals both an extrinsic and intrinsic 
contribution to cellular noise. Black-bordered circles represent the population averages. 
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3.2.3. Kinetic analysis of mRNA expression time courses 
 
Fig.3.20. Single-cell mRNA expression kinetics in the presence of siRNA 
Top panel: Single-cell time-courses of eGFP and CayRFP expression obtained using Huh-7 (a) 
and A549 cells (b) treated with eGFP- siRNA and control cells. Coloured lines represent the 
population averages. Grey and purple bars denote the incubation periods of mRNA and siRNA 
transfection respectively.  Middle panel: Schematic drawing of the kinetic model used in the 
analysis (c). The model accounts for mRNA translation, fluorescence protein maturation, mRNA 
and protein degradation as first order mass action processes. Bottom panel: The representative 
time-courses of eGFP and CayRFP expression in siRNA-treated (e) and control cells (d) together 
with related fits of the mathematical model. Residuals indicate agreement of fits and data. 
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To obtain an unbiased, time-independent measure for siRNA silencing efficiency 
we derive the absolute values of mRNA degradation rate constants (δ) by kinetic analysis 
of single-cell fluorescence time-courses. To this end, the mathematical modelling of 
expression kinetics is required. For practical reasons it is convenient to reduce the 
complexity of the molecular network underlying the expression by exploiting the mRNA 
delivery instead of pDNA used in previous experiments. Contrary to pDNA, mRNA does 
not require nuclear entry for efficient expression of encoded genes and omits completely 
the steps of transcription, nuclear transport and maturation of produced mRNA. The 
mRNA-based dual-reporter assay comprise of two sequential transfections. Firstly, the 
synthetic mRNAG and mRNAR constructs are delivered during 30 min cell incubation with 
mRNA/lipofectamine complexes. Secondly, the transfection medium is exchanged and a 
second 30 min incubation with eGFP-siRNA/lipofectamine complexes is performed. 
Importantly, we convert the obtained single-cell fluorescence intensities into the numbers 
of expressed proteins during the calibration procedure using a microfluidic device. We use 
the cells transfected only with mRNA as a control. Experiments are performed on Huh-7 
and A549 to confirm the generality of the findings. 
The representative examples of single-cell time-courses are presented in the 
Fig.3.20a. and Fig.3.20b.. The transient expression of mRNA presents more homogenous 
time profiles of protein numbers expressed in each single cell within the population 
compared to pDNA expression. Notably, the distribution of onset times is visually narrower 
and the shape of individual time-courses are more similar to each other. There is a 
significant difference between the maximal number of expressed eGFP molecules between 
siRNA-treated and control cells, both on single-cell and population-averaged level, as in 
the case of pDNA transfection. The kinetic model of protein expression following mRNA 
delivery comprises four processes (Fig.3.20c.). The same model applies for both reporter 
proteins. mRNA released into the cytoplasm of each cell (mRNAG0 = mG0) serves as a 
template for protein translation. Translated, non-mature proteins (eGFP*) undergo 
maturation into the fluorescent, mature state (eGFP). Both, mRNA and proteins also 
undergo a degradation process. We assume that the degradation kinetics of mature and non-
mature proteins is described by the same parameters. All processes are modelled using first 
order mass action kinetics. The related set of differential equations (ODEs, eq. 2.42-2.44.) 
is given in experimental section. Mathematical expression describing the time-dependent 
changes in the fluorescent protein numbers (eq. 2.45.) is obtained by solving given equation  
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Fig.3.21. Identifiability of fit parameters 
a) The repeated, independent fits to the same experimental time - course yielded varying 
interdependent parameter values when all free parameters underwent optimization. Plots present 
the correlations between pairs of parameters obtained in one hundred iterative fits of a two, eGFP 
and CayRFP, expression time-courses derived from single Huh-7 cell from control population. The 
initial values of parameters are varied between each fitting run. b) The parameter correlations are no 
longer visible (parameters have converged to a single point) when the protein maturation and 
degradation rate constants are fixed at the values determined during translation inhibition 
experiments. The parameter values of iterative fits are converging towards single, particular value. 
The effect is seen for both siRNA –treated (II) and control (I) cells. 
set and used while fitting the experimental data. Fitting of CayRFP and eGFP expression 
time-courses is done independently. This procedure resulted in four independent kinetic 
rate constants related to each of described kinetic processes and, additionally, the 
expression onset time as free parameters. Importantly, the initial number of mRNA 
molecules and the translation rate constant are fitted jointly as they are not separately 
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identifiable by the model. The jointed parameter m0ktl formally represents the initial 
translation rate. In case of siRNA-treated cells, both the unspecific and siRNA-related 
mRNA degradation are modelled by first order mass action kinetics. It implies that the 
effective mRNA degradation rate constants determined during the experiments are the sums 
of the rate constants describing both processes (δ G(siRNA) = δG + δG-siRNA). 
The chosen model agrees with the data in case of both siRNA-treated and control 
cells as demonstrated by the residuals in  Fig.3.20d. and Fig.3.20e.. Although, the repeated, 
independent fits to the same experimental time-course result in varying and interdependent 
parameter values when all free parameters have undergone optimization (Fig.3.21a.). This 
indicates that the parameter estimates are not unique. Such behaviour is commonly referred 
to as a structural identifiability problem.203 To eliminate described ambiguities, we further 
simplify the model by eliminating the maturation and degradation rate constants (km and β) 
from the pool of free parameters (Fig.3.21b.). Both values are determined in following 
independent translation inhibition experiments and fixed during analysis of mRNA 
expression time-courses. 
3.2.4. Translation inhibition experiments 
 
Fig.3.22. Translation block experiments – single-cell time-courses and mathematical model 
 (a) Single-cell time-courses of eGFP and CayRFP fluorescence following the blockage of 
translation. The green and red bars indicate the time of mRNA transfection. The onset of translation 
blockade is taken as time 0 and is represented as dashed line. (b) The reduced kinetic model used 
for data evaluation. Model accounts for protein maturation and degradation only. 
We determine the maturation and degradation constants of both proteins in single-
cell translation inhibition experiments. The translation blockade is induced following initial 
mRNA transfection by cell incubation in media containing cycloheximide, the translation 
blocking agent. Media exchange is done during the first hours of protein expression. As a 
result, the following changes in fluorescent protein numbers reflects the kinetics of the 
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protein maturation and degradation. The number of mature fluorescent proteins initially 
increases due to excess of translated, non-mature proteins that maturate over time and enter  
 
Fig.3.23. Population distributions of the maturation (km) and degradation (β) rate constants for 
CayRFP and eGFP 
Population distributions of the maturation (km) and degradation (β) rate constants for CayRFP (a) 
and eGFP (b). Black lines are given to guide the eye. 
the fluorescent state (Fig.3.22.). Subsequent decrease is associated with protein degradation 
that dominates the kinetics at late time scales. Described changes are following the kinetics 
described by reduced set of differential equations eq. 2.46-2.47. that are presented together 
with the analytical solution (eq. 2.48.) in the experimental section. The same model is used 
in the case of both proteins. Fig.3.23. shows obtained distributions of protein maturation 
(km) and degradation (β) rate constants. The corresponding mean values and related 
standard deviations are presented in table Tab.3. Data converted into the maturation and 
degradation halt-times are also given. eGFP and CayRFP show significant differences in 
both maturation and degradation kinetics. eGFP shows faster maturation (4-fold higher 
compared to CayRFP) and slower degradation (8-fold lower than CayRFP) compared to 
CayRFP. The measured mean values of both maturation and degradation kinetic rate 
constants are fixed during the analysis of single-cell mRNA expression time-courses. 
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Tab.3. Mean degradation (β) and maturation kinetic constants (km) (and related half-times 
τβ and τm) 
The mean degradation (β) and maturation kinetic constants (km) (and related half-times, τβ and τm 
respectively), together with related standard deviations (a̅), determined from single-cell analysis. 
 β ± aºÂ  [h-1] τβ ± aNºÃÃÃÃ [h] km ± a*ÃÃÃÃÃ [h-1] τm ± aN*ÃÃÃÃÃ [h] 
eGFP (5,22 ± 3,27) · 10-3 132,8 ± 92,2  1,26 ± 0,48 0,54 ± 0,21 
CayRFP (4,21 ± 1,32) · 10-2 16,45 ± 0,18 0,30 ± 0,08 2,29 ± 0,63 
3.2.5. Correlation analysis 
By fixing the protein maturation (km) and degradation (β) rate constants, we can 
determine the remaining kinetic parameters in a robust, unbiased manner. The analysis 
yielded the population distributions of I) initial translation rates, expressed as a product of 
initial mRNA molecule numbers and translation rate constant II) times of expression onset 
and III) the mRNA degradation rate constants. The parameters describing single-cell eGFP 
and CayRFP expression kinetics are obtained from both, siRNA-treated and control cells. 
Scatter plots (Fig.3.24 and 3.25) present values of parameters obtained from single-cell fits. 
Each point corresponds to the values obtained from one cell. In the following, we analyse 
the correlations observed between the expression parameters of both proteins. We 
demonstrate that, of the fitted parameters, the initial translation rates (m0ktl) and expression 
onset times (t0) are only moderately affected by siRNA activity, while the mRNA 
degradation rate constants exhibit a clear siRNA-mediated increase. 
For both the initial translation rates m0ktl and the expression onset times t0 we expect 
strong correlation between eGFP and CayRFP reporters. This is because, according to our 
hypothesis, both mRNAG and mRNAR constructs are co-delivered in equimolar ratio and 
should have the same fate in each individual cell. The values of initial translation rates 
(m0ktl) and expression onset times (t0) are indeed strongly correlated between eGFP and 
CayRFP reporters (Fig.3.24.). The slopes of the main axis of the t0 clusters for control cells 
were determined by linear fits. In contrast, the log-transformed m0ktl values of control cells 
were fitted to a linear function with slope 1 and intercept a. Since a log-log linear fit is 
equivalent to a power-law fit, we interpreted the logarithm of the intercept as the linear 
slope of m0ktl. In both cases the slopes in the eGFP vs. CayRFP plots are close to 1 (0,98 ±  
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0,01 for Huh-7 and 1,05 ± 0,01 for A549 in case of t0; 1,15 ± 0,02 for Huh-7 and 1,13 ± 
0,07 for A549 in case of m0ktl). The corresponding Pearson correlation coefficients (PCC) 
values of the log-transformed m0ktl correlations are 0,89 (p < 0,0001) and 0,71 (p < 0,0001) 
for Huh-7 and A549 control cells respectively. Similarly, correlations between t0 (eGFP vs. 
CayRFP) are described by PCCs of 0,9 (p < 0,0001) and 0,85 (p < 0,0001) for Huh-7 and 
A549 control cells respectively. Provided, that both mRNA and mRNA constructs are co-
delivered in equimolar amounts, the translation rate constant is found to be in average 15% 
and 13% higher than CayRFP for Huh-7 and A549 control cells respectively. 
 
Fig.3.24. Single-cell correlations between parameters obtained from eGFP and CayRFP time-
courses (m0ktl and t0) 
(a) The expression onset times (t0) and (b) initial translation rate (m0ktl) obtained with Huh-7 cells. 
(c) and (d) show the corresponding data obtained with A549 cells (Orange: siRNA-treated cells, 
blue: control). The light blue lines represent linear fits to the control data. Fits to the scattered m0ktl 
data are performed after logarithmic transformation of determined values. The fits revealed the 
correlation slopes of approximately 1 in case of both t0 and m0ktl. The average onset time of CayRFP 
is delayed in reference to eGFP. 
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Fig.3.25. Correlation dot-plots of expression onset times t0 and initial translation rate m0ktl (m0ktl 
vs. t0) 
The correlation dot-plots of expression onset times t0 and initial translation rate m0ktl obtained of 
the same protein for (a) Huh-7 and (b) A549 cells with both siRNA-treated and control cell 
populations (green – eGFP, red – CayRFP). The particularly strong negative correlation is seen 
for control population of Huh-7 cells (a).(The Pearson correlation coefficients revealed values of 
PCC=-0,34 (p<0,0001) and PCC=-0,13 (p<0,0001) for CayRFP and eGFP respectively in Huh-7 
siRNA-treated; PCC=-0,47 (p<0,0001) and PCC=-0,63 (p<0,0001) for CayRFP and eGFP 
respectively in Huh-7 control; PCC=-0,18 (p=0,0008) and PCC=-0,003 (p=0,48) for CayRFP and 
eGFP respectively in Huh-7 siRNA-treated; PCC=-0,03 (p=0,27) and PCC=-0,29 (p<0,0001) for 
CayRFP and eGFP respectively in Huh-7 control). 
Both, The m0ktl and t0 correlations are weakened upon siRNA treatment of cells 
(PCC = 0,56 (p < 0,0001) and 0,64 (p < 0,0001) for Huh-7 and A549 cells respectively in 
case of m0ktl and PCC = 0,58 (p < 0,0001) and 0,75 (p < 0,0001) for Huh-7 and A549 in 
case of t0). siRNA treatment results also in a shift towards higher m0ktl values and 
shortening of the expression onset times t0 of both proteins when values are compared to 
control cell results. Weakening of m0ktl correlation might be associated with the ribosome 
blocking activity of RISC complex.204–206 The shift towards shorter onset times might 
reflect the long-term effects of RISC activity. Here, the small amounts of late-released 
mRNA molecules are quickly degraded preventing the transfected cells from expressing 
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the targeted proteins. This claim is strengthen by the negative correlations observed 
between the number of released mRNA molecules (estimated using m0ktl) and the 
expression onset times t0 obtained for the same protein (Fig.3.25.). This observation 
indicates the existence of "temporal window of opportunity" for endosomal escape, the 
effect in which the efficient protein expression is achieved only when the transported 
nucleic acids are released from transfection complexes before being degraded in late 
endosomes.207, 208 Additionally, we find a significant delay between the average onset times 
of eGFP (t0G) and CayRFP (t0R) expression (delay of 1,81 h and 1,53 h for Huh-7 and A549 
control cells respectively and 1,83 h and 1,2 h for siRNA-treated Huh-7 and A549 cells 
respectively, quantified using the difference between population averages of both 
parameters). The delay is in accordance with observed difference in maturation time and 
translation rate constants between both proteins discussed previously. 
Next, we discuss the mRNA degradation rate constants (δ), which exhibit the most 
profound changes upon siRNA treatment. The control cell data show significant correlation 
(PCC = 0,53 (p < 0,0001)  for Huh-7 and PCC = 0,56 (p < 0,0001) for A549) between 
single-cell values describing eGFP- and CayRFP-mRNA degradation (δR and δG 
respectively). Data represented in double-logarithmic scale are presented in Fig.3.26. in 
orange and blue for siRNA-treated and control cells respectively. The degradation rate 
constants obtained for control cells are distributed over one order of magnitude in the case 
of both eGFP- and CayRFP-mRNA degradation constants. Here, the slope of the main axis 
of scattered distributions is given by the values of 0,46 and 0,36 for Huh-7 and A549 cells. 
We determine the slope by linear fit to log-transformed data. Notably, a slope of less than 
one indicates that the relation between δR and δG falls beyond linear proportionality and 
cannot be explained by assuming that a single enzyme is acting on both mRNA constructs 
with different affinities. Although, a simple model that incorporates two independent decay 
pathways, i.e. a minimum of two enzymes contributing, suffices to reproduce the observed 
slope as presented in further sections. We suspect that the differences between δR and δG 
might reflects the differences in codon usage in the eGFP and CayRFP coding sequences 
(Fig.3.27.).209–212 
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Fig.3.26. Correlation analysis of mRNA degradation constants (δ) 
Values of single-cell degradation constants of mRNAG and mRNAR are plotted (a, Huh-7 cells; c, 
A549 cells). The slopes of correlations of control cell data reflect non-linear relationship between 
mRNAG and mRNAR degradation constants (slope determined by linear fit to log-transformed data, 
log(δG) = 0.46*log(δR) – 0.35 for Huh-7 cells, log(δG) = 0.36*log(δR) – 0.55). The scattered clusters 
of values obtained with siRNA-treated cells of both cell lines (a and c) reveal significant shifts 
towards higher δG values. δG values range over three orders of magnitude. The same distributions 
reveal the existence of two subpopulations characterized by high and low degradation constants (b 
and d, top). The subpopulation with low values shows a broad overlap with the distribution of 
control cells. A small shift towards higher degradation constants is also seen in δR (b and d, bottom). 
The positions of peaks related with two subpopulations present within siRNA-treated cell 
population are determined from log-normal fits (black, solid and dashed lines). 
 In the context of the goal of our work, however, the most important finding is that 
we observe a significant shift in eGFP-mRNA degradation rate constants (δG) towards 
higher values for siRNA-treated cells in both cell lines. A profound broadening of the 
corresponding δG distribution is observed. This spread of the values reaches three and two 
73  3. Results 
orders of magnitude for Huh-7 and A549 cells respectively. Consequently, the distribution 
broadening results in weaker correlations between δG and δR (PCC = 0,09 (p < 0,0001) for 
Huh-7 and PCC = 0,27 (p < 0,0001) for A549). In addition, the δG distributions obtained 
from siRNA-treated cells reveals the existence of two cell subpopulations that present high 
and low values of mRNA degradation constants respectively. The latter subpopulation 
overlaps with the distribution derived from the control sample, and therefore might be 
attributed to the cells that either have not been successfully transfected with siRNA or do 
not respond to siRNA due to other factors. This effect is present in both cell lines, although 
it is more pronounced in A549 cells. Both the loss of correlation and the existence of cell 
subpopulations that have escaped siRNA transfection are most likely due to the stochastic 
nature of cellular uptake and endosomal release of siRNA complexes, which are 
independent of the mRNA degradation processes. 
Tab.4. mRNA degradation rate constants δ  (and related half-times τδ ) 
The medians of mRNA degradation rate constants δ  (and related half-times τδ ), together with 
standard errors (a̅), as determined from log-normal fits to single-cell distributions. Presented data 
are obtained with Huh-7 and A549 cells, for both target and reference mRNA constructs (eGFP 
and CayRFP respectively) and in both experimental conditions. a and b denote the values of the 
transfected and non-transfected subpopulations present among siRNA-treated cells respectively. 
Huh-7 
Control
 
siRNA-treated
 
Relative 
change 
δ ± aRÂ  [h-1] τδ ± aNRÃÃÃÃ  [h] δ ± aRÂ  [h-1] τδ ± aNRÃÃÃÃ  [h] 
eGFP (34,5 ± 0,2) · 10-2 2,01 ± 0,01 a (291,0 ± 9,5) · 10-2  
b
 (55,1 ± 4,3) · 10-2 
0,24 ± 0,01        
1,26 ± 0,10 
8,4 ± 0,3 - fold 
CayRFP (45,1 ± 0,6) · 10-2 1,54 ± 0,02 (53,7 ± 0,9) · 10-2 1,29 ± 0,02 1,19 ± 0,03 - fold 
A549 
control
 
siRNA-treated
 
Relative 
change 
δ ± aRÂ  [h-1] τδ ± aNRÃÃÃÃ  [h] δ ± aRÂ  [h-1] τδ ± aNRÃÃÃÃ  [h] 
eGFP (20,1 ± 0,2) · 10-2 3,45 ± 0,03  a (128,5 ± 7,6) · 10-2  
b
 (22,0 ± 1,8) · 10-2 
0,54 ± 0,03        
3,16 ± 0,26  
6,4 ± 0,4 - fold 
CayRFP (35,4 ± 0,6) · 10-2 1,96 ± 0,04 (46,5 ± 1,0) · 10-2   1,49 ± 0,03 1,31 ± 0,04 - fold 
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Finally, we determine the silencing efficiency as fold-change in mRNA degradation 
constants that arise upon siRNA activity. The distributions of siRNA-treated and control 
cell populations are analysed using log-normal fits to the experimental data. Two log-
normal distributions are used to account for two subpopulations existing in siRNA-treated 
sample. Shifts between positions of the dominant subpopulation of siRNA-treated cells and 
the control cells serve as a measure of silencing efficiency. The corresponding relative 
changes in the median of the mRNA degradation constants between those two distributions 
reveal 8,4 ± 0,3 – fold for Huh-7 and 6,4 ± 0,4 – fold increase in δG for A549 cells. The 
accuracy of determined values reaches 3,3% and 6% as quantified using relative error for 
Huh-7 and A549 cells respectively. The method eliminates also the bias introduced by the 
presence of cells that have not been successfully transfected with siRNA in the siRNA-
treated population. Additionally, a small shift towards higher values is also seen in case of  
δR (1,19 ± 0,03 – fold and 1,31 ± 0,04 – fold increase  for Huh-7 and A549 cells 
respectively) that might be related with the unspecific activity of siRNA or other side 
effects.201, 202 The degradation rate constants (δ) obtained from all log-normal fits and 
related mRNA half times (τδ ) are presented together with corresponding standard errors in 
Tab.4.  
3.2.6. Codon optimality of eGFP- and CayRFP-mRNA constructs 
We attribute the difference in degradation rates observed between CayRFP- and 
eGFP-mRNA to the significant differences in codon optimality within those two gene 
constructs (Fig.3.27.). Recently codon optimality has been found to be one of the 
determinants of mRNA stability. Although, up to now the underlying processes related with 
codon-optimality-dependent mRNA degradation are under dispute.209–211, 213 The relative 
abundance of the tRNA that recognizes given codons was causally linked with codon 
optimality defined by their translational efficiency. Codons related with the tRNAs of low 
abundance are translated less efficiently, which correlates with decreased mRNA stability. 
The causality of observed correlations was demonstrated by substitutions of optimal codons 
with synonymous codons of lower optimality in stable endogenous mRNA and vice versa. 
Described substitutions result respectively in a relative decrease and increase in mRNA 
stability.209–211, 213, 214 Arguably, the mRNA stability is affected, at least in part, by the speed 
of translation elongation since it was shown that the process of cognate tRNA recognition 
influences translation during elongation phase of the process.215 Although, the tight link 
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with common mRNA surveillance pathways is not found and the deadenylation and 
decapping mRNA degradation processes might play a crucial role in the increase of decay 
rates.209, 211 Evidence of Dhh1 RNA-dependent ATPase activity in the context of ribosome 
movement and reduced mRNA stability related with decapping was recently found.213 
 
Fig.3.27. Occurrences of codons encoding different amino acids as found in used eGFP and 
CayRFP coding sequences 
The occurrences of codons encoding different amino acids as found in used eGFP (green) 
and CayRFP (red) coding sequences compared to natural occurrence frequency in human genome 
(black) (represented as occurrence probability). CayRFP gene shows similar frequency of codon 
occurrences when compared with human genome. The eGFP coding sequence is optimized for 
maximizing expression efficiency in human cells as the most of silent base changes in the coding 
sequence favors the human codon-usage preferences. 
We propose a simplistic enzymatic model, that qualitatively and quantitatively 
explains the distribution and inclination of scattered clusters of mRNA degradation rate 
constants (Fig.3.28.). Assuming, that at least two enzymes (RNaze “X” and RNaze “Y”) 
following Michaelis-Menten kinetics are degrading mRNAG and mRNAR, one can derive 
the effective degradation constants of both mRNA constructs as: 
G = 	 t»ÄÄÅ»Ä &[*1eµ]+
t»ÄÈ	
Å»È&[*1eµ]                                                                                    (eq. 3.3.) 
where: [mRNA] denotes mRNA concentration, Vmaxx/y -maximum reaction rate of both 
enzymes, Kmx/y – Michaelis constant of both enzymes. Notably, the mRNA lipoplexes are 
formed with equimolar amounts of both CayRFP- and eGFP-mRNA. In this case, the 
concentration of both released mRNA constructs is roughly equal, [mRNAG] ≈ [mRNAR]. 
Further assumption holds that only one enzyme (RNaze “Y”) shows increased catalytic 
activity while degrading CayRFP-mRNA. Since the details on the regulation mechanism  
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Fig.3.28. Calculated dependence between CayRFP- and eGFP-mRNA degradation constants (δG 
vs. δR) overlaid with experimental data 
The non-competitive (a and b) and uncompetitive (c and d) allosteric regulation are considered. 
a,c) The calculations done for model of two enzymes degrading both mRNA constructs overlaid 
with scatter cloud of control Huh-7 cells (blue squares). Orange solid line shows the best agreement 
with the data and is obtained for VmaxX = 5 [nM h-1], KmX = 15 [nM], VmaxY = 2,8*10-2 [nM h-1], 
KmY = 1*10-3 [nM], α’ = 12,5. The dashed lines represent the traces obtained for following sets of 
parameters (from most grey to most orange): 
VmaxX = 5 [nM h-1], KmX = 15 [nM], VmaxY = 2,8*10-2 [nM h-1], KmY = 1*10-3 [nM], α’ = 1000; 
VmaxX = 1 [nM h-1], KmX = 50 [nM], VmaxY = 2,8*10-2 [nM h-1], KmY = 1*10-3 [nM], α’ = 12,5; 
VmaxX = 5 [nM h-1], KmX = 50 [nM], VmaxY = 2,8*10-2 [nM h-1], KmY = 1*10-3 [nM], α’ = 12,5. 
B,d) The blue lines represent the traces obtained when additional mRNAG degradation by RISC is 
taken into account (kcatRISC = 25,56 [h-1], KmRISC = 8,4 [nM]). Change in shape of blue lines 
represents the increasing concentration of siRNA-loaded RISC proportional to the amount of 
mRNA taken up by cells (proportionality parameter equals 0; 0,05; 0,1; 0,2; 0,4; 0,8; 1,6; 3,2 and 
6,4. Arrow indicates increase). Lines are overlying well with the experimental data obtained for 
siRNA-treated Huh-7 cells (orange squares). Black line on a and b is determined as a linear 
regression to data obtained for control population of Huh-7 cells (log(δG) = 0,46*log(δR) – 0,35). 
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of codon-dependent mRNA degradation are still under dispute, the general scenarios of 
allosteric regulation are considered. The inhibitor/activator-related allosteric regulation 
might occur within two underlying scenarios. Firstly, the regulator can bind to the enzyme 
only when a substrate is incorporated within the enzymatic complex (e.g. uncompetitive 
inhibition). Secondly, the regulator can bind to the enzyme independently of substrate 
incorporation (e.g. non-competitive inhibition). Both scenarios relate to different changes 
in kinetic parameters of the modulated enzyme. The non-competitive inhibition affects only 
the maximal reaction rate Vappmax, which scales with the concentration of the modulator. 
Y*x,Éx1J	 =	¤lY*x,J	 = ¤lY*x	                                                                            (eq. 3.4.) 
where, α’ is the proportionality parameter. On the other hand, uncompetitive inhibition 
leads to concurrent changes in the Michaelis constant (Kmy) and maximal reaction rate 
(Vmaxy), that keep the Kmy/Vmaxy ratio constant. 
*x,Éx1J	 = Å»
È,
¶ÊË	
¢r 	= Å»
È,
¢r ; 	Y*x,Éx1J	 =	¤lY*x,J	 = ¤lY*x	 	                           (eq. 3.5.) 
Depending on the choice of kinetic parameter values the relation eq. 3.4. and eq. 3.5. lead 
to the δG(δR) dependence as shown on Fig.3.28a. and Fig.3.28c. respectively. The 
characteristic slope seen in case of control cell population could be reproduced as an effect 
of different enzyme activity in case of both regulation mechanisms considered.  
Further, we introduce the RISC as additional enzymatic factor of siRNA-related 
degradation in case of eGFP-mRNA. Here, the amounts of siRNA taken up by each cell, 
thus the concentration of siRNA-loaded RISC, is assumed proportional to released mRNA 
and depends on endocytic activity of each cell. In this case, the eGFP-mRNA degradation 
constant is given by: 
G =	 t»ÄÄÅ»Ä &[*1eµ¶]+
t»ÄÈ
Å»È&Í*1eµ¶Î+
ÏÐ(ÑÒÓ[1[ZÉÔK(ÕÖ]
Å»	(ÑÒÓ&[*1eµ¶]                                                  (eq. 3.6.) 
Here, kcatRISC = 25,56 [h-1] = 7,1*10-3 [s-1] – RISC turnover number, KmRISC = 8,4 [nM] – 
RISC Michaelis constant [in vitro data]205, [RISCsiRNA] – concentration of siRNA-loaded 
RISC. When one also considers the siRNA-dependent degradation the characteristic shape 
of scatter cloud density is reproduced (Fig.3.28).  
The maximum reaction rates and Michaelis constants estimated here ((VmaxX = 5 nM 
h-1, KmX = 15 nM, VmaxY = 2,8*10-3 nM h-1, KmY = 1*10-3 nM) are varying significantly 
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(orders of magnitude) from the literature values obtained for most common RNases 
measured in vitro.216–219 This effect might relate with significantly different reaction 
conditions within the cells, associated with molecular crowding, low numbers of enzymes 
or extended network of regulatory pathways. Although, all numbers presented here need to 
be treated as rough estimations. 
4. Conclusions. 
In the first part of the work, we have presented a microfluidic-based method for the 
synthesis of monomolecular nucleic acid/lipid particles, mNALPs. We have demonstrated 
that by rational design of lipid composition, combined with microfluidic mixing by 
hydrodynamic focusing we have improved the control the over particle assembly process. 
Gained control over mixing times allowed us to enhance the physicochemical properties of 
particles such that the majority contain on average a single 21 bp dsDNA or siRNA covered 
with single, highly curved and PEG-grafted lipid bilayer. The synthesis is robust, 
reproducible and yields particles of superior colloidal properties when compared to the 
product of standard macroscopic mixing by vortexing.  
In particular, particles show narrower size distribution, minimized numbers of 
unwanted aggregates and a 20% higher efficiency of NA encapsulation. Further reduction 
of solvent mixing times using surface acoustic waves did not have a significant effect on 
particle properties.220 Importantly, the prospect of robust continuous-flow synthesis allows 
for automation and scaling up the production yield without losses in sample quality by 
parallelization of the process.  It was shown in previous studies that the reduced size of 
delivery agents (below 50 nm in diameter) enhances the efficiency of in vivo delivery into 
solid tumours and improves the bio-distribution of nanoparticles in general.64, 65 In this 
context, small and monodisperse mNALPs, that reach the minimal size limit of lipid-
bilayer-coated siRNA nanoparticles, could be an important system for possible medical 
applications in treatment of solid tumours.  
The functionalization of mNALPs with folate (FolA-mNALPs) resulted in specific 
binding and uptake by folate-receptor-overexpressing KB cells. The differential confocal 
microscopy studies presented indicate that uptake is related with receptor-mediated 
endocytosis. Kinetic studies using flow cytometry indicated that particles are efficiently 
internalised within 20 min of cell incubation. In the same time, surface passivation by PEG-
79  4. Conclusions. 
grafting of particle surface minimises the receptor-unrelated uptake and results in high 
specificity of targeting. Moreover, FolA-mNALPs present high stability in biological fluids 
(blood serum and plasma) has the potential to increase the lifetime of particles following 
in vivo systemic administration. Fola-mNALPs do not loose their properties up to 24 days 
of storage at room temperature.  
Despite the efficient cellular internalization, mNALPs are not capable of successful 
escape from endosomes as revealed by nanoparticle/endosome co-localization observed 
during confocal imaging. This effect might be related with thorough PEG-shielding that 
prevents particles from destabilisation of endosome membrane.221 However, the efficient 
gene silencing was triggered when KB/eGFPLuc cells expressing eGFPLuc reporter 
protein were subjected for treatment with endosomolytic agent - chloroquine. The finding 
indicates that the particles are capable of releasing the functional siRNA into the cytoplasm 
after facilitated endosomal release. Thus, the further development of mNALP system would 
need to involve additional release mechanism e.g. pH-dependent particle destabilisation or 
endosome membrane disruption.  
The small size, reproducible and efficient synthesis using a microfluidic platform, 
selective targeting and achieved silencing after facilitated endosomal release presents high 
promise for further development of mNALPs directed at potent in vivo siRNA delivery into 
solid tumours. 
The second part of the work presents a method for quantifying silencing efficiency 
of siRNA by changes in absolute parameters describing the single-cell-level kinetics of 
mRNA degradation. Data were collected using live-cell imaging on single-cell arrays 
(LISCA). We determined the kinetic parameters of mRNA decay by the mathematical 
modelling of protein expression following mRNA transfection. The expression was 
modulated by additional siRNA delivery. Moreover, in analogous experiments based on 
pDNA delivery, we explored the limits of standard silencing efficiency analysis based on 
changes in fluorescence intensity of reporter proteins. Using a dual-reporter assays, we 
compared the changes observed between siRNA-targeted eGFP reporter and the internal 
reference of CayRFP.  
Firstly, the outcome of commonly used fluorescence intensity analysis showed 
significant quantitative differences between single-cell-level and population-averaged data. 
The observed effect could be associated with cellular heterogeneity, effects of which are 
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averaged during population level analysis.122,159 The extrinsic noise contribution to 
heterogeneity in cellular responses, however, could be limited when the signal was 
normalized by internal expression reference. Additionally, the relative fluorescence used 
as a measure for silencing efficiency is strongly dependent on the selected time point of the 
measurement in the cases of both, single-cell- and population-level of analysis.  
Secondly, we performed the analysis of full kinetic changes in expressed protein 
numbers following mRNA transfection to access the mRNA degradation rate constants. 
Importantly, the shift in those values can serve as a time-independent measure for silencing 
efficiency. Use of mRNA delivery reduces the complexity of the molecular network of 
protein expression. It allows for limiting of the mathematical model to ordinary differential 
equations describing translation, protein maturation and degradation of both mRNA and 
protein as first order mass action kinetics. To further reduce the number of free parameters 
within the model, and to improve the robustness of the fitting procedure, we determined 
the protein degradation (β) and maturation (km) rate constants independently. The 
remaining parameters describing protein expression, namely initial translation rates (m0ktl), 
times of expression onset (t0) and mRNA degradation rate constants (δ), were determined 
by least-squares fits of the mathematical model to experimental data yielding the population 
distributions of single-cell values.  
Notably, the single-cell parameters disclosed correlations, which provided valuable 
insight into the mRNA delivery and siRNA-induced silencing. We observed a strong 
correlation between the eGFP and CayRFP initial translation rates (m0ktl) as well as the 
expression onset times (t0) suggesting that in average equimolar amounts of both mRNA 
constructs were released simultaneously into the cytoplasm of the cell. However, a 
systematic and yet unexplained shift between eGFP and CayRFP onset times was observed. 
This shift is in accordance with the observed longer maturation time of CayRFP compared 
to eGFP and with possibly higher translation rate of eGFP, yet none of those effects can 
explain it fully. Additionally, we observed that siRNA has a weak effect on translation, 
indicating that the RISC-associated blocking of ribosomes plays marginal role in the case 
of the investigated siRNA construct. 
The most profound effect of siRNA treatment was observed as a clear increase in 
the mRNA degradation constants (δ) compared to control cells that was present in both 
Huh-7 and A549 cell lines. Here, the siRNA-related shift in the median of eGFP-mRNA 
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degradation constants distributions (δG) revealed 8,4 ± 0,3 – fold and 6,4 ± 0,4 – fold 
increase for both Huh-7 and A549 cells respectively. This relative increase represents a 
sensitive, time-independent measure of the silencing efficiency. In addition, small 
difference in the CayRFP-mRNA degradation constants (δG)  was observed (1,19 ± 0.03-
fold and 1,31 ± 0.04-fold changes for Huh-7 and A549 cells respectively)  reflecting weak 
nonspecific side effects of siRNA treatment.201, 202 Moreover, the distributions of eGFP-
mRNA degradation constants revealed existence of two subpopulations of cells, related 
with high and low degradation rates. This feature served to identify subpopulations that are 
less susceptible to siRNA-based therapeutics under investigation and was accounted for 
during determination of relative changes in mRNA degradation constants. We also noted 
that codon optimality might explain the differences between degradation constants of 
eGFP- and CayRFP-mRNA constructs observed for control cells. 
Taken together, the presented method LISCA provides direct access to the protein 
expression and mRNA delivery kinetics as well as efficiency of siRNA constructs. The 
assay is fast, accurate and provides the time independent measure for siRNA silencing 
efficiency. Moreover, the method gives access to absolute values of mRNA degradation 
rate constants that can, in general, be directly converted into single-cell mRNA half-lives. 
In particular, screening for functional optimality of siRNA sequences is one of the core 
determinants for improved silencing efficiency in siRNA-based therapy and RNAi 
screens.29,38 Moreover, in mRNA based therapy, the stability of artificial mRNAs and their 
translational efficiency are of high importance.165, 222, 223 As presented, LISCA method 
allows studies on single-cell gene expression and gene regulation kinetics, revealing 
insights beyond population-averaged analysis. The method may play important role in 
development of novel assays for molecular biology, pharmacy and systems biology.  
Appendix.A1. Protocols 
A1.1. Master micro-structures for stamp and micro-chip preparation 
The stamp to prepare micro-patterns and micro-channels for the hydrodynamic 
focusing or fluorescence calibration micro-chip were created by curing PDMS on AZ 40XT 
and SU-8 master structure respectively. The master micro-structures themselves were 
prepared on a silicon wafer by UV-laser-based direct exposure using an AZ 40XT or SU-8 
100 photoresist (MicroChem Corp., Westborough, MA, USA). AZ 40XT and SU-8 100 
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was processed in accordance with the manufacturer’s instruction. The micro-structures 
were exposed using the LPKF ProtoLaser LDI. Pattern and channel designs were prepared 
using LPKF CAD/CAM software provided by LPKF Laser and Electronics. The master 
structures were silanized using trichloro(1H,1H,2H,2H-perfluorooctyl)silane in an 
evacuated exicator for 12 hours before further use. PDMS was cured on top of the master 
structures (crosslinker 10% (wt/wt), 50°C for 12h) forming the stamp or micro-channel. 
A1.2. Fabrication of microfluidic chip devices  
The microfluidic chip was made by covalently attaching a PDMS channel micro-
structure to a glass cover using oxygen-plasma-induced bonding. Glass cover was cleaned 
by sonication in isopropanol and deionized water baths for 40 and 60 min respectively and 
dried under a nitrogen flow. The PDMS channel was cut and pealed from the master, placed 
in the plasma cleaner together with the cleaned glass cover and chemically activated by 
exposing them to oxygen plasma (Femto Diener plasma generator at 10 W power, 3 min 
exposure). PDMS and glass surfaces were brought into contact immediately after treatment, 
causing the creation of Si–O–Si bonds between them. 
A1.3. Cell culture  
Human hepatocellular carcinoma cells (Huh-7; I.A.Z., Munich, Germany), human 
lung carcinoma cells (A549; ATCC CCL-185), wild-type human cervix carcinoma KB 
cells (KB/WT; Leibniz Institute DSMZ-German Collection of Microorganisms and Cell 
Cultures GmbH, Braunschweig, Germany) and KB cells stably transfected with the 
enhanced green fluorescent protein/luciferase gene (KB/eGFPLuc) were used. Huh-7 cells 
were cultivated in RPMI-1640 GlutaMAX media (Gibco, Life Technologies GmbH, 
Darmstadt, Germany) supplemented with 10% (v/v) FBS, 2 mM sodium pyruvate and 5 
mM HEPES (all from Life Technologies). A549 cells were cultivated in MEM media (C-
C-pro, Oberdorla, Germany) supplemented with 10% (v/v) FBS and 2,5 mM L-glutamine 
(both from Life Technologies). KB cells were cultivated in folate-free Gibco RPMI-1640 
supplemented with 10% (v/v) FBS (Life Technologies GmbH, Darmstadt, Germany). 
Additionally, the media for KB/eGFPLuc cell cultivation was supplemented with penicillin 
(100 U mL−1) and streptomycin (100 µg mL−1). All cell lines were grown at 37 °C in 
ventilated flasks in a humidified atmosphere containing 5% CO2. The cells were passaged 
every 3–4 days after reaching 80% surface confluency. For long-term microscopy 
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experiments, Huh-7 and A549 cells were incubated in the absence of CO2 in phenol-red-
free L-15 medium supplemented with 10% FBS. 
A1.4. mNALP assembly and activity  
A1.4.1. Materials 
Used lipids, namely DOTAP, 1,2-dioleoyl-3-trimethylammonium-propane 
(chloride salt); DOPE, 1,2-dioleoyl-sn-glycero-3-phos-phoethanolamine; DOPC, 1,2-di-
(9Z-octadecenoyl)-sn-glycero-3-phosphocholine; DSPE-PEG(2000), 1,2-distearoyl-sn-
glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium 
salt) and DSPE-PEG(2000)-FolA, 1,2-distearoyl-sn- glycero-3-phosphoethanolamine-N-
[folate(polyethylene glycol)- 2000] (ammonium salt) were provided by Avanti Polar Lipids 
Inc., Alabaster, Ala., USA and used without further purification. Single-stranded DNA 
oligonucleotides (lyophilized, HPLC-purified), sense and antisense strand, were purchased 
from Eurofins Genomics (Ebersberg, Germany). For FCS experiments the 5′-end of sense 
strand was conjugated with Cy3 dye; Cy3-dsDNA. For flow cytometry and confocal 
microscopy the 5′-end of both strands was conjugated with ATTO488. Oligonucleotides 
were diluted in 30 mM HEPES-KOH, 100 mM KCl, 2 mM MgCl2, 50mM NH4Ac, pH 7,5 
to a concentration of 100 µM and stored in −20 °C until further use. For gene-silencing 
studies, two siRNA duplexes (Axolabs GmbH Kulmbach, Germany) namely the GFP-
targeted sequence siGFP and the control sequence siCtrl were used. Chloroquine (N4-(7-
chloro-4-quinolinyl)-N1,N1-dimethyl-1,4-pentanediamine diphosphate salt) and folate 
(folic acid) were purchased from Sigma-Aldrich (Munich,Germany). 
A1.4.2. dsDNA and siRNA sequences 
Cy3-dsDNA:  
Sense strand: 5′-Cy3-CCAACAGTAAAAGGAATATCC-3′ 
Antisense strand: 5′-GGATATTCCTTTTACTGTTGG-3′ 
ATTO488-dsDNA:  
Sense strand: 5′-ATTO488-CCAACAGTAAAAGGAATATCC-3′ 
Antisense strand: 5′- ATTO488-GGATATTCCTTTTACTGTTGG-3′ 
siGFP:  
Sense strand: 5′-AuAucAuGGccGA cAAGcAdTsdT-3′ 
Antisense strand: 5′-UGCUUGUCGGCcAUGAuAU dTsdT-3′ 
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siCtrl:  
Sense strand: 5′-AuGuAuu GGccuGuAuuAGdTsdT-3′ 
Antisense strand: 5′-CuAAuAcAGGCcAAuAc AUdTsdT-3′ 
A1.4.3. Annealing of complementary oligonucleotides 
In order to obtain double stranded Cy3-dsDNA and ATTO488-dsDNA duplexes the 
complementary single strands (sense and antisense strands) where annealed. Two strands 
in equimolar amounts (20 µM:20 µM; 120 ml) where incubation at 96 °C for 2 min and 
slowly cooled overnight at room temperature. The 21 bp dsDNA was then dialysed against 
20 mM TRIS-HCl, 2 mM EDTA (2 × TE, pH 8) buffer and stored in −20 °C until further 
use. 
A1.4.4. Blood serum and blood plasma collection 
Blood samples were collected from healthy volunteer donors and informed consent 
was obtained from all of them. S-monovette coagulation sodium citrate (Sarstedt, 
Germany) system was used for blood plasma extraction and an S-monovette serum clotting 
activator (Sarstedt, Germany) system for blood serum extraction. Samples were centrifuged 
(10 min, 2300 rpm). Subsequently, the supernatant was collected. Centrifugation was done 
immediately in the case of blood plasma, and after incubation at room temperature for 30 
min in the case of blood serum. The blood plasma and serum supernatants were aliquoted 
and stored at −80 °C until further use. Each of 0,5 ml aliquotes were used once. Blood 
plasma/serum was thawed slowly at room temperature to avoid degradation or deactivation 
of plasma/serum components. 
A1.4.5. Preparation of mNALP samples 
Firstly, the required amounts of lipids dissolved in chloroform in the molar ratios 1 
: 5 : 6 : 1,2 DOTAP : DOPE : DOPC : DSPE-PEG(2000) for non-targeted mNALPs, or 1 : 
5 : 6 : 1 : 0,2 DOTAP : DOPE : DOPC : DSPE-PEG(2000) : DSPE-PEG(2000)-FolA for 
folate-targeted FolA-mNALPs, were mixed together in flat bottom glass vials, dried under 
a nitrogen flow and placed in a vacuum oven at room temperature for evaporation of 
chloroform residues. Lipids were then re-diluted in a mixture of isopropanol (UV/IR grade) 
and deionized water (60% (v/v) isopropanol/H2O) to the final DOTAP concentration of 
300 µM. Obtained lipid stock solution was sonicated using tip sonicator before further use. 
Secondly, molecular solutions containing lipids and dsDNA/siRNA in 50% (v/v) 
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isopropanol/H2O were prepared by gentle stirring. Importantly, this step can result in 
premature micro-precipitation of dsDNA/siRNA. For this reason, vigorous shaking, 
presence of multivalent cations (e.g. Mg2+) in the solution. Additionally, to avoid abrupt 
changes in lipid saturation that can also result in formation of precipitants, the following 
pipetting sequence should be adhered to: H2O, isopropanol, lipid stock solution, 
dsDNA/siRNA stock in 2 × TE. Finally, Lipid/siRNA nanoparticles were synthesized using 
solvent exchange method, by ten-fold dilution of molecular solutions in deionized water. 
Dilution of molecular solutions was done by vortex mixing by hand or hydrodynamic 
focusing in a microfluidic chip. In the first case, 75 µL of molecular solution was added 
drop by drop into 675 µL of water in a 4 mL glass vial and gently vortexed. In the second 
case, dilution was accomplished by hydrodynamic focusing of the molecular solution with 
deionized water and diffusive mixing. Flow rates were maintained at the same continuous 
level of 0,1 and 0,9 mL h−1 for molecular solution and water, respectively. Two TSE 
Systems syringe pumps (Model 540200) were used to control the flow rates. Subsequently, 
sample quality was investigated by fluorescence correlation spectroscopy (FCS). In 
addition, samples prepared by microfluidic mixing were used for stability, uptake and 
silencing experiments. Here, the samples were concentrated to the desired degree in an 
Eppendorf concentrator at 45 °C under high vacuum and re-diluted in cell culture medium, 
serum/PBS or plasma/PMS mixture. In this step, the residual isopropanol content is further 
reduced.  
During stability experiments FolA-mNALPs were concentrated 10 times and re-
diluted in biological fluids up to a starting concentration of Cy3-dsDNA. In the same time, 
final plasma and serum concentrations were kept in the ranges of 30 to 90% (v/v) and 10 
to 80% (v/v) respectively for plasma and serum samples. To gain vareing plasma/serum 
content biological fluids were mixed with PBS (pH 7,5) prior to addition of nanoparticles. 
Serum samples were stored at 21 °C in the dark. Plasma samples were kept at 4 °C to 
minimize sample coagulation. To investigate the shelf lifetime the non-diluted, non-
concentrated sample was stored at 21 °C in the dark for up to 24 days. 
A1.4.6. Cell binding and uptake experiments – Confocal Microscopy 
The KB/WT cells (25 × 104 cells per mL) were seeded on a µ-Slide VI0,4 ibiTreat 
(Ibidi, Munich, Germany) in folate-free RPMI-1640 medium (90 µL per channel) and 
incubated under standard cultivation conditions (see Cell culture section). An additional 
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batch of cells was grown in RPMI-1640 medium supplemented with 100 µM folate for 7 
days and kept under high FolA conditions during the experiment to block the receptor-
mediated uptake. 24 hours after seeding, RPMI-1640 medium containing FolA-mNALPs 
(50 nM of ATTO488-dsDNA) and the lysosome-specific dye LysoTracker Red DND-99 
(40 nM; Thermo Fisher Scientific) was placed on the cells and incubated for 50 min under 
standard growth conditions. Cells incubated with non-targeted mNALPs and uncoated 21 
bp ATTO488-dsDNA were used as controls. After rinsing twice with PBS (pH 7,5) cells 
were re-incubated in Lebovitz’s L-15 phenol-red-free CO2-independent medium (Gibco) 
and imaging was performed.  
A1.4.7. Cell binding and uptake experiments – Flow Cytometry 
Wild-type KB/WT cells were seeded in 24-well plates in folate-free RPMI-1640 
medium (400 µL, 5 × 104 cells per well) and incubated under standard cultivation 
conditions (see Cell culture section). Flow cytometry experiments were performed 24 h 
after seeding.  
During dose-dependent receptor binding and uptake studies, cells were incubated in 
folate-free RPMI-1640 medium (300 µL) containing FolA-mNALPs (10–85 nM of 
ATTO488-dsDNA) for 50 min under standard culture conditions. Cells incubated with 
medium containing the same amount of non-targeted mNALPs and uncoated 21 bp dsDNA 
were used as negative controls. After rinsing twice with ice-cold PBS (pH 7,5) the cells 
were detached using PBS containing 10 mM EDTA (pH 7,5). Subsequently, the cells were 
re-suspended in ice-cold PBS, pelleted, re-suspended once again and stored on ice in 1,5 
mL Eppendorf vials prior to FC analysis. 
Time-dependent receptor binding and uptake studies were performed in the similar 
workflow. Cells were incubated with medium containing FolA-mNALPs (50 nM; 
ATTO488-dsDNA) for 7,5–37,5 min, depending on the sample batch. To differentiate 
between the nanoparticles bound to cell surface receptors and nanoparticles incorporated 
into cells, surface-bound FolA-mNALPs were detached by exposing the cells to low pH, 
which induces dissociation of folate from the folate receptor. For this purpose two 
additional washing steps (∼10s each) with ice-cold acidified (pH 3,4) saline (10 mM 
sodium acetate, 150 mM NaCl + acetic acid) were performed before washing with PBS. 
The same negative controls were kept as in case of dose-dependent receptor binding and 
uptake studies used with according variations regarding incubation times. 
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A1.4.8. mNALP-induced silencing experiments – luciferase assay 
KB/eGFPLuc cells were seeded in 96-well plates in folate-free RPMI-1640 medium 
(4 × 103 cells per well) and incubated under standard cultivation conditions (see Cell culture 
section). GFP-siRNA (siGFP) was used for silencing the expression of the eGFPLuc 
protein, and the randomized siRNA sequence (siCtrl) was used as the negative control. 24 
h after seeding cells were incubated with cultivation medium containing FolA-mNALPs 
(50 nM of siGFP or siCtrl) diluted in culture medium (100 µL) under standard cultivation 
conditions for 48 h. Cells incubated with medium containing the same amount of non-
targeted mNALPs loaded with siGFP or siCtrl were used as negative controls. In a second 
set, experiments were performed as described above (including all mentioned controls) but 
in media supplemented with 100 µM chloroquine. Both experimental sets were carried out 
in parallel, with the same seeding batch and nanoparticle samples. After the incubation 
medium was removed and 100 µL of the lysis reagent (Promega, Mannheim, Germany) per 
well was added. Luciferase activity was evaluated using the luciferase assay kit (Promega, 
Mannheim, Germany). Fluorescence measurement was carried out using Centro LB 960 
luminometer (Berthold, Bad Wildbad, Germany). Silencing efficiency was quantified as a 
relative light units (RLU; fluorescence intensity level divided the value obtained in 
untreated control cells and represented as percent). 
A1.5. siRNA mediated mRNA degradation kinetics 
A1.5.1. Surface patterning and microscopy slide preparation 
Surface micro-patterns were prepared by selective oxygen plasma treatment (Femto 
Diener plasma generator at 40 W power, 3-min exposure) and passivation of activated 
surface areas of polymer coverslips (uncoated, Ibidi GmbH, Munich, Germany).169,170 
Selectivity was achieved by using polydimethylsiloxane (PDMS) stamps (Fig.2.8.) as a 
mask. Activated surface areas were passivated by a 20-min incubation with a PLL(20k)-
g(3,5)-PEG(2k) (SuSoS AG, Dübendorf, Switzerland) solution (1 mg mL-1) in aqueous 
buffer (10 mM HEPES, 150 mM NaCl pH 7,4). Washed and dried coverslips were then 
glued to bottomless slides (6-channel sticky-Slide VI 0,4; Ibidi GmbH). The remaining, 
non-passivated areas (30 µm × 30 µm squares) were then exposed for 1 h to fibronectin (50 
µg mL-1; YO Proteins AB, Huddinge, Sweden), rendering these areas cell adherent. Each 
channel was then thoroughly rinsed with PBS and stored at 4 °C until further use. 
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A1.5.2. In vitro transcription 
In vitro transcription was performed using pVAX-eGFP-A120 and pVAX-
CayRFP-A120 plasmids (plasmid maps are given in Fig.A1.3.) as templates for the 
synthesis of eGFP (mRNAG) and CayRFP mRNAs (mRNAR) respectively. The CayRFP 
(Atum, Newark, CA, US) and eGFP (Clontech, CA, US) genes were cloned into the pVAX-
A120 plasmid (kindly provided by Ethris GmbH, Planegg, Germany), which contains a T7 
promoter region and a 120-bp poly-A tail. Plasmids were linearized by digestion with NotI, 
which cleaves the sequence located immediately downstream of the poly-A tail. The 
linearized and purified plasmids were used as templates for in vitro transcription performed 
using the MessageMAX T7 ARCA-Capped Message Transcription Kit (Biozym Scientific 
GmbH, Hessisch Oldendorf, Germany) in accordance with the kit manufacturer’s protocol. 
One µg of plasmid was used to produce up to 2 µg of mRNA transcripts with an Anti-
Reverse Cap Analog (ARCA) (m2 7,3’-OG[5']ppp[5']G) on the 5' end. mRNAs were purified 
by precipitation with ammonium acetate and ethanol. Purified mRNA products were 
diluted to a final concentration of 100 ng µl-1 in RNase-free water, divided into 10-µl 
aliquots and stored at -80 °C until further use. 
A1.5.3. LISCA - silencing experiments 
Huh-7 or A549 cells were grown on micro-patterned 6 channel sticky-Slide VI 0,4 
(Ibidi, Munich, Germany). 1 × 104 cells were seeded in each channel 4h before experiment. 
The equimolar amounts of eGFP- and CayRFP-encoding pDNA or mRNA were used (total 
amount of 0,03pmol/channel and 0,38 pmol/channel in case of pDNA and mRNA 
respectively). pEGFP-N1 (pDNAG; Clontech, CA, US) and fpb-55-609_CayenneRFP 
(pDNAR; Atum, Newark, CA, US) plasmids were used (plasmid maps are given in 
Fig.A1.2.). mRNA was synthesized as described above. To prepare the transfection 
complexes 154,5 ng/179 ng of pDNAG/pDNAR or 152 ng/148 ng of mRNAG/ mRNAR was 
diluted in OptiMEM transfection media (Gibco) to a total volume of 150 µL and incubated 
for 5 min in room temperature. Similarly, 0,8 µL (in case of pDNA) or 0,748 µL (in case 
of mRNA) of Lipofectamine (Life Technologies) was diluted in OptiMEM (Gibco) to a 
total volume of 150 µL. pDNA/mRNA and Lipofectamine solutions were mixed together 
by pipetting, followed by another 20 min incubation at room temperature for forming 
transfection complexes.  
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In case of pDNA transfection cells were washed twice with PBS and once with 
OptiMEM immediately before transfection. 90 mL of pDNA/Lipofectamine complexes 
was placed in each channel and incubated for 1h under standard cultivation conditions (see 
Cell culture section). Simultaneously, the siRNA/lipofectamine complexes were made. 75 
pmol of GFP Duplex I siRNA (Dharmacon) was diluted in OptiMEM to a total volume of 
150 mL and incubated for 5 min in room temperature. Similarly, 1,2 mL of Lipofectamine 
was diluted in OptiMEM (Gibco) to a total volume of 150 mL. siRNA and Lipofectamine 
solutions were mixed together by pipetting and then incubated at room temperature for 20 
min for forming transfection complexes. Half of the cells transfected with pDNA were 
washed OptiMEM, each channel was filled with 90 mL of siRNA/lipofectamine complexes 
and incubated under standard cultivation conditions for another 30 min. As a positive 
control second half of cells transfected with pDNA were washed and incubated in culture 
medium for the same 30 min period. Subsequently, the transfection solution or culture 
medium were removed, all cells were washed twice with PBS and re-incubated in 
Leibovitz’s L-15 CO2-independent phenol-red-free media, 10% (v/v) FBS. Cells were 
imaged immediately after channels were sealed with anti-evaporation oil (Ibidi). 
 
Fig.A1.1. Crafted system of tubing used to exchange the fluids inside the microscopy slide 
Crafted system of tubing used to exchange the fluids inside the microscopy slide directly during the 
experiment. PTFE Tube 0,3 mm ID 0,76 mm ID was from one side glued using NOA81 adhesive 
(Norland Products) to in-house-made teflon male luer lock connectors (design to minimize the slide 
volume). The other side was connected via female luer connector to needle-free swabable valve 
(Nordstron Medical). The connection was sealed using a 3 cm piece of elastic Tygon tubing 0,8 mm 
ID 2,8 mm OD and a drop of NOA81 on its end. Two channels on the Ibidi Slide VI 0,4 were 
connected and the tube with the blind end was used as an outlet to dispose the waste. 1 ml syringes 
were used to exchange the fluids. Short incubation (20 min) with FBS containing medium resulted 
in the tubing surface passivation and the losses of Lipofectamine2000 complexes were not seen. 
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The mRNA transfection was done directly on the microscope stage during imaging 
to resolve the full dynamic range of changes in cell fluorescence. Media exchange was done 
using customized system of tubing (Fig.A1.1). Before starting the measurement, the cells 
were washed with PBS and the media was exchanged to Leibovitz’s L-15. Then, the tubing 
was connected and immediately before mRNA transfection, each condition (two channels 
interconnected with tubing, details presented on Fig.A1.1) was washed with OptiMEM. 
Right after, mRNA/Lipofectamine2000 were flushed into each channel. Cells were 
incubated on the heated microscopy stage at 37 °C for 30 min. Simultaneously, the 
siRNA/lipofectamine complexes were prepared as described above. 2x 300 mL of 
complexes were prepared for a single experiment (300 mL per condition). After 30 min 
incubation mRNA/Lipofectamine complexes were washed away and four out of six 
channels were filled with formed siRNA/Lipofectamine complexes for second 30min cell 
incubation. As a positive control mRNA-transfected cells in remaining channels were 
washed and incubated with Leibovitz’s L-15 media for the same 30 min period. Finally, 
the transfection complexes were then removed by washing and the cells were re-incubated 
with Leibovitz’s L-15, 10% (v/v) FBS media. In pDNA transfection experiments total of 
110 and 131 of siRNA-treated and control Huh-7 cells respectively were analysed. 
Similarly, in mRNA experiments 1252 (1216) and 411 (312) of siRNA-treated (control) 
Huh-7 and A549 cells respectively were analysed. 
A1.5.4. LISCA – translation inhibition experiments 
The mRNA transfection experiments were performed according to the pipeline 
described in the silencing protocol except for modifications of the mRNA amounts. To 
prepare the transfection complexes, 148 ng of mRNAR or 152 ng of mRNAG was diluted 
in OptiMEM (Gibco) to a total volume of 150 µL. Similarly, 0.374 µL or 0,379 µL of 
Lipofectamine for mRNAR and mRNAG respectively was diluted in OptiMEM (Gibco) to 
a total volume of 150 µL. mRNA and Lipofectamine solutions were mixed together by 
pipetting and then incubated at room temperature for 20 min. The transfection was done 
directly on the microscope stage using the tubing system described above during the first 
hours of 30h-long time-lapse experiment. After 30 min of incubation, the particle-
containing medium was exchanged with Leibovitz’s L-15, 10% (v/v) FBS. Subsequently, 
during the initial phase of protein expression (after 3, 5 or 7 hours post transfection) the 
media was exchanged and cells were exposed to Leibovitz’s L-15, medium 10% (v/v) FBS 
medium (Gibco) containing 15 µg mL-1 cycloheximide (Thermo Fisher). Cells were 
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incubated with cycloheximide-containing media throughout the rest of experiment. The 
measurements were done in two separate experiments for eGFP and CayRFP. In all, 461 
and 786 Huh-7 cells were analysed in eGFP and CayRFP experiments respectively. 
A1.5.5. Protein expression and purification 
To convert fluorescence intensities into numbers of eGFP and CayRFP molecules, 
these proteins were first expressed and purified. The eGFP or CayRFP gene sequence was 
cloned into the pET-23b(+) (Novagen, Merck Millipore, Darmstadt, Germany) expression 
vector. BL21 competent E.coli strain (New England Biolabs, Ipswich, MA, USA) was 
transformed with pET-23b(+)-eGFP or pET-23b(+)-CayRFP plasmid (plasmid maps are 
given in Fig.A1.4.). Both plasmids contained genes of His-tagged eGFP or CayRFP under 
the control of an IPTG-inducible promoter. For protein expression, an overnight culture of 
transformed cells was diluted 100 times up to a total volume of 50 mL in LB medium 
containing 0,1 mg mL-1 ampicillin and incubated at 37 °C during vigorous shaking. When 
the culture reached 0,4 OD the cells were induced with 1 mM IPTG and incubated for 6 h 
at 27 °C. Subsequently cultures were centrifuged and the pellets were re-suspended in lysis 
buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole pH 8,0). For complete lysis, 
cells where flash frozen multiple times in liquid nitrogen, slowly thawed on ice and tip 
sonicated. The suspensions of lysed cells were centrifuged again and the protein-containing 
supernatants were filtered through sterile 0,2 µm syringe filters. The His-tagged eGFP and 
CayRFP were purified using HPLC (ÄKTAexplorer Box-900, General Electric). Purified 
proteins where then dialyzed using 3,5 K Slide-A-Lyser cassettes (Life Technologies) 
against PBS pH 7,4 and stored at 4 °C until further use. 
A1.5.6. Plasmid and siRNA sequences, plasmid maps 
GFP Duplex I siRNA: 
Sense strand: 5’- GCAAGCUGACCCUGAAGUUC – 3’ 
Antisense strand: 5’- GAACUUCAGGGUCAGCUUGC – 3’ 
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Fig.A1.2. pEGFP-N1 (pDNAG) and fpb-55-609_CayenneRFP (pDNAR) plasmid maps 
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Fig.A1.3. pVAX-eGFP-A120 and pVAX-CayRFP-A120 plasmid maps 
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pVAX-CayRFP-A120 (3793bp) 
GACTCTTCGCGATGTACGGGCCAGATATACGCGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAA
TTACGGGGTCATTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCCCGCCT
GGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAG
GGACTTTCCATTGACGTCAATGGGTGGACTATTTACGGTAAACTGCCCACTTGGCAGTACATCAAGTGTAT
CATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACA
TGACCTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGG
TTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCATTGA
CGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCA
TTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCTCTGGCTAACTAGAG
AACCCACTGCTTACTGGCTTATCGAAATTAATACGACTCACTATAGGGAGACCCAAGCTGGCTAGCGTTT
AAACTTAAGCTTGGTACCGCCACCATGGTGTCAAAAGGGGAGGAATTGATCAAAGAGAACATGCATATG
AAACTGTACATGGAGGGAACTGTCAACAATCACCACTTCAAATGCACCTCAGAGGGCGAGGGAAAGCCC
TACGAAGGGACCCAGACCATGCGCATTAAGGTGGTCGAAGGCGGACCACTCCCTTTTGCATTCGACATCC
TGGCTACCTCCTTCATGTACGGATCGCGCACTTTTATCAAGTACCCGAAGGGGATCCCGGACTTCTTCAAG
CAATCCTTCCCTGAGGGATTCACTTGGGAACGGGTCACGACCTACGAAGATGGAGGCGTGGTGACCGTGA
TGCAAGACACTAGCCTGGAAGATGGCTGCCTTGTCTACAACGTGAAGATCAGAGGTGTGAACTTCCCATC
CAATGGCCCCGTGATGCAGAAAAAGACTCTGGGGTGGGAAGCCAATACCGAAATGCTCTACCCAGCGGA
CGGAGGACTCGAAGGCCGGTCTGACATGGCCCTGAAGCTGGTCGGAGGAGGACATTTGTCGTGTAGCTTT
GTGACTACGTACCGGTCGAAGAAGCCGGCCAAAAACCTGAAGATGCCGGGTATCCACGCGGTGGACCAT
AGACTGGAACGCCTGGAGGAGAGCGATAACGAGATGTTCGTCGTTCAGAGGGAACACGCTGTGGCACGA
TATTGCGATCTCCCGTCGAAGCTTGGTCACAAGCTCAATTAGGAATTCTGCAAAAAAAAAAAAAAAAAA
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAGCGGCCGCTCGAGTCTAGAGGGCCCGTTTAAA
CCCGCTGATCAGCCTCGACTGTGCCTTCTAGTTGCCAGCCATCTGTTGTTTGCCCCTCCCCCGTGCCTTCCT
TGACCCTGGAAGGTGCCACTCCCACTGTCCTTTCCTAATAAAATGAGGAAATTGCATCGCATTGTCTGAGT
AGGTGTCATTCTATTCTGGGGGGTGGGGTGGGGCAGGACAGCAAGGGGGAGGATTGGGAAGACAATAGC
AGGCATGCTGGGGATGCGGTGGGCTCTATGGCTTCTACTGGGCGGTTTTATGGACAGCAAGCGAACCGGA
ATTGCCAGCTGGGGCGCCCTCTGGTAAGGTTGGGAAGCCCTGCAAAGTAAACTGGATGGCTTTCTCGCCG
CCAAGGATCTGATGGCGCAGGGGATCAAGCTCTGATCAAGAGACAGGATGAGGATCGTTTCGCATGATT
GAACAAGATGGATTGCACGCAGGTTCTCCGGCCGCTTGGGTGGAGAGGCTATTCGGCTATGACTGGGCAC
AACAGACAATCGGCTGCTCTGATGCCGCCGTGTTCCGGCTGTCAGCGCAGGGGCGCCCGGTTCTTTTTGTC
AAGACCGACCTGTCCGGTGCCCTGAATGAACTGCAAGACGAGGCAGCGCGGCTATCGTGGCTGGCCACG
ACGGGCGTTCCTTGCGCAGCTGTGCTCGACGTTGTCACTGAAGCGGGAAGGGACTGGCTGCTATTGGGCG
AAGTGCCGGGGCAGGATCTCCTGTCATCTCACCTTGCTCCTGCCGAGAAAGTATCCATCATGGCTGATGC
AATGCGGCGGCTGCATACGCTTGATCCGGCTACCTGCCCATTCGACCACCAAGCGAAACATCGCATCGAG
CGAGCACGTACTCGGATGGAAGCCGGTCTTGTCGATCAGGATGATCTGGACGAAGAGCATCAGGGGCTC
GCGCCAGCCGAACTGTTCGCCAGGCTCAAGGCGAGCATGCCCGACGGCGAGGATCTCGTCGTGACCCATG
GCGATGCCTGCTTGCCGAATATCATGGTGGAAAATGGCCGCTTTTCTGGATTCATCGACTGTGGCCGGCTG
GGTGTGGCGGACCGCTATCAGGACATAGCGTTGGCTACCCGTGATATTGCTGAAGAGCTTGGCGGCGAAT
GGGCTGACCGCTTCCTCGTGCTTTACGGTATCGCCGCTCCCGATTCGCAGCGCATCGCCTTCTATCGCCTT
CTTGACGAGTTCTTCTGAATTATTAACGCTTACAATTTCCTGATGCGGTATTTTCTCCTTACGCATCTGTGC
GGTATTTCACACCGCATACAGGTGGCACTTTTCGGGGAAATGTGCGCGGAACCCCTATTTGTTTATTTTTC
TAAATACATTCAAATATGTATCCGCTCATGAGACAATAACCCTGATAAATGCTTCAATAATAGCACGTGC
TAAAACTTCATTTTTAATTTAAAAGGATCTAGGTGAAGATCCTTTTTGATAATCTCATGACCAAAATCCCT
TAACGTGAGTTTTCGTTCCACTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGATCTTCTTGAGATCCTTT
TTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGCTACCAGCGGTGGTTTGTTTGCCGGATC
AAGAGCTACCAACTCTTTTTCCGAAGGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACTGTCCTTCT
AGTGTAGCCGTAGTTAGGCCACCACTTCAAGAACTCTGTAGCACCGCCTACATACCTCGCTCTGCTAATCC
TGTTACCAGTGGCTGCTGCCAGTGGCGATAAGTCGTGTCTTACCGGGTTGGACTCAAGACGATAGTTACC
GGATAAGGCGCAGCGGTCGGGCTGAACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAACGACCTA
CACCGAACTGAGATACCTACAGCGTGAGCTATGAGAAAGCGCCACGCTTCCCGAAGGGAGAAAGGCGGA
CAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGGAGCTTCCAGGGGGAAACGCCT
GGTATCTTTATAGTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGATGCTCGTCAGGG
GGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGTTCCTGGGCTTTTGCTGGCCTTTTGC
TCACATGTTCTT 
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pVAX-eGFP-A120 (3835bp) 
GACTCTTCGCGATGTACGGGCCAGATATACGCGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAA
TTACGGGGTCATTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCCCGCCT
GGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAG
GGACTTTCCATTGACGTCAATGGGTGGACTATTTACGGTAAACTGCCCACTTGGCAGTACATCAAGTGTAT
CATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACA
TGACCTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGG
TTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCATTGA
CGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCA
TTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCTCTGGCTAACTAGAG
AACCCACTGCTTACTGGCTTATCGAAATTAATACGACTCACTATAGGGAGACCCAAGCTGGCTAGCGTTT
AAACTTAAGCTTGGTACCGAGCTCGGATCCACCGGTCGCCACCATGGTGAGCAAGGGCGAGGAGCTGTTC
ACCGGGGTGGTGCCCATCCTGGTCGAGCTGGACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGC
GAGGGCGAGGGCGATGCCACCTACGGCAAGCTGACCCTGAAGTTCATCTGCACCACCGGCAAGCTGCCC
GTGCCCTGGCCCACCCTCGTGACCACCCTGACCTACGGCGTGCAGTGCTTCAGCCGCTACCCCGACCACA
TGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAA
GGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGA
GCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTGGGGCACAAGCTGGAGTACAACTACAACAG
CCACAACGTCTATATCATGGCCGACAAGCAGAAGAACGGCATCAAGGTGAACTTCAAGATCCGCCACAA
CATCGAGGACGGCAGCGTGCAGCTCGCCGACCACTACCAGCAGAACACCCCCATCGGCGACGGCCCCGT
GCTGCTGCCCGACAACCACTACCTGAGCACCCAGTCCGCCCTGAGCAAAGACCCCAACGAGAAGCGCGA
TCACATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGGATCACTCTCGGCATGGACGAGCTGTACAAGTAA
GAATTCTGCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAGCGG
CCGCTCGAGTCTAGAGGGCCCGTTTAAACCCGCTGATCAGCCTCGACTGTGCCTTCTAGTTGCCAGCCATC
TGTTGTTTGCCCCTCCCCCGTGCCTTCCTTGACCCTGGAAGGTGCCACTCCCACTGTCCTTTCCTAATAAAA
TGAGGAAATTGCATCGCATTGTCTGAGTAGGTGTCATTCTATTCTGGGGGGTGGGGTGGGGCAGGACAGC
AAGGGGGAGGATTGGGAAGACAATAGCAGGCATGCTGGGGATGCGGTGGGCTCTATGGCTTCTACTGGG
CGGTTTTATGGACAGCAAGCGAACCGGAATTGCCAGCTGGGGCGCCCTCTGGTAAGGTTGGGAAGCCCTG
CAAAGTAAACTGGATGGCTTTCTCGCCGCCAAGGATCTGATGGCGCAGGGGATCAAGCTCTGATCAAGAG
ACAGGATGAGGATCGTTTCGCATGATTGAACAAGATGGATTGCACGCAGGTTCTCCGGCCGCTTGGGTGG
AGAGGCTATTCGGCTATGACTGGGCACAACAGACAATCGGCTGCTCTGATGCCGCCGTGTTCCGGCTGTC
AGCGCAGGGGCGCCCGGTTCTTTTTGTCAAGACCGACCTGTCCGGTGCCCTGAATGAACTGCAAGACGAG
GCAGCGCGGCTATCGTGGCTGGCCACGACGGGCGTTCCTTGCGCAGCTGTGCTCGACGTTGTCACTGAAG
CGGGAAGGGACTGGCTGCTATTGGGCGAAGTGCCGGGGCAGGATCTCCTGTCATCTCACCTTGCTCCTGC
CGAGAAAGTATCCATCATGGCTGATGCAATGCGGCGGCTGCATACGCTTGATCCGGCTACCTGCCCATTC
GACCACCAAGCGAAACATCGCATCGAGCGAGCACGTACTCGGATGGAAGCCGGTCTTGTCGATCAGGAT
GATCTGGACGAAGAGCATCAGGGGCTCGCGCCAGCCGAACTGTTCGCCAGGCTCAAGGCGAGCATGCCC
GACGGCGAGGATCTCGTCGTGACCCATGGCGATGCCTGCTTGCCGAATATCATGGTGGAAAATGGCCGCT
TTTCTGGATTCATCGACTGTGGCCGGCTGGGTGTGGCGGACCGCTATCAGGACATAGCGTTGGCTACCCG
TGATATTGCTGAAGAGCTTGGCGGCGAATGGGCTGACCGCTTCCTCGTGCTTTACGGTATCGCCGCTCCCG
ATTCGCAGCGCATCGCCTTCTATCGCCTTCTTGACGAGTTCTTCTGAATTATTAACGCTTACAATTTCCTGA
TGCGGTATTTTCTCCTTACGCATCTGTGCGGTATTTCACACCGCATACAGGTGGCACTTTTCGGGGAAATG
TGCGCGGAACCCCTATTTGTTTATTTTTCTAAATACATTCAAATATGTATCCGCTCATGAGACAATAACCC
TGATAAATGCTTCAATAATAGCACGTGCTAAAACTTCATTTTTAATTTAAAAGGATCTAGGTGAAGATCCT
TTTTGATAATCTCATGACCAAAATCCCTTAACGTGAGTTTTCGTTCCACTGAGCGTCAGACCCCGTAGAAA
AGATCAAAGGATCTTCTTGAGATCCTTTTTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCG
CTACCAGCGGTGGTTTGTTTGCCGGATCAAGAGCTACCAACTCTTTTTCCGAAGGTAACTGGCTTCAGCAG
AGCGCAGATACCAAATACTGTCCTTCTAGTGTAGCCGTAGTTAGGCCACCACTTCAAGAACTCTGTAGCA
CCGCCTACATACCTCGCTCTGCTAATCCTGTTACCAGTGGCTGCTGCCAGTGGCGATAAGTCGTGTCTTAC
CGGGTTGGACTCAAGACGATAGTTACCGGATAAGGCGCAGCGGTCGGGCTGAACGGGGGGTTCGTGCAC
ACAGCCCAGCTTGGAGCGAACGACCTACACCGAACTGAGATACCTACAGCGTGAGCTATGAGAAAGCGC
CACGCTTCCCGAAGGGAGAAAGGCGGACAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCA
CGAGGGAGCTTCCAGGGGGAAACGCCTGGTATCTTTATAGTCCTGTCGGGTTTCGCCACCTCTGACTTGA
GCGTCGATTTTTGTGATGCTCGTCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTA
CGGTTCCTGGGCTTTTGCTGGCCTTTTGCTCACATGTTCTT 
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Fig.A1.4. pET-23b(+)-eGFP and pET-23b(+)-CayRFP plasmid maps 
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pET-23b(+)-CayRFP (4364 bp) 
ATCCGGATATAGTTCCTCCTTTCAGCAAAAAACCCCTCAAGACCCGTTTAGAGGCCCCAAGGGGTTATGC
TAGTTATTGCTCAGCGGTGGCAGCAGCCAACTCAGCTTCCTTTCGGGCTTTGTTAGCAGCCGGATCTCAGT
GGTGGTGGTGGTGGTGCTCGAGTGCGGCCGCATTGAGCTTGTGACCAAGCTTCGACGGGAGATCGCAATA
TCGTGCCACAGCGTGTTCCCTCTGAACGACGAACATCTCGTTATCGCTCTCCTCCAGGCGTTCCAGTCTAT
GGTCCACCGCGTGGATACCCGGCATCTTCAGGTTTTTGGCCGGCTTCTTCGACCGGTACGTAGTCACAAAG
CTACACGACAAATGTCCTCCTCCGACCAGCTTCAGGGCCATGTCAGACCGGCCTTCGAGTCCTCCGTCCGC
TGGGTAGAGCATTTCGGTATTGGCTTCCCACCCCAGAGTCTTTTTCTGCATCACGGGGCCATTGGATGGGA
AGTTCACACCTCTGATCTTCACGTTGTAGACAAGGCAGCCATCTTCCAGGCTAGTGTCTTGCATCACGGTC
ACCACGCCTCCATCTTCGTAGGTCGTGACCCGTTCCCAAGTGAATCCCTCAGGGAAGGATTGCTTGAAGA
AGTCCGGGATCCCCTTCGGGTACTTGATAAAAGTGCGCGATCCGTACATGAAGGAGGTAGCCAGGATGTC
GAATGCAAAAGGGAGTGGTCCGCCTTCGACCACCTTAATGCGCATGGTCTGGGTCCCTTCGTAGGGCTTT
CCCTCGCCCTCTGAGGTGCATTTGAAGTGGTGATTGTTGACAGTTCCCTCCATGTACAGTTTCATATGCAT
GTTCTCTTTGATCAATTCCTCCCCTTTTGACACCATGGAGCTCGAATTCGGATCCCGACCCATTTGCTGTCC
ACCAGTCATGCTAGCCATATGTATATCTCCTTCTTAAAGTTAAACAAAATTATTTCTAGAGGGAAACCGTT
GTGGTCTCCCTATAGTGAGTCGTATTAATTTCGCGGGATCGAGATCTCGGGCAGCGTTGGGTCCTGGCCAC
GGGTGCGCATGATCGTGCTCCTGTCGTTGAGGACCCGGCTAGGCTGGCGGGGTTGCCTTACTGGTTAGCA
GAATGAATCACCGATACGCGAGCGAACGTGAAGCGACTGCTGCTGCAAAACGTCTGCGACCTGAGCAAC
AACATGAATGGTCTTCGGTTTCCGTGTTTCGTAAAGTCTGGAAACGCGGAAGTCAGCGCCCTGCACCATT
ATGTTCCGGATCTGCATCGCAGGATGCTGCTGGCTACCCTGTGGAACACCTACATCTGTATTAACGAAGC
GCTGGCATTGACCCTGAGTGATTTTTCTCTGGTCCCGCCGCATCCATACCGCCAGTTGTTTACCCTCACAA
CGTTCCAGTAACCGGGCATGTTCATCATCAGTAACCCGTATCGTGAGCATCCTCTCTCGTTTCATCGGTAT
CATTACCCCCATGAACAGAAATCCCCCTTACACGGAGGCATCAGTGACCAAACAGGAAAAAACCGCCCTT
AACATGGCCCGCTTTATCAGAAGCCAGACATTAACGCTTCTGGAGAAACTCAACGAGCTGGACGCGGATG
AACAGGCAGACATCTGTGAATCGCTTCACGACCACGCTGATGAGCTTTACCGCAGCTGCCTCGCGCGTTT
CGGTGATGACGGTGAAAACCTCTGACACATGCAGCTCCCGGAGACGGTCACAGCTTGTCTGTAAGCGGAT
GCCGGGAGCAGACAAGCCCGTCAGGGCGCGTCAGCGGGTGTTGGCGGGTGTCGGGGCGCAGCCATGACC
CAGTCACGTAGCGATAGCGGAGTGTATACTGGCTTAACTATGCGGCATCAGAGCAGATTGTACTGAGAGT
GCACCATATATGCGGTGTGAAATACCGCACAGATGCGTAAGGAGAAAATACCGCATCAGGCGCTCTTCCG
CTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCG
GTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAA
GGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCAC
AAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCT
GGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCG
GGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCT
GGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCA
ACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATG
TAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTAT
CTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACC
GCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATC
CTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGA
TTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATA
TGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCC
AGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCG
GAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGA
AGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTGCAGGCATCGTGGTGT
CACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCC
ATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTT
ATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGA
CTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTC
AATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGG
CGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGAT
CTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAA
GGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATC
AGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCG
CACATTTCCCCGAAAAGTGCCACCTGAAATTGTAAACGTTAATATTTTGTTAAAATTCGCGTTAAATTTTT
GTTAAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGAC
CGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGGACTCCAACGTC
AAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGG
GGTCGAGGTGCCGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGGGGAA
AGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTGGCAAGT
GTAGCGGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATT
CGCCA 
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pET-23b(+)-eGFP (4373 bp) 
ATCCGGATATAGTTCCTCCTTTCAGCAAAAAACCCCTCAAGACCCGTTTAGAGGCCCCAAGGGGTTATGC
TAGTTATTGCTCAGCGGTGGCAGCAGCCAACTCAGCTTCCTTTCGGGCTTTGTTAGCAGCCGGATCTCAGT
GGTGGTGGTGGTGGTGCTCGAGTGCCGCCGCTTTCTTGTACAGCTCGTCCATGCCGAGAGTGATCCCGGC
GGCGGTCACGAACTCCAGCAGGACCATGTGATCGCGCTTCTCGTTGGGGTCTTTGCTCAGGGCGGACTGG
GTGCTCAGGTAGTGGTTGTCGGGCAGCAGCACGGGGCCGTCGCCGATGGGGGTGTTCTGCTGGTAGTGGT
CGGCGAGCTGCACGCTGCCGTCCTCGATGTTGTGGCGGATCTTGAAGTTCACCTTGATGCCGTTCTTCTGC
TTGTCGGCCATGATATAGACGTTGTGGCTGTTGTAGTTGTACTCCAGCTTGTGCCCCAGGATGTTGCCGTC
CTCCTTGAAGTCGATGCCCTTCAGCTCGATGCGGTTCACCAGGGTGTCGCCCTCGAACTTCACCTCGGCGC
GGGTCTTGTAGTTGCCGTCGTCCTTGAAGAAGATGGTGCGCTCCTGGACGTAGCCTTCGGGCATGGCGGA
CTTGAAGAAGTCGTGCTGCTTCATGTGGTCGGGGTAGCGGCTGAAGCACTGCACGCCGTAGGTCAGGGTG
GTCACGAGGGTGGGCCAGGGCACGGGCAGCTTGCCGGTGGTGCAGATGAACTTCAGGGTCAGCTTGCCG
TAGGTGGCATCGCCCTCGCCCTCGCCGGACACGCTGAACTTGTGGCCGTTTACGTCGCCGTCCAGCTCGAC
CAGGATGGGCACCACCCCGGTGAACAGCTCCTCGCCCTTGCTCACCATGGTGGCGACCGGTGGATCCCGA
CCCATTTGCTGTCCACCAGTCATGCTAGCCATATGTATATCTCCTTCTTAAAGTTAAACAAAATTATTTCTA
GAGGGAAACCGTTGTGGTCTCCCTATAGTGAGTCGTATTAATTTCGCGGGATCGAGATCTCGGGCAGCGT
TGGGTCCTGGCCACGGGTGCGCATGATCGTGCTCCTGTCGTTGAGGACCCGGCTAGGCTGGCGGGGTTGC
CTTACTGGTTAGCAGAATGAATCACCGATACGCGAGCGAACGTGAAGCGACTGCTGCTGCAAAACGTCTG
CGACCTGAGCAACAACATGAATGGTCTTCGGTTTCCGTGTTTCGTAAAGTCTGGAAACGCGGAAGTCAGC
GCCCTGCACCATTATGTTCCGGATCTGCATCGCAGGATGCTGCTGGCTACCCTGTGGAACACCTACATCTG
TATTAACGAAGCGCTGGCATTGACCCTGAGTGATTTTTCTCTGGTCCCGCCGCATCCATACCGCCAGTTGT
TTACCCTCACAACGTTCCAGTAACCGGGCATGTTCATCATCAGTAACCCGTATCGTGAGCATCCTCTCTCG
TTTCATCGGTATCATTACCCCCATGAACAGAAATCCCCCTTACACGGAGGCATCAGTGACCAAACAGGAA
AAAACCGCCCTTAACATGGCCCGCTTTATCAGAAGCCAGACATTAACGCTTCTGGAGAAACTCAACGAGC
TGGACGCGGATGAACAGGCAGACATCTGTGAATCGCTTCACGACCACGCTGATGAGCTTTACCGCAGCTG
CCTCGCGCGTTTCGGTGATGACGGTGAAAACCTCTGACACATGCAGCTCCCGGAGACGGTCACAGCTTGT
CTGTAAGCGGATGCCGGGAGCAGACAAGCCCGTCAGGGCGCGTCAGCGGGTGTTGGCGGGTGTCGGGGC
GCAGCCATGACCCAGTCACGTAGCGATAGCGGAGTGTATACTGGCTTAACTATGCGGCATCAGAGCAGAT
TGTACTGAGAGTGCACCATATATGCGGTGTGAAATACCGCACAGATGCGTAAGGAGAAAATACCGCATC
AGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGC
TCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAA
AGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCT
GACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAG
GCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGC
CTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCG
TTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTAT
CGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCA
GAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGGA
CAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGC
AAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGAT
CTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGAT
TTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAA
TCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGC
GATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCT
TACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAAT
AAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATT
AATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTGC
AGGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAG
TTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAG
TTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAG
ATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCT
CTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAA
ACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTCGTG
CACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAA
TGCCGCAAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTAT
TGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAA
TAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTGAAATTGTAAACGTTAATATTTTGTTAAAATTC
GCGTTAAATTTTTGTTAAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGT
GGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCATCACCCTA
ATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGA
GCTTGACGGGGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAG
GGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCGCCGCTACAG
GGCGCGTCCCATTCGCCA 
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A549    human lung carcinoma A549 cells 
ACF    Autocorrelation function 
AGO2    Argonaute 2 protein 
ATTO488-dsDNA  ATTO488-labelled dsDNA 
AzMMMan   3-(azidomethyl)-4-methyl-2,5-furandione 
CayRFP   Cayenne Red Fluorescent Protein 
CFP    Cyan Fluorescent Protein 
Cy3-dsDNA   Cy3-labelled dsDNA 
Dicer    endoribonuclease Dicer 
DLinKC2-DMA   2,2-dilinoleyl-4-(2-dimethylaminoethyl)-[1,3]-dioxolane 
DOPC    1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine 
DOPE    1,2-dioleoyl-sn-glycero-3-phos-phoethanolamine 
DOTAP   1,2-dioleoyl-3-trimethylammonium-propane 
dsDNA    double-stranded DNA 
dsRNA    double-stranded RNA 
DSPE-PEG(2000) 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-
[methoxy(polyethylene glycol)-2000] 
DSPE-PEG(2000)-FolA 1,2-distearoyl-sn- glycero-3-phosphoethanolamine-N-
[folate(polyethylene glycol)- 2000] 
Drosha    Drosha ribonuclease III 
eGFP enhanced Green Fluorescent Protein 
eGFPLuc eGFP-Lucifersae fusion protein 
FBS    Fetal Bovine Serum 
FC    Flow Cytometry 
FCS    Fluorescence Correlation Spectroscopy 
FolA    Folate, folic acid 
FolA-mNALP Folate-functionalized monomolecular Nucleic Acid/Lipid Particle 
GalNAc    N-Acetylgalactosamine 
HBV    Hepatitis B Virus 
Huh-7    human hepatocellular carcinoma Huh-7 cells 
KB/WT    wild-type human cervix carcinoma KB cells 
KB/eGFPLuc   KB cells stably expressing eGFPLuc fusion protein 
LISCA    Life-cell Imaging on Singe-Cell Arrays 
LNP    Lipid Nanoparticle 
NA    Nucleic Acid 
NF-κB    Nuclear Factor-κB 
NP    Nanoparticle 
miRNA    microRNA 
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mNALP   monomolecular Nucleic Acid/Lipid Particle 
mRNA    messenger RNA 
mRNAG   eGFP-encoding mRNA 
mRNAR   CayRFP-encoding mRNA 
ODE    Ordinary Differential Equation 
PBS    Phosphate Buffered Saline 
PCR    Polymerase Chain Reaction 
PDMS    Polydimethylsiloxane 
PEI    Polyethylenimine 
pDNA    plasmid DNA 
pDNAG    eGFP-encoding pDNA (pEGFP-N1) 
pDNAR    CayRFP-encoding pDNA (fpb-55-609_CayenneRFP) 
PEG    Polyethylene glycol 
Pre-miRNA   precursor microRNA 
Pri-miRNA   primary microRNA 
RISC    RNA-induced silencing complex 
RNAi    RNA interference 
ROI    Region Of Interest 
rRNA    ribosomal RNA 
SEM    Scanning Electron Microscope 
shRNA    short hairpin RNA 
siGFP    GFP-targeting siRNA 
siCrtl    siRNA of randomized sequence 
siRNA    small interfering RNA 
SNALP    Stable Nucleic Acid/Lipid Particle 
tRNA    transfer RNA 
YFP    Yellow Fluorescent Protein 
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